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ABSTRACT 
Medication errors are a significant global concern and can cause serious medical 
consequences in children. Double checking of medicines by two nurses is one 
strategy used by many children's hospitals to prevent errors from reaching 
paediatric patients. This thesis involves different studies that evaluated the 
effectiveness of the double checking process in reducing and preventing medication 
administration errors in a children's hospital. In addition, a systematic review was 
conducted of medication errors studies in the Middle East. 
A systematic review was also conducted of published studies of double checking. 
Six electronic databases were searched for articles that assessed the double 
checking process during the administration of medicines. Sixteen articles were 
identified. Only one of them was a randomised controlled clinical trial in a clinical 
setting. Only one study was conducted in a children's hospital. The review found 
that there is insufficient evidence to either support or refute the practice of double 
checking and more clinical trials are needed to evaluate the double checking 
process in children's hospitals. 
Based on the findings that were highlighted from the systematic review, a 
prospective observational study of paediatric nurses using the double checking 
process for medication administration was undertaken. The study aimed to evaluate 
how closely double checking policies are followed by nurses in different paediatric 
areas, and also to identify any. medication administration errors during the study 
period. 2,000 drug dose administration events were observed. There was variation 
between paediatric nurses adherence to double checking steps and different 
medication administration errors were identified. 
I 
Based on the observational study, a semi-structured questionnaire study was 
developed. It was designed to explore the paediatric nurses' knowledge and 
opinions about the double checking process. The study showed that many nurses 
have insufficient knowledge on the double checking process and the hospital policy 
for medication administration. 
A simulation study was conducted to examine whether single or double checking is 
more effective in detecting and reducing medication errors in children. Each 
participant in this study was required to prepare and administer medicines in 
scenarios for two "dummy patients" either with another nurse (double checking) or 
alone (single checking). Different confounders were built into each scenario 
(prescribing and administration) for nurses to identify and address during the 
administration process. Errors in drug preparation, administration and failure to 
address confounders were observed and documented. The main findings from this 
study were that the double checking process is more likely to identify medication 
administration errors and contraindicated drugs than single checking. The time 
taken for drug administration was similar for both processes. 
Another systematic review was conducted to identify the published medication 
errors studies that have been undertaken in the Middle East. The review identified 
45 studies from 10 Middle Eastern countries. Nine of the studies focused on 
medication errors in paediatric patients. Educational programmes on drug therapy 
for doctors and nurses are urgently needed in the Middle East. 
These studies have contributed to the field of medication safety by providing more 
information about double and single checking medication administration processes 
in paediatric hospitals. More educational and training programmes for nurses about 
the importance of double checking and improving their adherence rate to the double 
II 
checking steps during medication administration are required to improve it's 
effectiveness. 
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CHAPTER ONE 
GENERAL INTRODUCTION AND OVERVIEW 
1 
1. INTRODUCTION 
1.1 General Background 
A safe environment is a high priority in health care systems. Safety culture has been 
defined as "the product of individual and group values, attitudes, perceptions and 
patterns of behaviour that determine a group or organisation's commitment to safety 
management in general or particularly in certain processes" (INSAG, 1991). 
The phrase 'medical errors' is a broad term used to describe all errors that happen 
within the healthcare system, including Medication Errors (MEs), mistakes in 
surgery, or technical failures. MEs have ranked as the most common type of 
medical error that occurs in health care organisations (Kohn et aL, 2000). In the last 
decade, the awareness of and attention about MEs has increased. 
MEs are a universal and global concern in all health care systems and can occur in 
any country. Different classifications for MEs in different studies are used (Kaushal 
et ai, 2001a; Ferner & Aronson, 2006), and there are different 'definitions and 
different methods that can be used to detect errors. One of these classifications 
depends on a psychological approach which categorizes errors as mistakes (which 
are errors in the planning of an action), slips (which are action-based errors) or 
lapses (memory-based errors) (Leape et aL, 1995). MEs are also classified 
according to where they happen in the medication process which includes drug 
prescribing or ordering, transcription, dispensing, administration, monitoring and 
documentation (Leape et aL, 1995). These differences in the classifications of MEs 
are reflected in the studies' results. 
MEs have a range of definitions according to different studies (Ghaleb et aL, 2006). 
The variation in these definitions and in the methods that are used to detect errors 
make comparisons between these studies results difficult. Cimino and his 
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colleagues defined MEs as "any error either large or small at any point in the 
medication system from the time the drug is ordered until the patient received it" 
(Cimino et aL, 2004). Another definition used has been "any error in the medication 
process, including ordering, dispensing, transcribing, administering and monitoring, 
even if the error was intercepted and corrected prior to reaching the patient" 
(Gandhi et aL, 2005). Moreover, MEs have also been defined as "a dose 
administered to the patient that deviates from the physician's orders, such as an 
omission, wrong dosage or unauthorized drug". For example, when one patient was 
given a dose intended for another patient (Barker et aI., 1982). On the other hand, 
Kaushal and colleagues defined MEs as an error in drug ordering, transcribing, 
dispensing, administering, or monitoring (Kaushal et aL, 2001 b), and differentiate 
between errors which are preventable and not preventable. 
The definition which is accepted by the United Kingdom (UK) Department of Health 
and the United State National Co-ordinating Council for ME Reporting and 
Prevention (NCCMERP) is "any preventable event that may cause or lead to 
inappropriate medication use or patient harm, while the medication is in the control 
of the health care professional, patient, or consumer. Such events may be related to 
professional practice, healthcare products, order communication, product labelling, 
packaging and nomenclature, compounding, dispensing, distribution, administration, 
education, monitoring, and use" (DoH, 2004). One study has argued that this 
definition is inadequate because it includes any preventable adverse events that 
cause harm or lead to harmful effects for the patients. The study suggests that 
events are preventable both when they result from error and when they are a 
consequence of the careful and rational decision to use a drug that causes 
unavoidable harm (Ferner and Aronson, 2006). 
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Moreover, Ferner and Aronson (2006) have proposed the following definition for 
MEs which is "A medication error is a failure in the treatment process that leads to, 
or has the potential to lead to harm to the patient". They use the word '1ailure" to 
signify that the process has fallen below standard, and they include all the 
medication treatment process stages. Their definition however, does not make the 
required treatment process standard explicit. Also, it does not indicate who may 
make the error. 
1.2 Medication errors in adults 
MEs are the most common error that can happen in hospitals and the most common 
single preventable cause of adverse events (10M, 2001). The Institute of Medicines 
(10M) estimated that between 44,000 to 98,000 hospitalised patients die every year 
as a result of medical errors in the US (10M, 2001). Approximately 7000 deaths 
occur annually across the patient population due to MEs in the US (Kohn et aI., 
2000). Another study reported that 1 - 2% of the patients admitted to the hospitals 
in the US suffer from MEs that result in harm, and 12% of the Adverse Drug Events 
(ADEs) were life - threatening (Bates et aI., 1995). There is also evidence that the 
death rate from MEs is increasing. Phillips and his colleagues invest!gated fatal MEs 
by examining US death certificates for a ten year period (1983 • 1993) (Phillips et aI., 
1998). They reported that the inpatient deaths which occurred due to MEs showed a 
2.3 fold increase for that time period (Phillips et aI., 1998). Leape et al (1995) 
conducted a prospective cohort study of MEs in 11 medical and surgical units in two 
tertiary care hospitals. They found that 39% of errors occurred during the 
prescribing stage and nearly half of those errors. were detected by nurses or 
pharmacists prior to them reaching the patient. They also reported that 38% of the 
errors occurred in the administration stage of the medication process but only 2% of 
those errors were intercepted before reaching the patient (Leape et aI., 1995). 
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The incidence of MEs in the UK is likely to be similar. In British hospitals 1 in 250 
prescriptions had a serious error (DoH, 2004). Approximately, 9% of hospital 
inpatients may suffer severe harm from MEs (NPSA, 2007a). Another study 
reported a 500% increase in drug errors over the last decade, leading to 1200 
deaths in England and Wales in 2001 (Scott, 2002). A study involving screening of 
36,200 medication orders by 25 ward pharmacists identified that 1.5% of orders 
contained errors, and most of those errors (54%) were in the drug dose, and were 
serious in 0.4% of cases (Dean et aI., 2002). 
1.3 Paediatric medication errors 
Most of the MEs studies have been performed on adults. Relatively, few studies of 
MEs have been conducted in children. Several studies have confirmed that MEs are 
a significant problem and occur more frequently in children (Lesar et ai, 1990; 
Kaushal et ai, 2001 a; Cousins et ai, 2002; Ghaleb et aI., 2006). They are more 
common in the paediatric and neonatal population for several reasons: 
• Drug doses must be calculated for each individual child's weight or body 
surface area involving sometimes complex calculations. 
• Most commercially available drugs purchased by the pharmacy are adult 
designed standard dosage forms which need re-calculation or manipulation 
for administration to the child patient. 
• The pharmacokinetics of many drugs vary with age, and this affects dosage, 
meaning that doses need to be adjusted with age (gestational and postnatal) 
as well as weight and surface area. 
• Most of the drugs used in paediatrics are off label and/or unlicensed and this 
may lead to MEs (Conroy et ai, 2000; Conroy, 2011). 
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• Because many formulations used are adult designed, the amount of the drug 
in vials that are used to administer medicines to neonates potentially allows 
10 fold or even 100 fold errors) (Chappell & Newman, 2004) .. 
These factors make the paediatric patients more susceptible to adverse drug events, 
which may be three times higher than in adult patients (Kaushal et aI., 2001 a). 
There is a difference between medication use and types of errors in children 
compared to adults such as dosing calculation based on the body weight, and so 
the strategies used to prevent errors in children should also be different. 
The UK Department of Health has recognised that children are a challenging group 
of patients for safe medication practice (DoH, 2004). The safety of paediatriC 
medication use is also an important issue in international organizations. The World 
Health Organization (WHO), UNICEF, European Society for Developmental 
Perinatal and Paediatric Pharmacology (ESDPPP), as well as other organizations, 
have all highlighted that children's medicines are a global problem. The WHO have 
launched a campaign to "make medicines child size" (Choonara, 2009). This 
campaign aims to raise awareness and to accelerate action in order to address the 
need for improved availability and access to safe child-specific medicines for all 
children (WHO, 2007). 
1.4 Incidence of paediatric medication errors 
A number of studies have been published during the last 10 years reporting the 
incidence rate of paediatric MEs in hospitals (Wilson et aI., 1998; Ross et aI., 2000; 
Kaushal et aI., 2001 a; Cousins et aI., 2002; Wong et aI., 2004; Ghaleb et aI., 2006; 
Miller et aI., 2007; Wong et ai, 2009; Ghaleb et aI., 2010). Different incidence rates 
are reported among these studies (0.15% to 27%) and comparison is difficult 
because each study used different denominators. 
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The variation in MEs rates between studies may be due to the differences in the 
definitions of MEs used, in the methods used to collect data and in the area of study. 
MEs in the prescribing stage occur in children more frequently than in adults: 5.89 
per 1,000 orders and 4.12 per 1,000 orders, respectively (Lesar et aI., 1997). 
An eight year review of MEs in children in the UK using press reports identified at 
least 29 deaths associated with MEs (Cousins et aI., 2002). A systematic review 
estimated that 5 - 27% prescriptions for children contain an error somewhere in the 
process, in the prescribing 3 - 37%, dispensing 5 - 58%, administration 72 - 75% 
and in the documentation stages 17 - 21% (Miller et aI., 2007). A prospective study 
in five hospitals in the UK found the MEs incidence rate in the prescribing stage to 
be 13.2% of medication orders and in the administration stage was 19.1 % of drug 
administrations (Ghaleb et aI., 2010). 
One estimated suggested that at least 1675 avoidable MEs may happen every year 
in paediatric inpatients of which 85 errors were likely to be moderate/severe 
(Stephenson, 2000). 
Patients in a Neonatal Intensive Care Unit (NICU) may be at higher risk for 10 fold 
dosing errors due to the dosing calculations needed in prescribing and in drug 
preparation (Chappell and Newman, 2004; Stavroudis et ai, 2008). Raju and 
colleagues in 1989 reported a ME rate of 14.7% of all admissions to a Paediatric 
Intensive Care Unit (PICU) and NICU over 4 year period. Vincer et al (1989) 
reported another incidence rate of MEs of 1 ~ . 4 4 per 1000 patient days over 2 years 
in NICU (Vincer et aI., 1989). Due to the different denominators used it is impossible 
to compare these error rates. 
A systematic review reported that antibiotics and sedative drugs were the most 
frequent drug classes associated with errors in children (Ghaleb et aI., 2006). In 
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addition, Holdsworth et al (2003) reported that most of the adverse drug events in a 
general paediatric unit and PICU were related to opiates and antibiotic drugs. 
MEs in children are also classified according to where they occur during the 
medication treatment process, i.e. prescribing, transcribing, dispensing, 
administration, monitoring and documentation (Leape et ai, 1995). 
1.4.1 Prescribing errors 
Different studies have used different definitions of prescribing errors (Dean et aI., 
2000; Condern et aI., 2009; Aronson, 2009; Ghaleb et aI., 2010). Prescribing errors 
include the incorrect choice of medication, wrong dose, wrong strength, wrong 
frequency, incorrect route of administration, inadequate instruction for use of a 
medication and wrong formulation. As already highlighted most paediatric drug 
doses 'are calculated individually according to the patient's weight, age, body 
surface area and the clinical condition of the patient. These differing parameters 
enhance the opportunities of prescribing errors and particularly dosing errors (Kozer 
et aI., 2002). Ten-fold dosing errors occur due to calculation mistakes, 
misplacement of the decimal point, omission of a zero prior to the decimal pOint, the 
use of the trailing zeroes and use of incorrect units (Fortescue et aI., 2003). 
Several studies have found that dosing errors are one of the most frequent type of 
paediatric prescribing errors (Wong et aI., 2004; Condern et aI., 2009; Ghaleb et aI., 
2010). 
As dosing error is the commonest type of paediatric prescribing error, interventions 
are needed to reduce such errors. Wong and colleagues in their Co-operative of 
Safety of Medicines in Children (COSMIC) report identified and analysed the 
interventions that have been implemented to reduce dosing errors in children. Key 
interventions included: electronic prescribing, guidelineS/formularies, double 
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checking, intelligent infusion pumps and Centralised Intravenous Additive Services 
(CIAS) (Wong et ai, 2007). 
As yet no specific tool has been validated that can be used to assess paediatric 
prescribers in order to identify weak prescribing (Sammons & Conroy, 2008). 
1.4.2 Dispensing errors 
Most drug formulations are designed to be used in adults because most clinical 
trials have been conducted on adults (Conroy et aI., 2000). The pharmaceutical 
services in most hospitals contribute to the safe and efficient use of medication and 
have an essential role in preventing errors. Studies have however found an 
incidence of dispensing errors of about 10% even in hospitals with advanced 
medication dispensing systems, such as Unit dose system (Allan & Barker, 1990; 
Hughes & Edgerton, 2005). Different definitions have been used to identify 
dispensing errors but the most common definition used in hospital and community 
pharmacies is an error detected and reported after the medication has left the 
pharmacy. The UK NPSA reported that around 900 million medicines every year are 
dispensed through community and hospital pharmacies in England and Wales 
(NPSA, 2007a). Also this report estimated that over 134,000 dispensing errors are 
detected in community pharmacies, most of these errors (85%) are detected by 
pharmacists before the drug is supplied to the patient (NPSA, 2007b). 
Dispensing errors involve dispensing the wrong drug, the wrong dose or providing 
an incorrect label, out of date medicines and wrong strength. look Alike and Sound 
Alike (LASA) drug names have been estimated to cause 33% of errors in dispensing 
according to the UK dispensing error analysis scheme, for example, LasiX® is 
(Frusemide) but loseC® is (Omeprazole) (NPSA, 2007b). A previous systematic 
review reported that the dispensing error rate in children ranged from 5% to 58% of 
all errors (Miller et ai, 2007). Preventing a ME from reaching the patient decreased 
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in the later stages of the medication treatment process (Antonow et aI., 2000; 
Stratton et aI., 2004). Antonow and colleagues (2000) estimated the extent of ME 
underreporting by comparing a nurse questionnaire survey results with hospital 
incident reports for the previous 6 months. 177 errors had been observed and 
identified by paediatric nurses. 76% of these errors had been detected at the 
prescribing stage, 70% at the transcription stage, 61% at the dispensing stage 
(which involved wrong medications, wrong dose and known allergy). Only 40% of 
the MEs were identified at the administration stage and prevented from reaching the 
patients. In contrast, only 51 incident reports were written within the 6 month period. 
Of these only 30% had a fully completed incident report. 5 (10%) of the incident 
reports were related to the dispensing stage (Anton ow et aI., 2000). 
The NPSA found that more than half (59.3%) of reported MEs in primary care 
happened during the dispensing of medicines (NPSA, 2007b). It has been 
suggested that dispensing errors may be reduced by putting double checking 
measures in place (Mahajan et ai, 2009). 
1.4.3 Administration errors 
One of the last steps in the medication treatment process is the administration of 
medicines which is usually performed by nurses when patients are in hospital. 
During drug preparation the nurse should follow the five rights as a part of everyday 
nursing routine: the right patient, the right drug, the right time, the right dose and the 
right route of administration. 
Administration errors have different definitions in practice (Barker et aI., 2002; Prot 
et aI., 2005; Ghaleb et aI., 2010). Ghaleb and colleagues defined Medication 
Administration Errors (MAEs) as the administration of a dose of medication that 
deviates from the prescription, as written on the patient medication chart, or from 
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standard hospital policy and procedures. This also includes errors in the preparation, 
and administration of intravenous medicines on the ward. 
MAEs include errors of incorrect preparation of medicines, omission errors, drugs 
given to the wrong patient, incorrect dose calculation, wrong route of administration, 
wrong rate and wrong administration time. 
Two studies reported that errors in the administration stage are more frequent than 
in prescribing (Miller et aL, 2007; Ghaleb et aL·, 2010). Miller et al (2007) reported 
that 5 - 27% of prescriptions for children have an error somewhere in the 
medication treatment process. 72 - 75% of these occur during drug administration 
compared to 3 -37% in prescribing (Miller et aL, 2007). Errors have also been found 
in 19.1 % episodes of drug administration compared to 13.2% in prescribing (Ghaleb 
et aL, 2010). 
1.5 Causes of medication errors 
An understanding of the causes of MEs is important for all healthcare professionals. 
1.5.1 Off-label and unlicensed medication use 
Lack of evidence from clinical trials and a lack of clinical trials in children have led to 
the use of medicines which are not licensed or more commonly are used outside the 
terms of their product license (off label) (Turner et aL, 1998). Both are more 
common in children than in adults and this may increase the chance of MEs 
occurring in children (Conroy, 2011). 
Conroy et al (2000) conducted a survey of unlicensed and off label drug use in 
paediatric wards in five European countries to examine the extent of their use, and 
found that 46% of all paediatric prescriptions were off label or unlicensed, and 67% 
of 624 paediatric patients received unlicensed or off label drugs. They concluded 
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that off label and unlicensed prescribing of drugs in paediatrics is a European 
problem. 
Mcintyre et al (2000) conducted a general practice study and also found that a 
significant number of prescribed medications for children were off label (Mcintyre et 
aI., 2000). Unlicensed prescribing was less of a problem in this setting. 
Conroy (2011) explored the relationship between the MEs reported in a hospital and 
use of off label and unlicensed drugs. Unlicensed drugs were more likely to be 
associated with reported errors compared to licensed drugs in both paediatric wards 
(OR 2.24, 95% CI 1.31 to 3.87), p = 0.0001, and neonates (OR 5.81, 95% CI 2.32 to 
14.55), p = 0.0001 (Conroy, 2011). 
1.5.2 Drug dosage calculation and guidelines 
Doses vary in children and are calculated according to age, weight, body surface 
area, organ system maturity and clinical condition (AAP, 2003). As noted earlier, 
drug dosage errors were the most frequent errors reported in the local and national 
media in the UK (Cousins et ai, 2002). Some studies have suggested that 
healthcare professionals have inadequacies in mathematical dose calculation 
(Glover and Sussmane, 2002, Rowe et aI., 1998). Wong et al (2004) found that drug 
dosage calculation errors were a significant problem in all ages of paediatric 
patients. In England, the incidence of dosing errors in paediatrics is estimated to be 
around 500,000 every year (Wong et aI., 2004). In addition, dosing e r r ~ r s s occur with 
neonatal patients in the NICU and incorrect doses have been found in 13.7% of 
reports (Raju et aI., 1989). 
1.5.3 Poor communication 
Poor communication is one of the most common causes for MEs (Stebbing et aI., 
2007, Wilson et al., 1998). In a study in primary care, doctors discovered that 50% 
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of adverse events resulted from communication difficulties (Bhasale et aI., 1998). 
Poor communication may result from poor handwriting, incorrect abbreviations, 
unclear drug labeling, and confusion between drug names. Communication skills in 
medical practice between care providers and their patients or parents are therefore 
important because they affect healthcare outcomes, especially when the patient is a 
child. 
1.5.4 Unfamiliarity with paediatric treatment 
Unfamiliarity of health care providers with paediatric patients and their medications 
may lead to MEs in their treatment. Also, inadequacy in education or lack of training 
for paediatricians and other healthcare professionals increase the chance of errors 
in the medication they are prescribing, dispensing or administering to paediatric 
patients (Folli et aI., 1987). Studies have found that poor practical experience of 
health care providers in paediatric hospitals or areas may contribute to recurrent 
MEs (Folli et aI., 1987, Wilson et aI., 1998). In addition, the problems may increase 
when new doctors or junior doctors make the transition from general medical 
practice to paediatrics (Wilson et aI., 1998). 
1.6 Interventions that may reduce paediatric medication errors 
Different interventions have been suggested by different studies to reduce or 
prevent MEs and to improve patient safety. 
1.6.1 Computerized Physician Order Entry (CPOE) Systems 
Computerised Physician Order Entry (epOE) systems play an important role in 
reducing prescribing errors by allowing physician orders to be entered into the 
computer rather than on paper. This system can be linked to drug - drug interaction 
warnings and decision support systems. Some studies evaluated the CPOE in 
general hospitals and suggest that after electronic prescribing is applied with a 
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CPOE system the prescribing quality in hospital inpatients significantly increases 
(Shulman et aL, 2005, Colpaert et aL, 2006, Donyai et aL, 2008). Vaidya and 
colleagues (2006) in their crossover study compared a handwritten group with a 
CPOE system in a PICU for ordering continuous IV drug infusions. They found a 
significant reduction in the prescribing error rate from 73% in the handwritten group 
compared to 4.3% in the CPOE system group (Vaidya et aI., 2006). 
In paediatric intensive care units that implemented CPOE the prescribing errors 
reduced by 99% (Potts et aL, 2004). Another study by King et al. (2003) found that 
CPOE systems implemented in the paediatric settings produced a significant 
beneficial effect on ME rates but not on the number of ADEs. 
In a recent systematic review, the authors conclude that there is some evidence of 
the effectiveness of CPOE to reduce prescribing errors in adult hospitals but the 
evidence base was limited by the modest study sample sizes and designs 
(Reckmann et aI., 2009). 
Despite CPOE systems being useful and effective in reducing MEs, some studies 
have reported new errors being introduced. These errors included the selection of 
an inappropriate formulation for a specific route, selection of an inappropriate item 
(Mahoney et aI., 2007), and inappropriate use or selection of default doses (Donyai 
et aL, 2008). 
1.6.2 Clinical pharmacists' services 
Pharmacists, clinical pharmacists and clinical pharmacologists play an important 
role in reducing MEs. After a clinical pharmacist was involved in a medical team 
round of the patients in the ICU, it was reported that more than 66% of errors were 
reduced relating to ordering errors or prescribing errors (Leape et aI., 1999), and 
that reviewing medication charts by pharmacists is very important to detect MEs. 
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While Kaushal et al (2008) found that the unit-based clinical pharmacists in the 
PICU found that 79% decrease in the rate of serious MEs in the PICU (Kaushal et 
al.,2008). 
In general, all reviewed studies have shown that pharmacists can reduce serious 
preventable MEs (Koren et aI., 1991; Fortescue et aI., 2003, Sanghera et aI., 2006, 
Conroy et aI., 2007b). Fortescue and colleagues (2003) reported that physician 
residents estimated that 81% of errors could be avoided by ward - based clinical 
pharmacists monitoring. Improving the communication between physicians, nurses 
and pharmacists e.g. by increasing nursing involvement in physician clinical ward 
rounds could avoid 86% of potentially harmful MEs that may occur (Fortescue et aI., 
2003). 
1.6.3 Use of bar-coding systems 
Bar coding replaces manual documentation with electronic scanning of unique 
identifier codes that are transmitted to a database. Bar-coding technology has been 
used previously in markets outside of health care, mainly in supermarkets and 
shopping centres (Simpson, 2001). In the health care system bar-coding technology 
has been used to prevent MAEs by verifying that the patient has received the right 
drug in the right dose via the right route at the right time. Bar-coding technology has 
also been used in hospital pharmacies to prevent dispensing errors during the 
dispensing process (Poon et aI., 2006). This study found that bar-code technology 
in a hospital pharmacy reduced the rate of dispensing errors from 0.37% to 0.06% 
including wrong formulations, wrong dose and wrong medication. 
1.6.4 Double checking process 
Double checking or checklists have been employed in the nuclear industries and 
aviation safety to reduce errors or human mistakes and to improve safety (Toft & 
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Mascie - Taylor, 2005). In aviation statistics, 2 errors happen per flight, and 60 -
80% of flight accidents involve human mistakes (Foushee, 1984). 
Double checking is one of the strategies that have been used in both medical and 
non-medical areas to reduce the risk of errors (Hales & Pronovost, 2006). In 
aviation, double checking or checklists have become a mandatory part of practice, 
to reduce human error. They significantly decrease the risk of errors and improve 
the outcomes in aviation safety (Hales & Pronovost, 2006). In healthcare systems, 
blood transfusion, anaesthesia and radiotherapy have all implemented the checklist 
or double checking concept to improve patient safety (Duggan et ai, 1997; Toft & 
Mascie-Taylor, 2005). 
Double checking of medications has been recommended as an intervention to 
reduce MEs (Grissinger, 2003; Merry & Webster, 2008; Conroy et aI., 2012) and 
has become standard practice in many children's hospitals and paediatric units in 
the UK (Conroy et aI., 2012). Many hospital policies in the UK require that the 
majority of children's medicines administration must be double checked (Conroy et 
ai, 2012). Double checking is defined as a procedure that requires two qualified 
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health professionals, usually nurses, to independently check the medication before 
administration to patients (Conroy et aI., 2012). Grissinger in recommending double 
checking suggests that this process should be implemented in situations involving 
high risk medications, complex administration processes and/or high risk patients 
such as children (Grissinger, 2003). This thesis will focus mainly on the evaluation 
of the double checking process performed by paediatric nurses in a children's 
hospital. 
Double checking depends on the effort of individual nurses, their knowledge, power 
of observation and ability to apply this strategy in practice. Some authors suggest 
that double checking should be applied only in certain situations, in high risk 
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patients (neonates, infants), or with high risk medications (chemotherapy, opiates, 
intravenous route), or in a complicated dose calculation process (Grissinger, 2003). 
1.7 The aims of the thesis 
Despite the fact that little research is available about the effectiveness of the double 
checking process in reducing MEs compared to other interventions in paediatric 
settings, the double checking process is widely used in hospitals and supported by 
healthcare professionals (Conroy et aI., 2012). Jarman et al (2002) suggested that 
single checking in adult inpatient units was as safe as double checking. However, 
MEs still occur in practice. 
I initially decided to perform a systematic review of the literature in order to establish 
what evidence was available to support the use of double checking of medicines 
(Chapter two). 
Based on the findings that were highlighted from my systematic review, which was 
that "there is insufficient evidence to either support or refute the practice of double 
checking the administration of medicines", I decided to do more studies and 
research to evaluate the double checking of the administration of medicines and its 
effectiveness in reducing MEs in practice in a children's hospital. 
Chapter three is a prospective observational study of the double checking process 
during medication administration and drug round times in a children's hospital. The 
study evaluated all the double checking process steps in different wards and with 
different paediatric nurses. Also, the study was performed to identify the MAEs that 
occurred during the study period despite double checking. The MAEs rate was 
reported a ~ d d all types of errors were documented in detail. 
Chapter four, a questionnaire (survey) study was conducted to assess the 
paediatric nurses' perceptions about the double checking process and also to 
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evaluate their opinions about its effectiveness in reducing MAEs. The survey is 
based on the observational study results (chapter 3) 
Chapter five A simulation study was used to compare paediatric nurses' drug 
administration with single checking against administration with the double checking 
process. This study was performed to measure the error rate and time of medication 
administration with each process. 
Chapter six provides a description of MEs in Middle Eastern countries using a 
systematic review of all MEs published in studies within the region. I did this 
systematic literature review because I am originally from this area and my future 
aims are to improve the use of medicines, both in Saudi Arabia and also in 
neighbouring Arab countries. This systematic review also describes all medication 
treatment stages, rates of incidence and suggests recommendations for future 
studies. This systematic review was conducted to determine what research on MEs 
has been done and is still required in that region in the future. 
Chapter Seven contains the conclusions of the thesis. 
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CHAPTER TWO 
DOUBLE CHECKING THE ADMINISTRATION OF MEDICINES: 
A SYSTEMATIC REVIEW 
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2.1 INTRODUCTION 
Patient and medication safety is a priority for the government, researchers and 
providers in the healthcare system (DoH, 2004). Reduction of MEs leads to an 
improvement in healthcare systems and positively affects patient safety (Lehmann & 
Kim, 2005). A number of strategies have been introduced to try to reduce errors. 
Computerized Physician Order Entry in prescribing is one such strategy to prevent 
MEs in the prescribing stage and can reduce serious prescribing error by 55% 
(Bates et ai, 1999). Bar-Coding technology, which is widely used in marketing 
outside the healthcare system, can prevent errors in dispensing or the 
administration of medicines (Poon et aI., 2006). Double checking is also used to 
prevent MEs in the whole medication treatment process including prescribing, 
dispensing, administration and documentation. Double checking is a strategy that 
has been used in both medical and non-medical areas (Hales, 2006). 
2.1.1 Double checking process 
Although, MEs are a significant problem in the medication treatment process, the 
administration of medicines is the process where the greatest numbers of MEs are 
identified (Kaushal et ai, 2001a; Miller et aI., 2007; Ghaleb et aI., 2010). 
Not all double checking methods are equally effective in preventing or minimising 
errors because double checking processes vary in definition among different 
organisations with different reliability levels (Table 2.1). 
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Table 2.1: Types of double checking and reliability levels (adapted from ISMP, 
2006). 
Type of double check Reliability Level 
(A) One person double checking Poor reliability because one person can 
themselves easily make the same mistake twice 
(8) Second person looking to verify the Slightly more reliable because it involves 
result a second person 
(C) Second person repeating a More reliable than A & B because the 
calculation after watching the first person performing the double check is 
person perform the calculation actually performing the calculation; 
however, observing the first person 
doing the same calculation makes it 
easy to duplicate an error. 
(D) Second person doing a calculation Called an Independent Double Check 
without having seen the first person's and is the most reliable method because 
calculation it eliminates the possibility of one 
practitioner biasing another. 
Independent double checking is thought to be the most reliable method of double 
checking. It is defined as a procedure that requires two qualified health 
professionals, usually nurses, independently checking the medication before 
administration to the patients. The word 'independent' means a second person 
follows a series of steps to arrive at a calculation result without prior knowledge of 
any previous calculation (ISMP, 2006). This approach is thought to reduce the 
possibility of bias which occurs when the person checking the medication is likely to 
see what they expect to see even if an error has occurred (U, 2003). It is, however, 
the most labour intensive method in that each health professional needs time to 
perform the calculations. 
This systematic review was performed to determine the existing evidence base on 
the effectiveness of the double checking process in reducing ME rates in dose 
calculation, dispensing and in administration. 
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2.2 METHODS 
2.2.1 Identification of relevant literature 
A search for articles describing double checking for medication in dose calculation, 
dispensing and administration in both children and adults was conducted in October 
2010. Also included were any studies reporting a double checking process for 
devices that were used in the patient medication administration process. In this 
search six databases were used: EMBASE (1980 to October 2010), MEDLINE 
(1950 to October 2010), BRITISH NURSING INDEX & ARCHIVE (1985 to October 
2010), CUMULATIVE INDEX to NURSING & ALLIED HEALTH LITERATURE 
(CINAHL) (1982 to October 2010), NATIONAL ELECTRONIC LIBRARY FOR 
MEDICINES (NeLM) (1998 to October 2010) and PsyciNFO (1806 to October 2010). 
These databases were used to ensure that all articles were included in this search. 
The search strategy included adults and children because evidence identified from 
studies in adults may be applicable to children. The search strategy included all 
languages and types of trials and studies. 
2.2.2 Search Terms 
In this search the keyword 'double check' was used in combination with AND for the 
terms 'drug safety', OR 'nurse', OR 'pharmacist' OR 'pharmacy technician', OR 
'drug administration', OR 'medication administration', in order to include all articles 
that had been published in the databases listed above. The term 'double check' 
was used as it is the term used by healthcare professionals and in most hospital 
policies .. 
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2.2.3 Inclusion I Exclusion Criteria 
All abstracts were evaluated and assessed according to the following inclusion 
criteria. Inclusion criteria were papers assessing or discussing double checking for 
medication drug dose calculation, dispensing or administration in hospitalised 
patients. This included patient identity, prescribing, dispensing and administration 
of medication. This search included quantitative and qualitative studies to obtain a 
full picture of the double checking process in drug administration. Full articles of the 
relevant abstracts were then searched and retrieved. The references of the 
retrieved articles were searched manually in order to identify additional appropriate 
studies. The relevant additional articles that met the inclusion criteria were also 
obtained. Any studies or articles that were obviously not related to double checking 
for medication preparation and administration such as opinion papers, letters, case 
reports and comments, were excluded. Duplicates were identified and removed. 
2.2.4 Data extraction 
All identified abstracts were read for their relativity to the inclusion and exclusion 
criteria. Full articles that were considered relevant were obtained and examined, 
and the following data was extracted: year of study; study design and sample size; 
patient population and place of study; efficacy outcome measures; type of 
medication in each study; error rate with double checking and without if applicable. 
Also, the Pharmline database was searched through the NeLM database and no 
further studies were identified. 
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2.3 RESULTS 
2.3.1 Search Results 
The search strategies yielded 752 abstracts from the five databases. There were 
289 duplicates. A further 357 articles were excluded because they were unrelated 
to double checking in the medication treatment process, patient identity or devices 
used in treatment (Figure 2.1). The full text of the articles that were remaining (106 
references) was reviewed and 92 further references were excluded because they 
were not evaluating the double checking of medications. Two additional studies 
were added after the references of relevant articles were reviewed manually. In 
total, 16 studies identified double checking in the medication treatment process and 
are included in this systematic review. 
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-EHBASE 
323 
MEDLINE 
250 
ClNAHL 
120 
BN INDEX 
13 
PsyclNFO 
46 I-
- -
351 REFERENCES EXClUDED 
Becau!:e they were unrelated 
to double checking 
92 EXCLUDED 
77 did not evaluate double 
checking 
9 Comments and letters 
4 Case studies 
2 Reports 
TITlES & ABSTRACTS 
IDENTIFIED 
152 
...------+1 .. 
1 
DUPLICATES 289 I 
ARTIClE REVIEW 
106 
ELIGBLE ARTIClES 
16 
RelEVANT STUDIES ADDED 
2 
Figure 2.1: Flow diagram of search and review process 
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2.3.2 Included Studies 
Full details of the studies are classified and summarised in Tables 2.2, 2.3, 2.4 and 
2.5. There were three quantitative studies (Kruse et ai, 1992; Ross et ai, 2000; 
White et ai, 2010). Two studies used both qualitative and quantitative methods 
(Leung et ai, 2007; Jarman et ai, 2002). Nine were qualitative studies (questionnaire 
and interviews) (Armitage G, 2008; Manias et ai, 2005; Evley et ai, 2010; Dickinson 
et ai, 2010; Sheu et ai, 2008; Davis et ai, 2010; Wong et ai, 2007; Winson et ai, 
1991; O'Connell et ai, 2007). Two studies were systematic reviews (Hodgkinson et 
ai, 2006; Jensen et ai, 2004). 
2.3.3 Quantitative studies 
Three quantitative studies were conducted to assess the effectiveness of double 
checking processes in reducing MEs for hospitalised patients (Table 2.2). The first 
study was conducted in Australia in 1992 (Kruse, 1992). It was a cross over study 
in three wards in a g ~ r i a t r i c c hospital. A total of 319 MEs were detected during the 
46 week study period. The authors found that the use of two nurses as opposed to 
one in administering medication significantly reduced the MEs rate from 2.98 per 
1000 medications administered (95% CI, 2.45-3.51) to 2.12 per 1000 medications 
administered (95% CI, 1.69-2.55). The clinical advantages, however, were unclear 
because the difference was so small and 95% of the reported errors were of a 
relatively minor nature. 
The. second study was a retrospective review of all MEs reports in a large children's 
hospital in the UK completed prospectively from April 1994 to August 1999 (65 
months) (Ross et ai, 2000). The main finding was that 195 MEs were reported 
during the study period. 130 of these errors occurred despite double checking 
being performed. There were 58 errors where it was confirmed that double 
checking did not occur and in seven errors it was uncertain whether double 
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checking was performed or not. In addition, during this study period a new 
pharmacy policy was introduced, where two people were involved in double 
checking all drugs before dispensing. This resulted in a reduction in drug 
dispensing errors. 18 dispensing errors were reported in 22 months, i.e. 9.8 errors 
per year, before the double checking process was introduced. Following the 
introduction of double checking, there were only 21 dispensing errors in 43 months, 
i.e. 6 per year. 
The third study was a high-fidelity (simulators respond to the nurses intervention 
such as heart and lung sound, chest rise and fall with respiration) simulation study 
of outpatient chemotherapy administration with ten nurses from that unit (White et ai, 
2010). An existing and a new checklist for an Ambulatory Infusion Pump (AlP) (a 
pump used to deliver chemotherapy agents) were compared to determine their 
effectiveness in detection of MAEs during nurses' practice. The old checklist had 
been used in the unit for a few months. One nurse programmed the AlP using the 
prescription and the drug label. The second nurse independently checked the pump 
programming using a checklist to double check the programming of the pump 
against the drug label and prescription. The new checklist was a revision of the old 
one including rearranging the steps that should be checked by the second nurse 
and including a specific item to check patient identity. In this simulation study a total 
of 130 errors were built into the simulation. Overall, the new checklist helped 
nurses to detect 76 errors (59%) compared to 66 errors (51%) with the old checklist. 
There was no significant difference in the detection of pump programming errors 
between the two checklists despite the changes made. There was however a major 
difference in error detection between the two checklists in relation to patient 
identification (16/20, 80% versus 3/20, 15%) respectively. Therefore the additional 
specific items incorporated in the new checklist such as check the medical record 
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number and patient name from the armband and medication label had a positive 
impact on error detection. 
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Table 2.2: Quantitative studies of actual error rates 
Type of study 
Cross over 
Study 
Retrospective 
study 
Intervention 
Three wards included 
WARD A: Control (with 2 
nurses) for first 23 weeks, and 
trial for second 23 weeks (with 
one nurse). 
WARD B: Trial (with one nurse 
for first 23 week, and control 
(with 2 nurses) for second 23 
weeks. 
WARD C: Control for all study 
period with 2 nurses 
administering. 
Retrospective review of 
medication error reports 
completed prospectively from 
April 1994 to August 1999 (65 
months). 
Settings 
Three wards of a 
geriatric 
assessment and 
rehabilitation unit, 
Australia 
This study 
reviewed data 
routinely collected 
in Royal Hospital 
for Sick Children 
(RHSC), Glasgow, 
UK 
Study 
population 
Registered 
Nurses 
Nurses and 
Pharmacy 
staff 
29 
Orugs 
Non-restricted 
medications 
All medicines 
Main finding Outcome Reference 
Total errors = 319 The use of two Kruse 
nurses to et ai, 
Error Rate 11000 administer 1992 
medicines administered medication, 
significantly 
(1 nurse) reduced the ME 
rate, but the 
2.98 95% CI2.45-3.51 clinical 
advantages 
(2 nurses) were uncertain. 
2.12 95% CI 1.69-2.55 
(P-value not reported) 
Total errors = 195 The introduction Ross 
of a policy of et al 
Dispensing errors = 39 double (2000) 
checking for all 
Without double drugs 
checking dispensed by 
18 dispensing errors 
pharmacy staff 
led to a 
reported in 22 month reduction in 
period, i.e 9.8 per year errors from 9.8 
With double checking 
to 6 per year. 
21 dispensing errors 
reported in 43 months 
period, i.e 6 per year. 
Table 2.2: Contd. 
Type of study 
Simulation 
study 
Intervention 
Two checklists for ambulatory 
infusion pump (AI P) were 
compared, one old, and one 
new. New checklist had a 
specific item to check patient 
identity. Study focussed on the 
ability of second nurse to detect 
errors by using the checklists. 
14 pumps were checked by 
each nurse 
Settings 
Simulated setting 
Toronto University 
Hospital, Canada 
Study 
population 
10 
Registered 
Nurses 
30 
Drugs 
Chemotherapy 
Main finding 
Overall, the new 
checklist helped 
nurses to detect 
76/130 (59%) of 
errors compared to 
66/130 (51%) with old 
checklist 
(P<0.01) 
Outcome 
No significant 
difference in 
detection of pump 
programming 
errors, but 
detection of errors 
in patient 
identification with 
new checklist 
(80%) was 
significantly higher 
than with the old 
checklist (15%) 
Reference 
White et al 
(2010) 
2.3.4 Mixed (Quantitative and Qualitative) studies 
Two studies included quantitative and qualitative data as shown in Table 2.3. The 
first study monitored ME reports after double checking for seven months and then 
after single checking for a similar time period in an adult hospital (Jarman et ai, 
2002). This was a study evaluating the effect of a change in policy that was 
introduced in the hospital whereby single checking replaced double checking. 
Unfortunately, the number of MEs identified in each time period was very small. 
There were five reports during the period with double checking compared to four 
reports during the period with single checking. The very small number of reports 
suggests that not all MEs were reported and makes statistical comparison 
impossible. The qualitative part of the study consisted of 129 nurses completing a 
questionnaire which asked them if they preferred double checking or single 
checking. The questionnaires revealed that the nurses preferred single checking. 
The other study involved a review of 52 MEs that occurred in a general hospital in 
Hong Kong (Leung et ai, 2007). The review of the MEs, however, did not contain 
any information about double checking. The qualitative part of the study involved 
focus groups and a questionnaire which 466 out of 748 nurses returned. The 
nurses felt that double checking was preferable to triple checking (which was the 
current practice). There was strong support for the principles of the five rights for 
drug administration (right patient, right drug, right dose, right route and right time). 
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Table 2.3: Quantitative and qualitative (mixed) studies 
Tytlt! of study Intervention Settings Study population Drugs _ Main finding 
Mixed methods Monitoring of medication errors all adult 129 nurses Not Only 5 reported 
(Quantitative & after single checking and then inpatient units, completed reported medication incidents 
Qualitative) compared with double checking Operating. questionnaire were identified over 
Mixed methC?ds 
(Quantitative & 
Qualitative) 
over 7 months in 3 clinical services Birthing and the 7 months period 
This study involved 2 stages, over 
18 months, to review and examine 
the current drug administration 
procedure of 3 checks and five 
rights. 
In stage 1: medication and drug 
incident forms submitted over a 1 
year period were reviewed. Focus 
group interviews were conducted 
with nurses, self-administered 
questionnaires distributed & 
observational studies conducted in 
the wards. 
In stage 2: data from stage 1 was 
analysed, new clinical model of 
drug administration was tested in 
each selected area for at least 3 
months. 
ED within with double checking 
Geelong compared to 4 
hospital reported incidents 
(Australia) during same period 
with single checking. 
27 selected 
clinical 
settings in 
General 
Hospital in 
Hong Kong 
-Focus group 
interviews (n=29) 
-Questionnaires 
(n=466) 
-Individual interview 
(n=3) 
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Not 
reported 
Total errors = 52 
In review of drug 
incident forms, main 
causes of MEs were 
noncompliance with 
policies or procedure 
(48%), 
communication failure 
or misinterpretation of 
orders (23%). In this 
study most nurses 
(63%, n=29) 
performed three 
checks during drug 
administration, while 
(35%, n=16) did two 
checks 
Outcomes 
No significant 
difference in error 
rates between 
single and double 
checking. 
However, very few 
MEs detected. 
From this study 
two checks and 
five rights for drug 
administration 
was more 
practical, safe, 
saved nurses 
time, enhance 
effective checking 
over three checks 
model. 
Reference 
Jarman et al 
(2002) 
Leung et al 
(2007) 
2.3.5 Qualitative studies 
Nine studies identified in this review were qualitative studies as shown in Table 2.4 
(Armitage G, 2008; Manias et ai, 2005; Evley et ai, 2010; Dickinson et ai, 2010; 
Winson G, 1991; O'Connell et ai, 2007; Sheu et ai, 2008; Davis et ai, 2010; Wong et 
ai, 2007). In six of the studies health professionals preferred double checking as 
they felt this was more likely to detect drug administration errors (Armitage, 2008; 
Manias et ai, 2005; Evley et ai, 2010; Dickinson et ai, 2010; Sheu et ai, 2008; Davis 
et ai, 2010). In two of the studies the majority of the participants felt that single 
checking was adequate (Winson, 1991; O'Connell et ai, 2007). In one study the 
double checking process was identified as an intervention with significant potential 
to reduce MEs (Wong et ai, 2007). 
A collaborative qualitative study, between the National Patient Safety Agency, Royal 
College of Anaesthetists and Association of Anaesthetists of Great Britain and 
Ireland, explored the feasibility of introducing a practice of double checking of drugs 
used during anaesthesia (Evley et ai, 2010). Two different methods (second person 
checking and electronic bar code checking) were considered. Subsequently, focus 
groups were held to determine whether health professionals felt that either system 
would help reduce MEs. The pilot study found that health professionals had the 
opinion that double checking would have a significant effect on patient safety if it is 
performed properly without any distraction or time pressure. However, they also 
found that the problem with this method was the second person availability. It was 
therefore felt that the electronic system was probably more feasible. Different 
models of double checking were identified as being used in different healthcare 
centres in a survey of 35 health professionals and parents/carers in the COSMIC 
report (Wong et ai, 2007). Interviews were performed with 40 health professionals 
in a single hospital in the UK (Armitage G, 2008). Many of the individuals 
33 
interviewed felt that the double checking process was inconsistent and may lead to 
reduced responsibility, accountability and lack of time. Despite this the participants 
still preferred double checking. 
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Table 2.4: Qualitative studies only 
Type ot s t u c l y _ l n t ~ r v e ! l t i o ! l _ _ _ __ __ Settings _ Study population __ __ D r ~ g s s
Interview Data analysed from a Teaching 40 health Not reported 
study review of 991 drug error hospital in professionals (15 
reports, and interviews with Northem doctors, 15 nurses, 7 
40 health professionals to England pharmacists. and 3 
assess the effectiveness of pharmacy 
double checking mediCines, technicians) 
for 3 months period. 
Prospective Incorporating participants University 12 graduate nurses in Parenteral 
Cohort study observation during teaching medical and surgical medication, Opioid 
medication administration hospital, in units analgesics and 
and interviews Australia certain oral 
medication 
Qualitative To assess the feasibility of Seven NHS 61 participants (36 Drugs given during 
study introducing second-person or settings in UK, consultant anaesthesia 
electronic bar-code for 3 month anaesthetists, 3 
confirmation of drugs period trainees, 15 Operating 
administered during Department 
anaesthesia. Seven NHS Practitioners and 7 
settings in UK (five used anaesthetic nurses 
second-person & two used participated). 
bar code confirmation) 
3S 
Outcomes 
Errors occurred despite 
double checking. Most 
participants (34/40) 
believed that double 
checking process is 
inconsistent. 
Found that double 
checking for high alert 
medication is strongly 
recommended. But double 
checking may be 
sacrificed when time is 
short and there are not 
enough qualified staff 
Both methods were 
perceived to contribute to 
the prevention of drug 
errors. Two person 
confirmation has significant 
effect on practice but has 
less feasibility than 
electronic confirmation 
Reference 
Armitage G (2008) 
Manias et al (2005) 
Evley et al (2010) 
Table 2.4: Contd. 
Type of study _  n t e r v E ! n t i o n _ _ _ __ Settings_ . __ S t u d y ~ p u l a t i o n n Drugs 
Descriptive To understand a practice of Children's hospital, 19 paediatric nurses Not reported 
qualitative double checking medication New Zealand 
design & identify barriers to the 
process. Data collected via 
three focus group interviews. 
Seven paediatric nurses 
participated in homogenous 
groups based on level of 
practice. 
Semi-
structured 
questionnaire 
To encourage nurses to 
describe their feelings around 
administration errors, and to 
increase the understanding of 
nurses for error related problem 
and to identify high alert 
situations, by using snowball 
sampling to recruit participants. 
A semi structured questionnaire 
was used to record types of 
error. 
Taiwan 85 nurses participated 
36 
High alert situation 
(insulin, 15% KCL and 
Pitocin (oxytocin 
injection) and two 
conditions: patients on 
IV pumps and patients 
undergoing CPR. 
Outcomes 
Independent double check 
is accepted and promoted 
as best practice in the 
paediatric settings. There 
is a lack of clarity of double 
check process in both 
practice and literature. This 
study supports the findings 
of others in relation to the 
influence of workload 
distraction and 
environmental factors 
Survey results suggest 
that nurses should double 
check medication 
administration in known 
high alert situations. 
Reference 
Dickinson 
et al (2010) 
Sheu et al 
(2008) 
Table 2.4: Contd. 
Type of study Intervention Settings Study population _ Drugs 
Questionnaire A questionnaire survey of responses to a A tertiary 185 paediatric 
Survey number of factorial vignettes. These vignettes paediatric nurses Not reported 
Descriptive 
study 
considered a combination of seven contextual hospital in 
and policy factors that influence nurses Australia 
judgments relating to medication administration 
Survey questionnaire to identify any 
interventions used in reducing dose calculation 
errors in paediatrics. 
Different 
paediatric 
healthcare 
settings from UK, 
US and EU. 
37 
35 participants 
(nurses, pharmacists, 
doctors and parents) 
Not 
reported 
Outcomes 
Double checking the 
patient, double checking 
the drug and checking the 
legality of the prescription 
were the three strongest 
predictors of nurses 
actions regarding 
medication administration. 
Different double checking 
models identified but no 
evidence to support one over 
another. Also, no available 
data for effectiveness of 
double checking in reducing 
medication calculation 
errors. 
Reference 
Davis et al 
(2010) 
Wong etal 
(2007) 
Table 2.4: Contd. 
Type of study 
Questionnaire 
Survey 
Questionnaire 
Survey 
NA: Not Available. 
Intervention 
Survey questionnaire to measure the 
registered nurses opinion regarding 
to single checking of the 
administration of medicines. 
Structured evaluation involved 
conducting two surveys, prior to and 
after implementation of single 
checking. 
Settings 
General 
hospital, UK 
Acute-Care 
hospital, 
Australia 
Study population 
328 nurses 
124 nurses 
38 
Drugs 
NA 
NA 
Outcomes 
Determined that most 
children's nurses in a small 
general hospital agreed 
that registered nurses 
should be able to 
administer medicines on 
their own. 
Nurses welcomed the 
single checking medication 
procedure, and felt more 
confident using single 
checking, and perceived 
that it made them more 
accountable for 
administering medications. 
Reference 
Winson, 1991 
O'Connell et ai, 
2007 
2.3.6 Previous systematic reviews 
Two previous systematic reviews were identified in this review (Table 2.5). The first 
systematic review (Hodgkinson et ai, 2006) evaluated interventions in minimising or 
reducing MEs in elderly adults. They identified a total of 20 studies and three 
systematic reviews but only two studies that evaluated the effectiveness of single 
checking against double checking (Kruse et ai, 1992; Jarman et ai, 2002). 
The second systematic review was of studies conducted to prevent errors in 
intravenous drug administration in anaesthesia (Jensen et ai, 2004). In their review 
Jensen et al introduced a list of recommendations. One of these recommendations 
was that drug labels should be checked with a second person or a device before a 
drug is administered. They strongly support the double checking of drugs before 
administration. 
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Table 2.5: Previous systematic reviews 
Focus of review 
Medication errors in the elderly 
Errors in intravenous drug 
administration in anaesthesia 
Methods 
1986-2005 
PubMed 
Embase 
CINAHL 
Current Contents 
Cochrane 
1978-2002 
PubMed 
Medline 
Embase 
Main findings References 
Six strategies were identified that may reduce Hodgkinson et al (2006) 
medication errors. These included double checking. 
List of 12 recommendations that reflect the best Jensen et ai, (2004) 
evidence available. One of them was that labels 
should be checked with a second person or a 
device before a drug is administered. 
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2.4 DISCUSSION 
The aim of this review was to evaluate the effectiveness of double checking for 
medication administration, in reducing or preventing MEs. Each year several 
children die in the UK as a result of MEs (Cousins et ai, 2002). MEs are therefore a 
major clinical problem and measures to reduce MEs should be welcomed. 
Double checking was introduced into nursing practice, as it was assumed that it 
would reduce MEs. It is now standard nursing policy in many children's hospitals 
(Conroy et ai, 2012). Double checking the administration of medicines is labour 
intensive in that it requires two qualified health professionals. This has a significant 
impact on nursing time and it is therefore surprising that double checking is a 
widespread process with minimal supportive evidence. It is of concern that there 
has only been one randomised controlled clinical trial, a study involving adult 
patients on a geriatric unit in Australia (Kruse et ai, 1992). This clinical trial 
suggested that double checking may be beneficial but that the clinical advantages 
are unclear. The retrospective review of MEs in Glasgow Children's Hospital 
reported that dispensing errors were reduced following the introduction of double 
checking procedures in the pharmacy department (Ross et aI., 2000). The overall 
incidence of reported errors in this study, however, was very small and this 
suggests that a significant number of errors not reported. This questions the validity 
of the findings in this paper . 
. The vast majority of the papers identified consisted of asking health professionals 
(usually nurses) whether they felt double checking w a ~ ~ helpful or not. The majority 
of the studies confirmed that the nursing staff felt that double checking, if done 
properly, would result in fewer MEs. These studies, however, all identified that there 
were practical problems associated with ensuring the double checking process was 
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performed correctly. These often involved staff shortages or an emergency 
situation. Three studies reported that nurses preferred single checking over double 
checking process (Winson, 1991; Jarman et ai, 2002; O'Connell et ai, 2007). 
Reported disadvantages of double checking were that the process is time 
consuming, reduces the responsibility and may be associated with deference to 
authority (Armitage, 2008). It is dependent on the availability of sufficient nurses. 
Some nurses raised concerns that the double checking process reduced their 
responsibility and may actually predispose to MEs. It was felt by some nurses that 
double checking should be used only in high risk patients (neonates, infants or with 
high risk medications such as chemotherapy, opiates and intravenous routes (Sheu 
et ai, 2009). 
A number of different interventions have been suggested to reduce errors in 
calculations of paediatric drug doses such as Centralised Intravenous Additive 
Services (CIVAS), CPOE, Unit Dose Dispensing Systems (UDDS) and Intelligent 
Infusion pumps (liP) (Wong et ai, 2007). These are likely to contribute to a reduction 
in other types of paediatric errors through they may however also introduce new 
errors. It is however beyond the scope of this chapter to discuss them further. 
The time saving from using the Single checking process was estimated in two 
studies (Ross et ai, 2000; Jarman et ai, 2002). In the randomised controlled clinical 
trial the authors found that one nurse rather than two nurses administering 
medications would save 17.1 hours of nursing time per 1000 medications 
administered (Kruse et ai, 1992). In one study following the introduction of single 
checking, nursing staff felt that approximately 20 minutes was saved on each 
medication round (Jarman et ai, 2002). 
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I feel that the process of double checking of the administration of medicines should 
be evaluated scientifically. We recognise that there are major practical difficulties in 
performing such a clinical trial in children within the UK, as double checking is now 
accepted as a standard nursing procedure. One could, however, perform clinical 
trials in adult inpatients, where double checking is not routinely used, to establish 
whether double checking is effective in reducing MEs. 
However, from this review of the literature we can summarize that the lack of 
studies evaluating the effectiveness of double checking means that there is 
insufficient evidence to confirm or refute the effectiveness of double checking in 
reducing errors. 
All qualitative studies described the researchers' suggestion and their assessments 
or measurements, and the theoretical opinion of participants or their feeling 
regarding double checking, rather than the practical measurement of double 
checking effects on clinical practice. These qualitative studies therefore provide 
limited evidence to verify that the double checking process may be able to reduce 
MEs or may be considered as a contributory factor for MEs. In most of the 
qualitative studies that have been conducted the participants were nurses. The 
nurses explain their opinion according to their place of work, their environment and 
their dealing or experience with double checking, however, this does not necessarily 
reflect the reality of all nurses practice during drug administration process. 
In spite of some evidence for double checking, some studies believe that the double 
checking process may lead to more MEs, rather than reduce MEs. Some studies 
indicated that the change from double checking to single checking saves nurses' 
time and gives them more space to do more work with their patients. Also, one 
study suggests that the number of MEs does not change when the process of 
double checking is switched to Single checking (Jarman et ai, 2002). 
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Healthcare providers disagree in their opinions of the double checking process but 
some of them consider that double checking process is useless and believe that the 
double checking process does not improve patient and medication safety (Armitage, 
2008). 
This systematic review suffered from some limitations. There were very few studies 
and the comparison between those identified studies was difficult as they were 
performed in different situations and settings. They differed in design, duration, 
methodology, and each study used a different definition of MEs and the double 
checking process. Although, the double checking process in theory is a good idea 
and some studies identified in this review suggested that it can reduce MEs, 
publication bias was not excluded from this study. Also, in this review we did not 
distinguish between practical intervention studies and technological intervention 
studies. 
For future work, this systematic review for the evidence base regarding the 
effectiveness of the double checking process in reducing MEs reveals that there is 
insufficient evidence to prove that double checking of medication reduces the risk of 
MEs and the generalisability of the results is limited. In contrast, the evaluation of 
this process and its effect on ME rates would be a useful step forward. Most 
researchers suggest that the randomized controlled clinical trial is the gold standard 
for study design. It is difficult to perform this type of study in medication error 
prevention research (Conroy et ai, 2007a; Reckmann et ai, 2009). This is because 
there is a complicated interaction between health care providers, systems, patients 
and drugs, and these may impact on the study results. Where double checking is in 
place it would be unethical to remove this without good evidence. 
44 
2.6 CONCLUSION 
This systematic review was performed to determine the existing evidence base for 
the effectiveness of the double checking process in reducing MEs rates in dose 
calculation, dispensing and in administration. There is insufficient evidence to 
confirm that double checking of medication reduces the risk of MEs. This does not 
mean that double checking is ineffective but simply that its effectiveness has not yet 
been proven. Further work is required to examine scientifically, the effectiveness of 
the double checking process in reducing MEs for hospitalized paediatric patients. 
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CHAPTER THREE 
ADHERENCE OF PAEDIATRIC NURSES TO DOUBLE 
CHECKING PROCESS STEPS DURING MEDICATION 
ADMINISTRATION IN A CHILDREN'S HOSPITAL: AN 
OBSERVATIONAL STUDY 
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3.1 INTRODUCTION 
Medication safety is important for both the hospitalised and non-hospitalised patient. 
In hospital, safety is reliant upon the medication management systems used, along 
with clear policy, procedures, human factors and organisational factors (e.g. work 
environment, communication). 
Studies have revealed that MEs in children occur most frequently during 
administration (Miller et ai, 2007; Ghaleb et ai, 2010). Few studies in the UK have 
investigated MAEs in children's hospitals and none of them have formally evaluated 
the double checking process during the administration of medicines (Nixon and 
Dhillon, 1996; Conroy et aI., 2007; Ghaleb et aI., 2010). Different rates of 
administration errors have been reported in different studies: 1.2% (Conroy et ai, 
2007), 5.1 % (Nixon and Dhillon, 1996) of administrations and 19.1 % of opportunities 
of error (Ghaleb et ai, 2010). 
One study conducted in the Derbyshire Children'S Hospital, which has a double 
checking process for medication administration, observed 752 drug administrations 
in total (642 oral and 110 IV) (Conroy et ai, 2007). This study commented that the 
failure of paediatric nurses to follow double checking and patient identity procedures 
were risk areas for errors in drug administration. 
Double checking of medication before and during administration by two qualified 
paediatric nurses is an intervention used in many hospitals to reduce errors (Conroy 
et ai, 2012), particularly in neonates and children. However as shown in chapter 2, 
there is little research to confirm or refute its effectiveness. This is especially true in 
children's hospitals and in the UK. 
Different methods are available to detect MEs in hospitals. Most researchers have 
recognised that no single method of MEs detection will work in all areas or settings 
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(Barker et ai, 2002). The observational method has been described as one of the 
best methods to detect MAEs (Allan and Barker, 1990; Barker, 1980). The first 
observational method used to detect MEs in drug administration was conducted in 
1962 (Baker and McConnell, 1962). The observation technique is reported to 
produce results that are significantly more valid and reliable than other methods 
used to achieve the same objectives (Dean and Barker, 2001; Flynn et ai, 2002). 
This study focused on the everyday, routine processes of medication administration 
in the Derbyshire Children's Hospital and, in particular, focused on how the double 
checking process is conducted. According to the hospital policy and procedures all 
medications should be double checked before administration to children (Derby 
Hospitals NHS Foundation Trust, Medicines Code, 2008 (accessed 23 January 
2012). 
Double checking is defined as a procedure that requires two qualified health 
professionals, usually registered nurses, checking the medication before 
administration to the patients (White et ai, 2010; Conroy et ai, 2012). Checking the 
prescription and medication occurs before administration, during preparation, 
calculation or administration to the patient or a combination of all steps. 
A previous literature review of factors contributing to MEs identified personnel, 
systems and managerial problems (O'Shea, 1999). Factors involved mathematical 
skills of nurses, nurses' knowledge of medications, length of nurses experience and 
nurses shifts, workload, distractions and interruptions (O'Shea, 1999). However, 
another study added that the poor drug dose calculation competency and poor 
knowledge of drugs were the most common identified factors that lead to MAEs 
(Pauly-O'Neil,2009). 
In addition, other factors can contribute to MAEs; for example, heavy workload due 
to a shortage in nursing staff, distractions and interruptions to the nurses during 
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their drug round time or during their delivery of care to paediatric patients. These 
can have a direct effect on the safety of medication administration (Fry & Dacey, 
2007). 
3.2 DERBYSHIRE CHILDREN'S HOSPITAL NHS TRUST 
This study took place in the Derbyshire Children's Hospital at the Royal Derby 
Hospital. This hospital is part of the Derby Hospitals NHS Foundation Trust in the 
East Midlands area of the UK. The Trust provides health care services to a local 
population of over 600,000 children. Derbyshire Children's Hospital is a teaching 
hospital with 78 beds. The hospital itself consists of outpatient clinics, a children's 
Emergency Department and four inpatient wards. In addition, there is a Neonatal 
Intensive Care Unit which opened in a new building in the autumn of 2007. The 
Derbyshire Children's Hospital has a long history of excellence and the staff are 
proud to deliver a health service to the children and young people of the Derbyshire 
area (Cooke, 2004). 
The children's outpatient clinics see more than 39,000 children per year in different 
clinics. In 2010, over 60,000 children and young people used the Derbyshire 
Children's Hospital's services throughout their departments. The Children's 
Emergency Department reviews over 25,000 children and young people per year. 
Four wards are available for children who need admission or observation and these 
include: Puffin ward, which looks after children and teenagers with medical and 
surgical problems; Dolphin ward, which is a paediatric Intensive Care Unit (PICU); 
Sunflower ward, which is a trauma and elective surgical ward; Ladybird ward, which 
at the time of the study was a day-case and observation unit; and the NICU, which 
is a patient care area that provides care to premature babies and infants who are 
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either critically ill or who remain in hospital for extended observation or to gain 
weight. 
The Trust provides acute medical and surgical services for children and neonates 
across a wide range of specialities and the findings from this study are likely to be 
generalisable to other paediatric clinical areas in the country. A double checking 
process for medication administration is well established in this hospital for all types 
of drugs by all routes of administration and in all clinical paediatric areas. 
3.3 STUDY AIMS AND OBJECTIVES 
This study was conducted to establish how closely the Derbyshire Children's 
Hospital's double checking policies were followed by nurses in paediatric areas. I 
also wished to identify the types and frequency of MAEs occurring despite the 
double checking process. 
3.4 DEFINITIONS 
Many different definitions have been established for MAEs (Pepper G, 1995; Dean 
B, 1999; Greengold et ai, 2003; Ghaleb et ai, 2010). In my study I followed the 
definition set out by Ghaleb et al. (2010) which defined a MAE as an administration 
of a dose of medication that deviates from the prescription, as written on the 
patient's medication chart, or from standard hospital policy and procedures. This 
includes errors in the preparation and administration of IV medicines on the ward 
(Ghaleb et ai, 2010). 
The double checking process has previously been defined as a procedure that 
requires two qualified health professionals, usually nurses, checking the medication 
so 
before administration to the patients (ISMP, 2005; White et ai, 2010; Conroy et ai, 
2012). 
3.5 METHODS 
This study was a prospective, direct and undisguised observational study of nurses 
administering medicines prescribed for children as part of their routine medical care, 
which was conducted in the wards of the children's hospital. In this study, I 
observed and documented how paediatric nurses implemented the double checking 
process for medication preparation and administration according to the process 
described later. Data was collected on the number, type and frequency of MAEs 
that occurred in spite of the double checking process being used. All medicines 
observed were prescribed for the patient as part of their routine care. 
The process of observation was conducted during weekdays and at the weekend. I 
attended at different times of the day in order to observe medicines administration 
by different nurses and shift patterns. 
3.5.1 Ethical considerations 
The study was considered to be service evaluation by the National Research Ethics 
Service. It therefore did not require ethical or Research and Development 
department approval. Derby Hospitals NHS Foundation Trust clinical governance 
procedures were followed. This included attending the Trust induction day and an 
honorary contract was obtained for me following Criminal Records Bureau 
clearance and other Trust procedures. To comply with National Information 
Governance Board procedures written, informed consent was obtained from the 
parents/carers of all patients observed before observation took place. 
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3.5.2 Participant selection and recruitment 
Paediatric nurses in the hospital were informed about all aspects of the study by the 
Chief Investigator (a Paediatric Clinical Pharmacist who works in the hospital as well 
as for the University of Nottingham) by attending ward meetings. I also attended the 
ward meetings and clarified the information for all participating nurses in the hospital. 
Before each observation, I asked each nurse for verbal permission to accompany 
them on the drug administration round. If permission was refused I would not 
observe drug administration for that nurse during their shift. During the study period, 
however all nurses agreed to be involved in the observation process. Also, all 
patients' parents agreed for me to observe drug administration to their child except 
in 3 cases. 
For a participant to be included in this study they had to satisfy the following criteria: 
A - The participant should be a registered paediatric nurse. 
B - The participant should be employed by the Derby Hospitals NHS Foundation 
Trust where the study took place. 
C - The participant should have a responsibility for administering medicines. 
In addition: 
o - Written informed consent from the parents/carers of patients must have been 
obtained before any observation of medicines administered to that child took place. 
3.5.3 Data collection method 
The data collection form for this study was designed to collect details of adherence 
to all steps during the medication administration and double checking process 
(Appendix A). I planned to observe 2000 drug administration events, which would 
be the highest number observed in the UK in a children's hospital. A one day pilot 
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study was conducted by the project chief investigator and myself on selected wards 
shortly prior to the actual data collection period. This was to introduce me to the 
nursing staff and to make them aware of the project and its aims. The pilot study 
checked the practicability and feasibility of the methodology used and the 
effectiveness of the data collection form. All data collected on this day was excluded 
from analysis. 
The data collection form used reflected the drug administration process in the Derby 
Hospitals NHS Foundation Trust's Medicines Code. 
The process of observation was conducted during weekdays (Monday - Friday) and 
also at the weekend. I attended different· work shifts of the day in order to observe 
the medication administration process by different paediatric nurses and shift 
patterns (8 am, 2 pm, 4 pm, 6 pm and 8 pm). During the observation process I tried 
to avoid interrupting or disturbing the nurses during their drug administration. In one 
situation, when a potentially serious error was identified however, I made the nurses 
aware in a polite manner without disturbing the nurse or the patient before the 
medication was administered. 
I observed each drug administration and recorded all the steps of the double 
checking and drug administration process on a data collection form. For each 
observation, demographic information including the patient's initials, date of birth, 
weight and drug name was recorded. In addition, adherence to the following steps 
was recorded on the data collection form: 
• Drug due: Both nurses should check the frequency of the prescribed 
medication, that the time of administration is correct and when the last dose 
was given. 
S3 
• Correct drug: The packaging or pharmacy label and instructions or any 
precautions stated should be checked by both nurses. 
• Correct dosage form: The dosage form for each prescribed drug should be 
checked with the one prepared for administration and its appropriateness for 
the patient's clinical situation. 
• Dose calculation: Two qualified nurses should independently calculate the 
drug dose that is to be prepared or administered and confirm the result with 
each other. 
• Measurement of dose: The two nurses should prepare and check the drug 
dose measurement before administration. 
• Drug route: The route of drug administration should be checked and 
confirmed by the nurses and should be suitable for the patient's situation 
and age. 
• Drug expiry date: Both nurses should check the drug expiry date before 
administration and that it is in an acceptable condition for administration. 
• Rate of IV bolus: Both nurses should check the drug is given at the correct 
administration rate. 
• IV infusion volume and rate: Both nurses should check the pump settings 
for volume and rates are correct for the prescribed drug. 
• Drug diluents and volume: Both nurses should check that the appropriate 
• 
diluents and volume have been used according to the hospital IV preparation 
guidelines. 
Flush syringes labelled: Syringes filled with sodium chloride 0.9% (saline) 
for use to flush IV access devices should be labelled. 
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• Drug allergy: The patient's drug or food allergy status should be checked by 
both nurses by asking the patient himself or his parents or checking what is 
written on the medication chart 
• Patient identity (10) (using wristband): The patient name, date of birth and 
10 number (as written on the wristband) should be checked by two nurses 
and compared with the information written on the medication chart 
• Administration to the patient: Both nurses should be present at the 
patient's bed to administer the medicines to the patient. If parents wish to 
give the medicine to their child both nurses should witness the patient when 
he/she takes the medicine. 
• Documentation to Medication Administration Record (MAR): Both 
nurses should document and record the drug administration after giving the 
prescribed drug by signing the MAR. 
All the data that was collected from this observational study was anonymous and 
only initial letters were used for each patient. All data was transferred and entered 
onto an Excel database. All data was stored on a password protected University of 
Nottingham computer. All papers based data was stored securely in locked offices 
in the University of Nottingham. 
3.5.4 Data analysis 
The data was analysed using a Microsoft Office Excel programme. Numbers of drug 
doses that were observed and administered were documented and the adherence 
rate to the hospital policy was calculated from the total drug doses observed. For IV 
medications, the adherence rate was calculated according to the total number of IV 
drugs observed during the study period. Also, the difference between the double 
checking steps adherence rate was calculated for week days and weekends. 
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Identified MAEs were categorised according to their type and frequency. The 
incidence rate was calculated by dividing the total number of MAEs by the total 
number of drug doses observed during the study period multiplied by 100. 
Probability value was calculated by Chi - square test to compare the MAEs results 
between week days and weekends. 
3.6 RESULTS 
3.6.1 Demographic information 
Data was collected from April to July 2012. The characteristics of the wards and the 
nurses are shown in Table 3.1. 
Table 3.1: Characteristics of the observed wards and nurses 
Characteristics Medical Surgical PICU NICU Total 
Number of beds 31 25 4 18 78 
Number of 5 3 2 4 14 
nurses/shift 
Total number of 30 25 16 53 124 
nurses 
, 
I 
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Two thousand drug doses were observed and evaluated in terms of the adherence 
of nurses to the double checking procedure during drug preparation and 
administration. MAEs, types and frequency were also documented. In total, drug 
administration to 876 patients was observed during the study period. Demographic 
information of the patients is described in Table 3.2. The rate of drug doses 
observed for each patient was 2.3 administered doses per patient. 
More than half of the patients (60%) were observed on the surgical ward and just 
under one third (32%) on the medical ward. Most of the observations of drug 
administration occurred on these two wards with a relatively even split between 
them (45.6% on the surgical ward and 42% on the medical ward). There were 
relatively few patients on either of the ICUs and subsequently there was less 
observation of drug administrations in these areas. The smallest number of patients 
observed was on the NICU due to difficulties in obtaining consent from the babies' 
parents. This was due to parents often visiting in the evenings when I was not 
present, together with there being no scheduled drug-round times in these areas 
with nurses preparing each drug for each individual patient separately. 
Oral medications (liquids and tablets) made up the vast majority (80.7%) of the 
formulations that were observed during the medication administration process 
(Table 3.2). Oral drugs were administered and observed most frequently on the 
surgical ward (Figure 3.1). Both IV and inhaled drugs were administered and 
observed most frequently on the medical ward. 
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Table 3.2: Patients and drugs administered: 
Characteristic Medical Surgical PICU NICU Total 
No. of patients (%) 281 (32%) 523 (60%) 52 (6%) 20 (2%) 876 
Age (months) 
Median 67 84 36 6.8 (days) 
-
(Range) (0.9-211) (32 - 204) (0.6 -205) (2 -119 days) 
Weight (in kg) 
Median 14.4 22.6 12.8 2.27 
-
I 
(Range) (2.13 - 108.7) (4-105.2) (2.8 - 54) (0.9 -3.8) 
No. of oral drugs observed ("Io total) 588 (29.4'7'0) 899 (45%) 112 (5.6%) 15 (0.7%) 1,614 (80.7%) 
No. of IV drugs observed (% total) 176 (8.8%) 11 (0.6%) 77 (3.8%) 38 (1.9%) 302 (15.1%) 
No. of inhalers drugs observed (% total) 74 (3.7%) 0 7 (0.4%) 0 81 (4.1%) 
No. of topical drugs observed (% total) . 1 (0.05%) 2(0.1%) 0 0 3 (0.15%) 
Total no. of drugs administered & 839 (42%) 912 (45.6%) 196 (9.8%) 53 (2.6%) 2,000 (100%) 
observed 
- -- ----- -
.. 
- --- - -- --------
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Figure 3.1: Types of observed dosage form administered in each ward. 
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NICU 
Oral drugs 
Inhaler drugs 
Intravenous drugs 
Topical drugs 
3.6.2 Types of drugs 
Different types of medications were administered and observed during the study 
period. Non-opioid analgesics (including paracetamol and non-steroidal anti-
inflammatory drugs) were the drug class most frequently administered and observed 
in this study (Figure 3.2). The other main group of drugs were antibacterial drugs, 
which made up just under one quarter of the drug administrations observed. 
Antibacterial drugs were more commonly administered and observed in the medical 
unit, PICU and NICU compared to other drug classes. Analgesics were 
administered more frequently than other drug classes in the surgical ward. 
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Laxatives 0.35% 
Antidiabetic 0.05% 
Diuretics 0.05% 
Respiratory stimulants 0.45% 
Antisecretory drugs 0.50% 
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Figure 3.2: Drug class of medications administered and observed during study period. 
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3.6.3 Adherence rate to double checking policy steps 
In this study, 11 double check steps for each administered drug dose were 
assessed and evaluated (Table 3.3). For IV drugs, there were an additional four 
steps in the double checking process which were assessed and evaluated. 
Adherence to these steps was variable between the nurses. Adherence rates were 
greater than or equal to 90% for 11 of the steps observed. Double checking of the 
calculation of the dose was observed in less than one third of cases. In relation to IV 
drugs, issues identified were the rate of the IV bolus and the labelling of flush 
syringes. The one other step that had an adherence rate of less than 90% was 
double checking the actual administration of the medicine to the patient. 
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Table 3.3: Adherence rate to double checking policy steps 
Steps Double check adherence rate n=2000 Double check adherence rate (%) 
I 
Drug due 1,848 92 
Correct drug 1,964 98 
Correct dosage formulation 1,798 90 
Dose calculation 591 30 
Measurement of dose 1,972 99 
Drug route 1,943 97 
Drug expiry date 1,895 95 
Allergy check 1,851 93 
Patient ID 1,919 96 
Administration to patient 1,667 83 
Documentation to medication record 1,987 99 
IV Drugs: 
Drug diluent & volume 280 93 
tV volume & rate 277 92 
Rate of I. V bolus 213 71 
Flush syringes labelled 203 67 
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3.6.4 Comparison between weekdays and weekends adherence rates 
1,594 drug administrations (including 173 IV drug administrations) were observed 
during weekdays (56 days). During weekends (22 days), 406 administrations 
(including 129 IV drug administrations) were observed (Table 3.4). There was a 
statistically significant difference in nurses' adherence rate to the double checking 
steps between weekdays and weekends in 9 steps (P < 0.05) (Table 3.4). Overall 
nurses adhered more closely to double checking steps at weekends compared to 
weekdays. 
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Table 3.4: Comparison between weekdays (Monday to Friday) and weekends (Saturday and Sunday) double checking policy adherence 
rate 
Steps Week days (56 days) (1 ,594 drug doses Weekend days (22 days) (406 drug P-value 
observed, 173 IV drugs) doses observed, 129 IV drugs) 
Adherence rate Adherence rate (% Adherence rate Adherence rate (%) 
(N) (N) 
Drug due 1,459 92 389 96 0.005 
Correct drug 1,591 99 406 100 0.875 
Correct dosage form 1,383 87 397 98 <0.0001 
Dose calculation 398 25 193 48 <0.0001 
Measurement of dose 1,589 99 383 94 <0.0001 
Drug route 1,542 97 401 99 0.0425 
Drug expiry date 1,507 95 388 96 0.483 
Allergy check 1,455 91 396 98 <0.0001 
Patient 10 1,525 96 394 97 0.2662 
Administration to patient 0 1,389 87 278 68 <0.0001 
Document to MAR 1,583 99 404 99 0.923 
IV Drugs 
Drug diluents & volume 150 87 127 98 0.0006 
I. V volume & rate 153 88 124 96 0.0288 
Rate of I. V bolus 114 66 99 77 0.0551 
Flush syringes labelled 117 68 86 67 0.958 
- ---- ----
L- _______ 0._ L ____ 
-- -- --
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3.6.5 Medication administration errors 
191 MAEs were detected during the study observation period; giving a MAEs rate of 
9.6% of drug administrations (Table 3.5). These errors were classified according to 
type and their incidence (Ghaleb et ai, 2010). The most frequent type of 
administration error involved the medicine being given to the parents to administer 
to the child when the nurse was not present. There were 64 instances where this 
occurred. The nurse not observing the administration of the drug by the parent is a 
deviation from the hospital policy and procedure for drug administration. The other 
administration errors identified included incorrect administration of the medicine (IV 
bolus drugs being given too rapidly usually), incorrect preparation errors and 
medicines being given at incorrect times. 
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Table 3.5: Medication administration errors identified 
Type of error Examples Number of errors 
Drug given by Ranitidine oral dose was given by mum without observation from 64 
parents (i.e. not the nurses. 
observed by nurse) 
Ibuprofen oral dose was given by parents without observation from 
the nurses. 
Wrong administration Co-Amoxiclav IV bolus administered within 2 minutes instead of 5 51 
techniques minutes as prescribed. 
Salbutamol inhaler given with poor technique. 
Incorrect preparation Saline flush syringes were prepared without labels. 44 
errors 
Cefuroxime IV bolus prepared & diluent was added but not mixed 
properly. 
Wrong time of drug Ceftriaxone IV bolus given 11 :17 am instead of 10:00 am (1 hour 32 
administration (i.e. 17 minutes late). 
:t1hour of prescribed 
Amoxicillin IV bolus given at 9:38 am instead of 8:00 am (1 hour 38 time) 
minutes late}. 
-- --
-- _._-_ ... _------ ---
-
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There was no statistically significant difference in the rate of MAEs between 
weekdays and weekends. Drugs being given by parents unsupervised by nurses 
were the most frequent administration errors during both weekdays and weekends. 
For example, incorrect preparation errors were observed less at weekends (1 %) 
compared to during drug administration on weekdays (2.5%) (Table 3.6). 
Table 3.6: Medication errors observed on weekdays versus weekends 
Type of error Weekdays (total Weekends (total 406 p. value 
1,594 drugs) drugs) 
N(%) N (%) 
Drug given by parents 52 (3.3%) 12 (3%) 0.87 
(i.e. not observed by 
nurse) 
Wrong administration 46 (2.9%) 5 (1.2%) 0.0756 
techniques error 
Incorrect preparation 40 (2.5%) 4 (1%) 0.085 
errors 
Wrong time of 24 (1.5%) 8 (2%) 0.502 
administration error (i.e. 
%1 hour of prescribed 
time) 
Total 162 (10.2%) 29 (7.2%) 
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3.6.6 Clinical significance of errors 
It was not possible to collect data on patient outcomes; however the majority of 
errors were unlikely to have caused serious harm to patients. Sixteen examples of 
poor inhaler technique were of concern. These could have resulted in poor symptom 
control for patients and also were not a good example to parents who were likely to 
have to administer such drugs at home. Three IV antibiotic doses were given 
without flushing, these have the potential to result in irritation to the vein. Three 
examples of antibiotic injections being prepared without correct mixing with the 
diluent had the potential to result in incorrect dose administration. 
3.6.7 Factors affecting adherence to the double checking process 
During my observation I identified a few factors which were not in my study aims. 
Identification of these factors may be beneficial for the hospital management. These 
factors may have an effect on the nurses' adherence rates to the double checking 
process: 
• Shortage of nurses in the wards. 
• High nurse workload. 
• Interruptions by other nursing staff. 
• Medicines received late from the pharmacy. 
• Drugs distributed randomly in trolleys with little organisation included 
drugs for patients waiting for discharge. 
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3.7 DISCUSSION 
To our knowledge, this is the first observational study that has focused strictly on 
the double checking process and the adherence to hospital policy by nurses in 
neonatal and paediatric areas. As mentioned earlier, the observational method has 
been shown to be objective and more reliable than other means of spontaneous 
reporting or patient chart reviews (Barker 1980, Allan & Barker 1990, Fortescue et al. 
2003). It has been reported that people checking the work of others will find about 
95% of all mistakes (Grissinger M. 2003, Cohen M. 2007). In this study, I identified 
191 MAEs, which is a rate of 9.6%. The most common type of errors (64 errors) was 
related to drugs given by parents without observation from nurses. Most of the 
errors reported with paediatric patients than with neonates. This type of error can be 
considered as a deviation from the hospital policy and procedures rather than an 
actual administration error. If one therefore excludes these errors, the error rate 
was reduced to 6.4% of administrations. Another study carried out in this hospital 
over five years ago described a MAEs rate of 1.2% (Conroy et al. 2007a), this 
variation in error rates between these two studies could be because this study 
included weekend days in the observation process and also involved a higher 
number of IV medications. The MAE rate reported in this study is within the range 
that has been reported in previous studies in paediatric patients: 5% to 27% 
(Nahata, 1988; Schneider et ai, 1988; O'Brodovich & Rappaport, 1991; Prot et ai, 
2005; Chua et ai, 2010; Ghaleb et ai, 2010). 
3.7.1 Nurses adherence to double checking steps 
All nurses were expected to follow the hospital double checking policy. Fifteen steps 
were observed and evaluated during each drug dose administration episode: 11 
steps involved all drug forms and 4 steps were related to IV drugs. There was a 
wide ranging variation amongst nurses in their adherence to different double 
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checking process steps ranging from 30% to 99%. Some steps appeared to be 
double checked in most administrations while other steps were checked less often. 
This inconsistency may have resulted from disagreement between nurses or their 
knowledge about the double checking process, despite all of them were working in 
the same hospital. This is consistent with the findings of others ''there was not 
always consistent practice between paediatric nurses, even among those working in 
the same area" (Dickinson et al. 2010). 
Nurses checking the identification of patients by a bar coding system prior to drug 
administration were reported only in 17.4% of 1344 administrations in a general 
hospital in London (Franklin et ai, 2007). Another observational study carried out in 
adult patients in two different hospitals in Australia tried to assess interruptions 
during drug administration and found that nurses checked patient identification in 
41 % of 4271 drug administrations (Westbrook et al. 2010). 
A study conducted in the same location as this present study found that patient 
identification was checked in 89% of drug administrations (Conroy et al. 2007a). Our 
study results report a higher rate (96%) of patient identification during the double 
checking process. The adherence rate to this double checking step has therefore 
improved since the previous study was performed in this hospital. 
3.7.2 Problem areas 
Double checking of drug dose calculation, rate of IV bolus, flush syringe labelling 
and drug administration by two nurses at the bedside were the areas where the 
nurses' adherence rate was low compared to other steps. Drug dose calculation 
according to the hospital policy should be performed independently (which means 
each nurse should calculate the dose separately and confirm the result with the 
other nurse). This, however, was often not obviously performed in practice during 
my observation period. The nurses' adherence rate to the prescribed rate of IV 
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bolus was also low. This may be due to the nurses being busy with other duties or 
due. to differences with administering very small volumes so slowly. The 
pharmacist's practice of endorsing prescriptions with 'bolus over 5 minutes' has 
changed as a result of my study to 'bolus over 3 - 5 minutes' for this reason. 
Labelling of flush syringes was another problem area despite the printed label being 
available and ready to use in each ward. It is not clear why nurses did not perform 
these specific tasks in accordance with the hospital policy. Clearly further research 
is needed to seek the views of nurses in relation to these steps in the medication 
administration process. 
3.7.3 Adherence rate during weekdays and weekends 
The adherence rate of nurses to many of the double checking steps during weekend 
drug administration was significantly better compared to weekday administrations. 
There has been no previous published research looking at the effect of day of the 
week and the administration of medicines. Possible reasons are that the nurses are 
less likely to be interrupted at weekends by different groups of doctors and other 
staff which invariably occur during weekdays allowing them to concentrate better on 
administration procedures. 
3.7.4 Study Implications 
The low adherence rate (30%) to independent dose calculation by the nurses was of 
most concern. Drug dosing errors (including prescribing, administration and 
dispensing) are the most common type of MEs in paediatrics (Koren et aI., 1986; 
Kaushal et al. 2001a; Kozer et al. 2002; Ghaleb et al. 2006). Dosing errors were the 
most frequent cause of MEs in children resulting in fatalities in a study in the UK 
(Cousins et aI., 2002). It is thought that independent drug dose calculation is more 
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likely to pick up drug dosing errors but despite an apparent lack of this no dosing 
errors were identified in our study. 
A specific educational or training programme for nurses about the importance of 
independent drug dose calculation may be beneficial. Previous research has shown 
that educational or training programmes have reduced MAE rates (Otero et aI., 
2008; Taylor et aL, 2008; Raja et aL, 2009; Chedoe et aL, 2012). Other studies also 
have confirmed that educational programmes have an ability to decrease MEs in 
paediatrics (Cimino et aI., 2004; Simpson et aL, 2004). Additionally, one study has 
revealed that there is a strong theoretical basis for education and training 
interventions in reducing MEs (Conroy et ai, 2007b). 
3.7.5 Study limitations 
There were a number of limitations highlighted in this study. Firstly, the study was 
conducted in a single hospital. One cannot, therefore, extrapolate to either other 
children's hospitals in the UK or to other parts of the world. The hospital is however 
fairly typical of small UK children hospitals. Secondly, the presence of the observer 
may have had an effect on the nurses and the way they administered medicines. A 
previous study addressed validity and reliability concerns about this method, and 
revealed that the observation of nurses during drug administration did not 
significantly affect the MAE rate (Dean and Barker, 2001). Another study also found 
that there is no significant observer effect on the observed subject (Barker et ai, 
2002). This therefore would not seem to be a major limitation. A third limitation of 
this study was that the observer could not observe the administration of every single 
medication at all times. The large number of medication administrations observed, 
however, would suggest that this is a representative sample. 
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3.8 CONCLUSION 
In conclusion, this study found that there was a variation between paediatric nurses' 
adherence rate to double checking steps during medication administration. The 
independent drug dose calculation step had the lowest adherence rate. There was a 
statistically significant difference in the adherence rate to double checking steps 
during weekends compared to weekdays. The possible reason for this may be that 
the nurses were subjected to more interruptions during weekdays. Also, this study 
showed that the MAE rate was 9.6% of drug administrations. Drugs given by 
parents without observation from nurses was the most frequent type of MAE 
reported in this study, followed by wrong administration technique. 
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CHAPTER FOUR 
NURSES' KNOWLEDGE, PERCEPTION AND OPINIONS OF 
THE DOUBLE CHECKING PROCESS: A QUESTIONNAIRE 
STUDY 
7S 
4.1 INTRODUCTION 
Nurses are more frequently involved in MEs than physicians or pharmacists 
(Benjamin, 2003). Nurses spend up to 40% of their work time in the medication 
administration process· (Armitage & Knapman, 2003). During medication 
administration, nurses playa significant role in ensuring patient safety because they 
conduct the last step that can prevent or reduce drug errors from reaching the 
patient. 
Different reasons have been reported as to why MAEs occur. Lack of adherence to 
the medication administration policy and procedure, is one of the reasons identified 
in Chapter 3. Furthermore, paediatric nurses are responsible for checking whether a 
prescription is appropriate and all five of the standard 'rights' have to be 
implemented properly before drug administration (right medication, right dose, to the 
right patient by the right route at the right time). 
Most descriptive studies have focused on nurses' perceptions about how and why 
MEs occur and their personal experiences with the causes and the reporting 
systems of MEs (Wakefield et ai, 1998; O'Shea, 1999; Jarman et ai, 2002; 
Karadeniz & Cakmak<ti, 2002; Mayo & Duncan, 2004; Maryyan et ai, 2007; Tang et 
ai, 2007; Armitage, 2008; Armutlu et ai, 2008; Hassan et ai, 2009; Jones & Treiber, 
2010; Petrova et ai, 2010; Kim et ai, 2011). 
A few descriptive studies have assessed nurses' perceptions of the double checking 
process (Dickenson et aI., 2010; Conroy et ai, 2012). However, little attention has 
been paid by researchers to evaluate the paediatric nurses' knowledge and opinions 
about the double checking process, and how it impacts on their practice. 
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The Derbyshire Children's Hospital has a double checking policy for all medication 
administration for inpatients, we therefore wished to evaluate paediatric nurses' 
knowledge and opinions about the double checking process. 
4.2 METHODS AND MATERIALS 
A structured questionnaire was used to obtain the paediatric nurses' opinions and 
perceptions of the double checking process for medication administration. 
This survey was performed in the Derbyshire Children's Hospital which is one of the 
children's hospitals in the East Midlands area of the UK. The questionnaire 
consisted of multiple-choice and open-ended questions (Appendix 8). It was 
designed after the observational study (Chapter 3) results were analysed and was 
informed by its findings. The first section consisted of questions regarding 
medication administration and the double checking process, followed by 
demographic information questions. All the information in the questionnaire was 
anonymous and the nurses were asked to return the completed questionnaires into 
boxes provided in each ward. Follow-up reminders were sent to all potential 
participants two weeks after the distribution of the questionnaire. 
4.2.1 Participants 
All registered paediatric nurses who worked in the wards of the Derbyshire 
Children's Hospital and had conducted double checking for medication 
administration were invited to participate in this study. Questionnaire forms were 
distributed to 124 registered paediatric nurses throughout the four inpatient areas 
(Medical, Surgical, PICU and NICU) in the hospital. 
77 
4.2.2 Data collection procedure 
I distributed the questionnaire forms to the nurses in each unit during regular 
handover times. Questionnaires were placed in each ward for each nurse by name. 
A cover letter accompanying the questionnaire explained the objectives of the study, 
emphasizing that participation was voluntary, confidential and anonymous. 
I collected all the completed surveys from each department and then kept them in a 
locked drawer in the research office (University of Nottingham, Medical School 
offices). 
4.2.3 Ethical consideration 
This study was considered to be service evaluation by the National Research Ethics 
Service. It therefore did not require ethical or R&D department approval. Derby 
Hospitals NHS Foundation Trust clinical governance procedures were followed. 
4.2.4 Data analysis 
This was a qualitative study and analysed descriptively. 
4.3 RESULTS 
4.3.1 Response rate 
Out of 124 questionnaire forms, 5 of the forms were returned uncompleted (3 forms 
returned because the nurses were on maternity leave, 2 forms because the nurses 
had left the Trust). 
Of the remaining 119, 48 questionnaire forms were completed and returned 
(response rate 40%). 
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4.3.2 Demographic and background information of respondents 
All the demographic and background information of the respondents is shown in 
Table 4.1. The majority (96%) were female and most of them (35%) were between 
21 and 30 years-old. Twenty seven nurses (56%) were full-time, with the remaining 
(21 nurses, 44%) being part time. The majority of respondents (28 nurses, 58%) 
had more than 10 years experience with drug preparation and administration to 
paediatric patients. 
Table 4.1: Demographic data of the paediatric nurse respondents 
Demographic characteristic Number (n) Percentage % 
Gender 
Male 2 4 
Female 46 96 
Age (Years) 
Under 21 0 0 
21 -30 17 35 
31-40 7 15 
41-50 10 21 
Over 51 14 29 
Years of experience with 
preparation/administration to 
paediatric patients 
Less than one year 1 2 
One to less than 2 years 2 4 
Two to less than 5 years 6 13 
Five to less than 10 years 11 23 
Over than 10 years 28 58 
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4.3.3 Nurses' knowledge and feelings about double checking 
Approximately two-thirds of respondents (30 nurses, 63%) reported that they had 
seen the Trust double checking policy in a written format (Table 4.2). Four nurses 
stated that they had seen the double checking process written in the Trust 
Medicines Code Policy. 
When asked whether they understood the policy. the majority (40 nurses, 83%) 
responded that they had clear and exact knowledge about the double checking 
process in their units (Table 4.2). 35 nurses (88%) responded with comments. All 
comments stated incomplete definitions of the double checking process, for 
example "double check all children's medications" ''two nurses checked prescription 
and patient" "medication checked by 2 trained staff and both check patients' 
identification". Only one nurse wrote a complete definition (Le. "two registered 
nurses should check the drug dose separately, drug due, patient identification, rate, 
route of administration, drug administration and both of them should sign the 
medication chart"). More than half of the nurses (54%) had received no training on 
double checking (Table 4.2). 
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Table 4.2: Paediatric nurses knowledge about double checking 
Item Number (n) Percentage (%) Comments 
Have you seen the Trust 
double checking process 
written down either in paper 
format or on the intranet? 
Yes 
30 63 Trust medicines code 
No 
18 37 Not seen in the Unit 
Do you know exactly what the 
Trust double checking process 
should involve 7" 
Yes 40 83 85% incomplete 
definition 
No 8 17 
Have you undergone any 
specific training in the 
Derbyshire Children's 
Hospital, on how to do double 
checking for administration of 
medicines to paediatric 
patients? 
Yes 22 46 
No 26 54 During training period 
The majority (44 nurses, 92%) responded that they double checked all drug dosage 
forms with another nurse before administration for both preparation and 
administration stages (Table 4.3) 
Similarly, 36 nurses (75%) believed that double checking process are equally 
effective with both dosage forms (oral and IV), while 10 (21 %) respondents believed 
that the double checking process was more effective with IV medicines because 
intravenous medicines are more dangerous than oral medicines (Table 4.3). 
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Table 4.3: Nurses perceptions about double checking 
Item Number (n) Percentage (%) 
Which of the following do you always double check with 
another paediatric nurse?" 
Oral/IV preparation 4 8 
OralllV administration 0 0 
All 44 92 
What is the most important reason for you doing the 
double checking process? 
Hospital policy says that I must 0 0 
To protect children from MEs 39 81 
To learn more about the medicines. 0 0 
To protect myself from making a mistake 3 6.3 
2&4 3 6.3 
All 3 6.3 
Is double checking more effective with oral or intravenous 
medicines?"Can you explain why? 
Oral medicines 1 2 
Intravenous 10 21 
Both 36 75 
Not answered 1 2 
What are the most common factors that you think have a 
direct effect on your ability to do double checking on your 
ward? 
1. Shortage of paediatric nurses & workload 1 2 
2. Disturbance & interruption 7 15 
3. Unavailable second person 2 
4. 1,2 and 3 25 52 
5. 1,2 9 18 
6. 1,3 5 10 
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4 .. 3.4 Factors affecting nurses' adherence to double checking 
Over half (25 nurses, 52%) of the respondents felt a shortage of nurses, disturbance 
and interruption by other staff members and an unavailable second person to carry 
out the double check affected their adherence to the double checking policy (Table 
4.3). 
4.3.5 Differences in the double checking process during days and shifts 
Most (45 nurses, 94%) of the respondents reported that there was "no difference" 
between weekdays and weekends and commented that "all times are equally busy" 
when following the double checking policy (Table 4.4). 
More than half (25 nurses, 52%) of the respondents believed that the double 
checking process was followed equally at all times and there was no difference 
between shift times. Fifteen nurses (31%) however, reported that they could follow 
the double checking process more easily during the nightshift than other shift times. 
They believed that "they were less interrupted during the night shift compared to 
other shift times" (Table 4.4). 
Also, in the survey I asked the participants "Do you think the double checking 
process by another nurse is ineffective, effective, or vel}' effective in detecting 
medication preparation and administration errors?". Over half (26, 54%) of the 
respondents considered that the double checking process is vel}' effective in 
detecting medication preparation and administration errors. The remaining 
participants (22 nurses, 46%) reported that double checking is effective in both 
processes. No participants believed that the double checking process is ineffective 
in detecting medication preparation and administration errors. 
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Table 4.4: Nurses perceptions about double checking· days and times 
Item 
Can you follow the double checking process 
more easily during weekdays, weekends or is 
there no difference 
Weekdays 
Weekends 
No difference 
Can you follow the double checking process 
more easily in a specific shift time? 
Morning 
Afternoon 
I ' 
Evening 
At night 
All times 
Not answered 
Number (n) 
2 
1 
45 
1 
2 
3 
15 
25 
2 
4.3.6 Recognition of medication administration errors 
Percentage (%) 
4 
2 
94 
2 
4 
6, 
31 
52 
4 
The nurses perception of the number of medication preparation/administration 
errors that they had made or identified during the last month during the double 
checking process is shown in Table 4.5. 
Over half (25 nurses, 52%) of respondents reported that they had not made or 
identified any medication preparation/administration errors in the last month. 
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Table 4.5: Nurses identification of medication administration errors 
Item Number (n) Percentage 
(%) 
How many medication preparation/administration 
errors do you remember making and/or finding last 
month that were identified during the double 
checking? 
No errors 25 52 
Less than 5 errors 22 46 
5 -10 errors 1 2 
4.3.7 Opinions on effectiveness 
Two open questions in this survey were designed to explore the nurses' attention to 
the double checking process and its effectiveness in reducing MEs. Over half (26 
nurses, 54%) of participants answered these questions. When asked about the 
elements of the double checking process that the nurses paid least attention to 
during drug administration, all respondents reported that no less attention was paid 
to any elements either for oral or intravenous medication administration. 
One question was designed to explore the nurses' perception and their thinking 
about what may increase the effectiveness of the double checking process "The 
literature suggests that double checking is carried out in a variety of ways, with 
varying degrees of effectiveness, How do you think an effective process should be 
performed and do you do this in practice?" Ten nurses (21%) thought that the 
double checking process could be more effective if it could be done without 
interruptions, while 8 nurses (17%) had another view, believing that implementing 
the five rights of practice aids an effective double check process. 
85 
4.3.8 Opinions of the single checking 
One question in the survey asked the participants about single checking. Half the 
respondents (24 nurses, 50%) reported that a single checking process should not 
be implemented for any medicines (Table 4.6). They stated that this is for safety 
reasons (Le. human mistakes and errors can occur with drugs if not double checked 
by another), particularly with paediatric and neonatal medications. More than one-
third (18 nurses, 38%) of the respondents believed that the single checking process 
should be applied for certain types of medicines, for example, paracetamol and 
vitamins. 
Table 4.6: Paediatric nurses perception about single checking 
Item 
Do you think single checking (i. e. one nurse 
prepares and administers the medicine alone) 
should be allowed for? 
No medicines 
Oral medicines 
IV medicines 
- Alltypes 
Certain medicines 
4.3.9 Additional comments 
Number (n) 
24 
5 
o 
1 
18 
Percentage 
(0/0) 
50 
10 
o 
2 
38 
The last question in the survey asked the nurses if they had anything else to add 
that was not mentioned in the previous questions about the double checking 
process. Seventeen (36%) nurses added comments. Most of the respondents (14 
nurses, 29%) reported that they agreed with, and preferred, to do double checking 
for all paediatric medicines; 2 respondents (4%) also agreed with the double 
checking process but they indicated that it was time consuming. 
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4.4 DISCUSSION 
Only two previous studies have explored paediatric nurses opinions of the double 
checking process (Dickinson et al. 2010, Conroy et al. 2012). The focus of this study 
was to evaluate nurses' knowledge, perception and opinions of the double checking 
process of medicines administration in a children's hospital. Our results show that 
nurses have unclear knowledge and perceptions of the double checking process's 
definition and steps. Many believed they were aware but failed to give a good 
definition. This is consistent with a study by Dickinson et al (2010) who reported that 
clarity is needed in hospitals to achieve the best practice. In our study the exact 
meaning of the double checking process and its steps seemed to be unclear for 
many nurses. The majority of nurses (85%) could only provide an incomplete 
definition of double checking. This suggests that the hospital policy for medication 
administration requires clarification for all staff. 
Another important finding was that, over half (54%) of the respondents stated they 
had had no training on the double checking process during their work in the hospital. 
Training for all nurses for drug administration to neonates and children in the 
hospital would be useful. 
In addition, our study findings highlighted that the majority of nurses believed that 
multiple factors had a direct effect on their ability to follow the double checking 
process according to the hospital policy. Factors that were identified in this survey 
are consistent with previous studies, for example, distraction and interruption, heavy 
workloads (Dickinson et al. 2010, O'Shea 1999, Wakefield et al. 1998, Tang et al. 
2007, Kim et al. 2011), and unavailable second checkers (Evley et ai, 2010). 
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Most nurses recalled making or identifying less than 5 errors in the last month. This 
is consistent with other studies which found the mean number of errors recalled was 
from 2 to 4.9 errors per nurse (Mayo & Duncan 2004, Mrayyan et al. 2007). 
The vast majority of the respondents' strongly agreed that Single checking should 
not be introduced in the hospital. A few suggested that single checking may be 
useful for certain types of medicines. This variation in their opinions may be affected 
by their experiences with drug administration and the double checking process or 
may be affected by their confidence and their responsibility in their practice. This 
opinion is consistent with other studies findings, which was that the double checking 
process remains the most stable safeguard against MEs, particularly when high risk 
drug or complex drug dosages are used (Pape 2001, Manias et al. 2004, King 2004). 
In contrast, others have found that nurses welcomed the single checking process of 
medication administration because it gave them more accountability for medication 
administration than when using double checking (O'Connell et al. 2007). This study 
also stated that the single checking process encouraged the nurses to update their 
drug information and knowledge (O'Connell et al. 2007). 
In addition, one study found that the majority of the nurses appreciated changing 
their practice to the single checking process (Jarman et al. 2002). They felt that 
single person checking of medications saves time and provided them with more 
responsibility and accountability. 
Anderson & Webster (2001) also found that the use of single checking saved nine 
hours per week during medication administration giving the nurses more time for 
patients needs. 
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4.5 STUDY LIMITATIONS 
There are several limitations in this study. The survey was conducted in only one 
setting. Therefore, this study's results were obtained from one children's hospital 
and may not be generalized to another setting or other registered paediatric nurses. 
Another limitation is the relatively low response rate (40%). It is common for mailed 
surveys to yield limited responses (Jones et ai, 2010) and this may increase when 
requesting sensitive information as this study did. The convenience sample might 
not reflect the actual population. 
4.6 CONCLUSION 
. The survey results showed that the paediatric nurses suffered from insufficient 
knowledge and lack of clarity on the double checking process's definition and steps 
in the hospital policy and routine practice during medication administration. Also, 
this study has shown that the double checking process is supported by participants 
as appropriate practice in the children's hospital. However, this result supports the 
findings of other studies in relation to the factors that affect the nurses' adherence to 
medication administration and the double checking process policies. Most of the 
participants were agreed in their preference of the double checking process over 
single checking for patient safety for all types of medicines in practice. This study 
suggests that more training and clarification of the double checking process are 
required for all paediatric nurses to improve the implementation of double checking 
in practice. 
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CHAPTER FIVE 
MEDICATION ADMINISTRATION ERRORS WITH SINGLE AND 
DOUBLE CHECKING IN PAEDIATRIC PATIENTS: 
SIMULATION STUDY 
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5.1 INTRODUCTION 
5.1.1 Overview 
MAEs involve different types of errors including, for example, incorrect preparation, 
incorrect rate of intravenous (IV) administration, incorrect dose,· omission and 
commission errors, incorrect drug, incorrect patient and the wrong formulation 
(Miller et aI., 2007; Ghaleb et aI., 2010) 
Different strategies have been established, developed and implemented in an effort. 
to reduce or prevent MEs. Double checking of medicines by two registered nurses 
is one such strategy that has been used to attempt to reduce or prevent MEs from 
reaching the patient (Conroy et ai, 2012). This strategy has not yet been proven to 
be an effective process in reducing MEs and they continue to occur despite it. 
My systematic review (Chapter 2) highlighted that there is insufficient scientific 
evidence to justify double checking of medicines. Therefore more studies and 
research are needed to evaluate double checking of the administration of medicines 
and its effectiveness in reducing MEs. 
5.1.2 Nurses role in medication administration 
Nurses frequently administer medications for in-patients and they are often the last 
line that can prevent MEs from reaching patients, as administration is the last stage 
of the medication process other than documentation and patient monitoring 
(Dowdell, 2004). A previous study has found that nurses are the profession most 
likely to detect MEs (Kohn et ai, 2000). 
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5.1.3 Simulation study 
In the last ten years, there has been an interest in using simulation methods for the 
purpose of improving patient safety and patient care through a variety of 
applications (Gaba, 2004; Laer and Meibohm, 2011). Simulation is a technique, not 
a technology, to replace or amplify real experiences with guided experiences (Gaba, 
2004). The use of simulation in the study of nurses' practice to provide evidence 
prior to new procedures being implemented in the clinical setting is relatively new. 
This study was conducted to reduce the knowledge gap about whether double or 
single checking is more effective in detecting and reducing MEs in paediatric 
inpatients. 
A simulation study design was chosen for three reasons. Firstly, we wished to 
compare double and single checking processes, but in the Derbyshire Children's 
hospital, the drug administration policy requires double checking for all drugs and 
without good evidence it was thought unethical to change these. Secondly, with 
simulation there was no risk or hazard to patients because dummy patients were 
used. Thirdly, simulation can be a powerful learning tool for participants and may 
improve nurses' knowledge through the investigator's feedback to the participants. 
This study was designed in such as way as to reflect the daily routine practice of 
drug preparation and administration by paediatric nurses in the hospital. 
5.2 AIMS AND OBJECTIVES 
This study was primarily intended to examine which intervention, either single or 
double checking, is more effective in detecting and reducing MEs in children. A 
secondary aim was to measure and compare the amount of time required for single 
checking and double checking procedures in medicines administration. 
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5.3 METHODS AND MATERIALS 
This study was an observational simulation study performed in a single children's 
hospital to assess the effectiveness of the double checking process by two nurses 
on drug administration and to compare that with a single checking process 
performed by the same nurses. 
5.3.1 Ethical Approval 
Ethical approval was obtained from the University of Nottingham Medical School 
Research Ethics Committee (Ref: N19042012 (12038) GEMS). (Appendix C). 
Approval was also obtained from the Derby Hospital's NHS Foundation Trust 
Research and Development (R&D) department (Ref: DHRD/20121034) (Appendix 
C). Written informed consent was obtained from all participating nurses (Appendix 
C). 
5.3.2 Recruitment 
All senior paediatric nurses were informed about the study by the investigators 
during a nurses' meeting. All registered paediatric nurses in the wards were 
informed individually using an information pack. This included an invitation letter, 
participant information sheet, two copies of a consent form and an empty envelope 
addressed with the investigator's name and address for return of consent forms for 
those who were willing to participate in the study (Appendix C). 
The investigators explained to all partiCipants, that entry into the study was entirely 
voluntary, their work would not be affected by their decision to participate or not and 
that they could withdraw from the study at any time. It was explained that if a 
participant wanted to withdraw part way through the study the data already collected 
would be used in analyses. Three weeks after the first invitation a reminder letter 
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was sent to all nurses. The participants who replied were asked to advise the days 
and the times that they would be available to do the study. 
5.3.3 Simulated scenarios 
In an empty patient bed space on a medical ward, nurses who agreed to participate 
were given two prescriptions and two dummy patients. The required quantity of 
medicines was determined and purchased by the project chief investigator 
(Paediatric clinical pharmacist) from the pharmacy department before the study 
commenced. Study medicines were stored in the pharmacy when not in use. 
The investigators provided each participant in each simulation session with 
information about the simulated patients and their medicines. They were then asked 
to prepare the following prescriptions: 
- Two simple prescriptions (one oral analgesic medicine and one oral 
antibiotic). 
- Two more complex prescriptions (an IV bolus of antibiotic, one 
requiring drawing up and one also needing reconstitution). 
- Two IV infusions (one antibiotic requiring reconstitution and dilution 
and another antibiotic requiring a volume calculation). 
Two separate scenarios with two patients each including the above requirements 
were designed. Different types of Medication Prescribing Errors (MPEs) and other 
confounders were built into each scenario involving both prescribing. and 
administration. Each nurse was required to prepare and administer the prescriptions 
in a pair with another nurse with double checking, and alone for single checking on 
different days. Different scenarios were used for double and single checking. No 
nurse did the same scenario twice. 
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The scenarios varied sufficiently enough to act as an independent test. At the end of 
each session of the study the investigators would give feedback immediately to the 
participants, individually (for single checking process) or for both participants 
together (for double checking process) on their performance in order to improve 
their knowledge and skills of medication administration, and also to increase their 
awareness about patient safety. This was done in a friendly non critical manner. 
In simulation scenario 1 (case 1) the patient was 6 years old, female, weight 20.5 kg, 
had no known allergy to drugs or foods, had been admitted to the hospital with a 
urinary tract infection (UTI) and had pain (Figure 5.1). Prescribed drugs were: 
- Paracetamol 300 mg orally every 4 hours when required. 
-Ibuprofen 120mg orally every 6 hours when required. 
-Trimethoprim 40 mg orally once daily for prophylaxis. 
- Cefuroxime 400 mg IV every 8 hours for 5 days. 
- Gentamicin 50 mg IV every 8 hours (on separate Chart). 
Two confounders were built into this case. The first confounder: paracetamol had 
been given 2 hours earlier (as a once only dose on the front of the chart), and 
therefore the participant should not give the paracetamol dose again. The second 
confounder, was that gentamicin levels had been taken but no result had been 
recorded therefore the participant should ask the doctor or the pharmacist about the 
gentamicin serum level and ensure that it was safe before giving the next due dose 
to the patient. 
The nurses should therefore administer four medicines only. A child size dummy 
was provided for this scenario including a patient wrist band and IV cannula. 
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Figure 5.1: Simulation scenario 1 (Case 1) 
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-. -. -. FOR CHILDREN OVER 8·WEEKS OLD -. * * 
Patient addressograph 
AU;XfrwO£J:J ~ ~ ( i l f f
S C!tvEwDrs:.H Wfty 
Iv\ I CK L ~ o v v €;e.- Dog. 
o l - 0 6 · · ~ o - S I I
Weight 
2csk 
. ..... 9 
• For babies 0-8 weeks old - use NICU gentamicin prescription 
• For CF patients - use once daily TOBRAMYCIN prescription 
• For children with renal impairment - consider alternative treatment. 
Indication for gentamicin (tick 
one or more): 
o Pseudomonas (non-CF) 
DUTil pyelonephritis 
o Micro I sensitivities 
If gentamicin is the only option, discuss with Consultant and pharmacy. 
• Use dosing guidelines below, UNLESS a recent dose available for same patient in last 6 months. 
Age Dose regimen Preparations available 
(non-CF patient) 
8 weeks to 12 years 2.5mg/kg 8-hourly 10mg/ml and 
12 -18 years 2mg/kg 8-hourly 40mg/ml 
Therapeutic Drug Monitoring 
Target levels Trough: Less than 2mgll 
Peak: 5-10mg/l (higher end for Pseudomonas) 
• Take filli level at 3rd dose (immediately pre-dose and ONE hour post-dose) 
• Interpret these levels before giving 4th dose 
• If dose CHANGED, REPEAT level at 3rd dose of new regimen. 
• If dose remains the SAME, repeat levels every 4 days 
For advice on changing doses, please contact pharmacy - the table below is intended as a basic 
guide and does not take into account patient-specific factors. 
Levels Potential action. - please d/w pharmacy 
Trough <lmgll, peak Increase dose, usually assume linear kinetics 
low i.e. for 20% increase in level, increase dose by 20%. 
NB: If a dose increase >50% required, please discuss with Senior Dr. 
Trough 1-2mgll, peak Increase dose as above but consider increasing dose intervai as well 
low e.g. extend from a-hourly to 12-hourly. Increasing dose on top of a 
trough level already above 1mgl1 will cause a further increase In trough 
level 
Trough <2mgll, peak Reduce dose, usually assume linear kinetics I.e. for 20% reduction in 
high level, reduce dose by 20%. 
Trough high, peak high Consider omitting dose, then reduce dose and increase dose Interval 
If levels very high, consider repeating before recommencing doses 
Trough >2mgll, peak Consider omitting dose, then increase dose interval 
OK 
Trough >2 mg/l, peak Consider omitting dose, then increase dose and increase dose interval 
low 
Pilot - February 2008 
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TDM Results 
I DatB: 
"';'--+-_ -----1,-
-' I DB,te,.!-: ___ ~ D : ! : ! 1 . : ; : t e ~ : := ~ ~__ l_D_at __ e _ ,,=j_...J' ' 
~ - - - , - = : = = J ~ b ~ . - U U
Prescription 
Also prescribe "Gentarnldn-' on the ·Regular Prasc:riptio,' part oftreaMlent ca'd and add ''See l I ~ a ( ' . h o d d sheet". 
Sign this entry and keep this preectlplil>n ;n 'patient's Observation fi'e', 
Pilot· February 200B 
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In simulation scenario 1 (case 2), the patient was 5 months old, female, weight 6.7 
kg, had no known allergy to drugs or foods, and had been admitted to the medical 
ward with ?sepsis and ?aspiration (Figure 5.2). Prescribed drugs were: 
-Ceftriaxone 540 mg IV once daily for 7 days. 
- Metronidazole 125 mg IV every 8 hours for 7 days. 
One confounder was built in to case 2. The metronidazole dose was incorrect (a 
rectal dose had been prescribed as IV). It was hoped that the participant would 
check the dose and identify that it was incorrect and request it to be corrected 
before administering the dose. The nurses should administer two medicines (after 
dose correction). A baby size dummy was provided for this scenario including a 
patient wrist band and IV cannula. 
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Figure 5.2: Simulation scenario 1 (Case 2) 
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SAFE PRESCRIBING (refer to Medicines Code' 
• Write clearly in black ink and use approved names 
• All prescriptions ml!lll!t fully signed and dated 
• Each prescriber should include bleep number at least once 
• If a dose is to be intentionally withheld. mark the chart I8l 
• If discontinuing. draw a line through. state reason, sign & date 
• Cross reference UW! of supplementary charts on front 
If KNOWN TREATMENT WITH LONGTERM ANTIBIOTICS, PflESOIBE ON REGULAR SIDE. 
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In simulation scenario 2, (Case 1), the patient was 10 years old, male, weight 32.4 
kg, was allergic to penicillin (caused rash), and was admitted to hospital with 
appendicitis and pain (Figure 5.3). Prescribed drugs were as follow: 
- Paracetamol 650 mg orally every 4 hours (for pain). 
- Diclofenac 30 mg orally every 8 hours (for pain). 
- Cefuroxime 640 mg IV every 8 hours for 7 days. 
- Metronidazole 245 mg IV every 8 hours for 7 days. 
In the above case, two confounders were built into the prescription. A paracetamol 
dose had been given to the patient on admission, so the nurse participant should 
not duplicate the dose. The second confounder was that the participant should not 
give the cefuroxime dose until confirming with the doctor that this was acceptable 
given the patient's penicillin allergy. The nurses should therefore administer three 
medicines only. 
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Figure 5.3: Simulation scenario 2 (Case 1) 
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SAFE ADMINISTRATION (refer to Medicines Code) 
• Always check patient 10 and 
allergies bffgr.e administration 
• Record all administrations on 
chart with initials. Second check 
should be recorded as shown 
• Reule patient's own medicines 
• Retord self·administration 
of medicines (SAM) on the 
administration record 
L 1 • full SAM. U. Hurw ~ r v i s t ! d d
~ ) : : : D C J ~ ) L l l i oeJ, 
-
Do" 13 
Gw,n 
Oo\f 
18 
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""" 22 
( , . ~ ~
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22 G_ 
Route 
CHECK PAnE NT NAME AND HOSPITAL NUMBER 
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In simulation scenario 2 (Case 2), the patient was 5 days old, male, weight 3.6 kg, 
and was admitted with meningit!s and was in pain (Figure 5.4). The prescribed 
drugs were as follow: 
- Paracetamol 48 mg orally every 4 hours. 
- Ibuprofen 22 mg orally every 6 hours. 
- Cefotaxime 180 mg IV every 6 hours for 10 days. 
- Amoxicillin 360 mg IV every 6 hours for 10 days. 
Three confounders were built into the Case 2. The patient allergy information had 
not been completed, and therefore the participant was expected to ask the parents 
before giving the drug to confirm that there was no allergy which would 
contraindicate the drug. The other errors built into this prescription were that both 
the cefotaxime and amoxicillin dose frequencies were written incorrectly (prescribed 
four times daily instead of twice daily). The nurses should therefore administer three 
medicines (Le. both antibiotics after requesting the frequency of antibiotic doses to 
be changed to twice daily and either paracetamol or ibuprofen). 
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Figure 5.4: Simulation scenario 2 (Case 2) 
l1li"' •• ,,".'-1.' • . T . ' ~ " i i • DrugIFood allergies Description of reaction 
o No known allergy 0 Red wristband in place 
Prrn"rn-ameanastginrnd, 'bT.±:.P"'j------..", Iu;;.:,., .. ;-----I 
Patient Admitted Date :3 .. '" .12.. 
CHART Started Date 3· 9 /2 
I Number of Main Charts in use of Use this space for specific Information/stickers/stamps 
1 Charts In us •. ( .... ) 
0 lo/TPN 
0 Iinsulin 10lpCA 
",,0 !Genta ~ ~1'·'·01 .,... .. ~ : ~ : :IVTE I 0 
r: I AKI risk stage I ICKD ""V" I 0 
:: 
- - - ~ ~
----
-
. ~ ~ . - . ~ ~ - .0 • 
10 Hepatic 
10 "" '" • 
.... Inlt •• 1 Dolt" Time 
.... ., '" ONf'Omle" Guld ... _ 
" 
MttdicinH R«ondllatlon I 0 : 
n A g"" I Ch";'k . " . r ~ i ' ; ' ; , : ; " t I " t ' '.. Allergy Information o __ h-_L --;-Ii I Cytotoxic Medicine. 0 I ~ . ! ' c ~ r . : ~ ' . r r" , , ; ; : ~ , ~ ~ I . ' ' Information Sources <"") P.tlent 0 PODS r;:;2--GP 0 N o t e s . ~ ~Other , Initial Date 
H II ' 0 I ~ : ; : : ; ~ : : ; . . 'io', mon'"'' lad,,,,, dote ~ - - - .---I,i: , Compliance .id on .dmfulon 0 ,., 1 1 : ; ' ; ~ l i n n 0 I = : . : : ' : ' ; ~ : : , ~ ~ ~ ' ~ y : ~ ~ ~ Compli.n<e aid .SMument [J 
lOp,,,,,,, 0 I ~ : : ; : ~ o : ' ; ~ ~ ; t ~ o : : ; . ~ ~ ~ ~ ' ' Medicines Information g,,,en 0 
I NSAID. 0 I U ~ . ~ ~ ~ ~ , ! : n n the .'.o"y. wah Discharge prescript jon wppUed 0 
ISeda'ives 0 I : : : n ' ~ : ' ' ~ : : . : r . h h p.odud end Ref.".1 to Community Ph.rmaciJt 0 
-. l . q l l · h ' l ~ · . . ;1:::II
T1 l::t "" (".:.111.' ,. :-11 :t. 1 •• l0.,::at {O: a ~ a ! . .
~ ; ; , : ~ ~ " .. ~ : . ~ ; ' . ' , ~ ~ ~ • p Pr..cribed Drug Dose directions r--;;:;.-' c : ~ ~ ~ ~ l l I"'''''' "HARM Oat. (.PPfoved n.me) ,,,., .. ';p, t--
: 
, : 
..:. : 
.. ,._---
i 
i i v ~ , , " , ; " " , , ~ ~ . ;"'.'." . , . ~ . ' - ' ' >'. ~ o < < , ,._'" .. '. , ... ( .. , . ~ ~ " , .. "-"_' or - ~ ~
109 
: 
I ! l . ~ ~ ; . l ' . J U ~ ; { I ' U I J , , l:i' J;l 
.'Il'l_ I : . U · I ' = ~ : : IC\'.I(li"i ~ D I I ' _ _
SAFE ADMINISTRATION (refer to Medicines Code) RECORD ~ v , . , ,.... ~ , , ~ , ~ ~ ~
• Always check patient 10 and • Reuse patient's own medicines ! Route Indication Print names ana sign 
allergies bdoN administration • Retord self·administration 
• Record all administrations on of medicines (SAM) on the : chart with initials. Second check administration record 
should be recorded as shown l1 .Full SAM, L2= Nur5f tuperviMd 
• All COs, IV and other high risk ... _ .... ....... 
medicines should be second ea i checked 
--- -
: 
, 
r . : . , " ' 1 : f : : { ' l ' J I : i ~ · , I ~ : l : : $ . ' 1 t ! i ' i l ~ U · J J • • NUMBER 
' " R U p ~ ~ ~ / ~ . . . /0.,. 
. TAMOL- 1 ' i ~ l n n... 
R.,V1. 1;;;Pf;';::-'Y'+ lIP"') / Ph"m. p" 100M 
1 \ 3 t 7 ~ ~ r Z A L . ~ ~ ~ ~ n ~ t " P I I Slopd.tt IG,- : : : : : : : 
,RIA> 7"B'c/f5"1-of EN' "- 10• ,• 2 t ~ ~ Ir .... 
Roult' ~ ~ ~ ~ Pt'cHm. Po /00M II;?:, I Print rJdmt- & \190 (111(/. blE'pp) Stopd<tut IGI'IOn : : : : : 1';: iZ/lLC 1.11.,414 L : : 
. I :)RuG (Approved N < l n ~ 1 1 00", I Oat. 
: In ... 
~ ~ Rou'. Ilndk.atiofil MuO'I. trQGuen(y ,"'a,m. 00M 
2 
~ t a r r O i t t p : : I ,,,Ilt n.m> & "9" (i.,d bl"pJ i"upd.te 
IG'- ~ ~ i : : : : 
.' 
~ f t u G G i.Apploved Nalllf!j ,D'It I Dol. 
" I rome j 
~ ~ ROlJti (Indk41IQn I "'''II 1 r e q u e ~ ~ iPh.,m. 00M 
.', 
~ ~ ')tartO .. te I,,,nt ow .... I I ""I> d.1< : ; : : : i : j i i .' I Given : : : : : : { , '''n" u"" IDa" 
% I rome 
'/, Routt Ind¥.dtIOC'l'M.)I; trequ(>n(y Ph')ffl'1. 
" I DoH ~ ~
l ')(¥t Dite Pllnl "-lmt I: ~ , . , , (fll(1. blft'P) P'OPda" i i i i : i : : : : ! (ii_ : : : : 
i.' ORul1 \ A " , p r O ¥ ~ ~ Nlllme) I""'" ~ ~ .\l:fl; 
; I Time 
l' 
\ i{CIljte Indr,atlQllIM'lI fteQ4le(\(Y I Ph.,m. , 
00M t ",,'Oat, Pnnt !lime • SIgn (10d. Dleep) Iltop dale I Given ; : ; : : : 
...:. 
. 
+ l'/':'1 ~ ~ r . : . l : i l l l ::'1'1.'1-1::'1 ~ a : : $ . ' 1 ~ . i . 1 1 LilJ 'n ~ ~ CHECK PATI£NT NAME AND HOSPITAL NUMBER 
>,- ClRCU TIMEI RJ.QlIIAEO OR E N T ~ ~ D J ~ l l R $ ~ i i .... 
DRUG (AppfOIlf'd name) Colt 
l 8 : : : : : : : : : G_ flwte S ~ l j l l O l r r c . l i o n ~ ~ Coot 13 : : : : : : <iovtn 
! iUrtDatr 1101> O"'l'h.,moq Cow 18 : : : G_ : : : : : Pnnt NMllf I: Sign (wi bh,oep) -22 : : : G I ~ ~ : : 
€ 
ClRuG \ ~ j . l l o . " e J J n.meJ 
-
8 G_ : : : : : : : : : 
flolJur: !>pe(I.lIIOIle<tioni 
-
13 s_ : : : : 
~ t , l r t t 001(" 
Ilop M. C''''''''Y [)me 18 
c,,"'" : : : : : : : : 
Pr,nt N..,ma & ~ l i g l l l (mcl, blttp) Coot 
22 ;< G_ : : : : : ~ ~
!. 
1.,-- ." .. " .. ' . ' , ~ . . 'h., ., < ..... "'.",' '''- ~ ~ ,. " ~ , . . , . 
110 
;'Idrt Doll 
5· • , ",'luG {A, 
t , 
Route 
I CHECK PATIENT NAME AND HOSPITAL NUMBER 
SAFE PRESCRIBING (refer to Medicines Code) 
• Write clearly in black ink and use approved names 
• All prescriptions lIlustl!§ fully signed and dated 
• Each prescriber should include bleep number at lealt once 
• If a dose is to be intentionally withheld, mark the chart ~ ~
• If discontinuing, draw a line through, state reason, sign & date 
• Cross reference use of supplementary charts on front 
If KNOWN TREATMENT WITH LONGTERM ANTIBIOTK5, PRESCRIBE ON REGUlAR 510£. 
STAT£ COURSE LENGTH. REVIEW DAilY. SWITCH FROM IV TO ORAL ROUT! AS SOON AS POSSIBLE . 
• ~ - - ~ - - - - L - ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ r - - - - - ~ ~ · - 1 ~ ~ r - ~ t - - - 1 - - - ~ - - - t ~ - 1 l i r - - - 1 1 __ ~ - - - t ~ - 1 1~ = =~ - + - - - r - - + - - - ~ - 4 ~ - r ~ i f ~ ~ - ; - r ~ + - ~ ~
~ ~ ~ - - ~ ~ ~ ~ ~ ~ ~ - - ~ r + : - ~ ~ ~ : - + - - r ~ ~ I r - ~ ~ - - ~ ~ ~
Route ~ ~ ~ ~~ ~ ~ + - ~ - - - r - - r - - + ~ ; f r - - T - - ; - ~ - - ~ ~~ ~ / V - - 4 - - - ~ ~ - - - - ~ - - ~ - - ~ - r + - - r - - ~ - r - 4 - - ~ ~ l ; r - ~ ~ : - ~ ~ ~
~ f - t - ~ t - ~ t - - - ~ ~ ~ ~ ~ ~ i ' r - ~ t - ~ ~ ~ r - ~ f f
~ ~ - - ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ + - - r ~ - - + - - r - ~ ~ ! i r - ~ ~ : - ~ ; ;
~ r - t - - - ; - - - - r - - - t ~ - 1 - - ~ r - ~ · ! r - - - ; - - - - r ~ - t ~ - - 1 1~ ~ ~ ~ ~ - - ~ - - - - ~ - 4 L - - - ~ ~ - - ~ ~ - - ~ ~ ~__ ~ ~ ! ; ~ - r r__ r - - r ~ ~
~ r - r - - - r - - - t - - - + - - - + - - - ; - ~ s ' r - - - t - - - + - - - + - - - ' i iat 
~ ~ - + - - - - ~ ~ - - - - ~ r - ~ - - - - ~ ~ ~ - + +__ + - ~ ~ - r ~ r - ~ j ~ ~ - + ~ ; - ~ ~ ' '
Stdft Date Print Name & Slgn (inc!. bliE'Jl) 
094-98% 0 
INDICATE !>All • 
ClIICLf TlMIS OIlIN'I" • 
Othe, ~ h l r a t l o n n __________________ _ 
111 
. .............. .. 
. ! ~ . ~ ' n O N ~ l & O W t o t b b .... . 
It was hoped that the participant would detect these confounders before preparing 
the drugs and giving these to the dummy patients. The confounders built into the 
prescriptions were based on common errors occurring in the hospital (which had 
been reported in the hospital incident reporting system). There were 3 confounders 
in total in scenario 1 and 5 in total in scenario 2. 
5.3.4 Inclusion/exclusion criteria 
All registered paediatric nurses in the wards of the Derbyshire Children's Hospital, 
who were responsible for administering medicines, were eligible to be involved in 
this study. Student nurses were excluded. 
5.3.5 Sample size 
All 120 registered paediatric nurses in the wards were informed about this study and 
invited to participate. Twenty three nurses agreed to take part. Of these, two nurses 
withdrew because they were moved from medical wards to the children's 
emergency department and both of them were unavailable to do the study. Overall, 
21 nurses took part. 
5.3.6 Duration of the study 
The study was conducted over a 6 week period (from September - October) in 2012. 
5.3.7 Data collection forms 
Each simulation scenario session began with an orientation of the participants about 
the study and its purposes. The participants were given brief information about each 
clinical case and asked to give the patient medication as prescribed. Data collected 
included the name of the drug administered; completion of all individual steps of 
drug administration, start and end time of administration, and other additional 
observer's comments, if applicable (Appendix C). 
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5.3.8 Data analysis 
Data analysis was performed using SPSS version 17.0 for Windows. A P-value of 
0.05 was considered statistically significant. Results were calculated according to 
the means and standard deviation with 95% Confidence Intervals (CI). The Mann-
Whitney test was used to assess and measure the significance of time taken for the 
medication process between the two independent samples (double and single 
checking). 
5.4 RESULTS 
5.4.1 Demographic data 
The study included a total of 21 participants, from different wards and areas within 
the hospital. In total, 10 simulations of the double checking process were conducted 
by 20 nurses and 20 simulations were conducted with single checking. also by 20 
participants (Table 5.1). Two participants did not do both checking processes (Le. 
one of the participants did single checking only and another participant did double 
checking only). due to time and clinical duty constraints on the nursing staff. 
The participants were selected randomly for each simulation. Most of the 
participants (14 nurses) conducted double checking as their first simulation. 
Thirteen participants performed the single checking process as their second 
simulation (Table 5.1). 
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Table 5.1: Participants distributed randomly between two simulations. 
Nurse Code 
A 
B 
C 
D 
E 
F 
G 
H 
J 
K 
L 
M 
N 
o 
P 
Q 
R 
S 
T 
U 
First simulation 
Scenario 1 (Double checking) 
Scenario 1 (Double checking) 
Scenario 1 (Double checking) 
Scenario 1 (Double checking) 
Scenario 1 (Single checking) 
Scenario 1 (Single checking) 
Scenario 1 (Single checking) 
Scenario 2 (Single checking) 
Scenario 1 (Double checking) 
Scenario 1 (Single checking) 
Scenario 2 (Double checking) 
Scenario 2 (Double checking) 
Scenario 2 (Double checking) 
Scenario 2 (Double checking) 
Scenario 2 (Double checking) 
Scenario 2 (Double checking) 
Scenario 2 (Double checking) 
Scenario 1 (Single checking) 
Scenario 2 (Single checking) 
Scenario 1 (Double checking) 
Scenario 1 (Double checking) 
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Second simulation 
Scenario 2 (Single checking) 
Scenario 2 (Single checking) 
Scenario 2 (Single checking) 
Scenario 2 (Single checking) 
Scenario 2 (Double checking) 
Scenario 2 (Double checking) 
Scenario 2 (Double checking) 
Scenario 1 (Double checking) 
Scenario 2 (Single checking) 
Scenario 2 (Double checking) 
Scenario 1 (Single checking) 
Scenario 1 (Single checking) 
Scenario 1 (Single checking) 
Scenario 1 (Single checking) 
Scenario 1 (Single checking) 
Scenario 1 (Single checking) 
Scenario 1 (Single checking) 
Scenario 2 (Double checking) 
Not available to do simulation 
Scenario 2 (Single checking) 
Not available to do simulation 
Table 5.1: Contd 
First simulation Second simulation 
Checking Single Double Single Double 
Scenarios 
Scenario 1 5 7* 7 1* 
Scenario 2 2 7* 6 5* 
Total 7 14 13 6 
rtThe odd number of simulations for nurses with double checking is explained by the 
presence of a nurse who had previously performed single checking. 
5.4.2 Confounders in scenarios 
Overall, a total of 118 confounders were built into the simulation sessions. A total of 
76 confounders were built into the single checking scenarios and 42 into the double 
checking scenarios (Table 5.2). 
Significantly fewer confounders were detected during single checking (49n6, 64%) 
than during double checking (37/42, 88%), (P = 0.0136). 
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Table 5.2: Confounders in the scenarios and errors made 
Checking 
Double 
checking 
Single 
checking 
Overall 
Scenario 
Scenario 1 
Scenario 2 
Total 
Scenario 1 
Scenario 2 
Total 
No. of Total No. of drugs 
participants to be 
administered 
4 pairs 24 
6 pairs 36 
20 60 
12 72 
8 48 
20 120 
180 
Total No. of 
confounders 
present 
12 
30 
42 
36 
40 
76 
118 
116 
Total No. of Total No. of Total No. of Total No. of 
confounders not confounders errors made by near misses 
detected detected participants 
0 12 0 0 
5 25 1 0 
5 37 1 0 
10 26 1 
17 23 3 o 
27 49 4 1 
32 86 5 1 
5.4.3 Undetected confounders 
A total of 32 confounders were not detected. The majority (27) of these were not 
detected during single checking (Table 5.3). 
Table 5.3: Undetected confounders for single and double checking 
Checking 
Single 
Double 
Undetected confounders 
• Incomplete information 
Allergy information 
Drug contraindication i.e. patient is allergic to penicillin 
and cefuroxime was given, without asking for 
confirmation before administration). 
• Incorrect dose frequency prescribed (cefotaxime, amoxicillin 
IV doses). 
• Wrong dose prescribed (metronidazole IV doses). 
Total 
• Incomplete information 
Frequency 
8/12 
8/8 
6/8 
5/12 
27ns 
• Allergy information was not completed on the medication 1/30 
chart. 
Drug contraindication i.e. patient is allergic to penicillin 4112 
and cefuroxime was given, without asking for 
confirmation before administration). 
Total 5/42 
5.4.4 Influence of simulation on participants 
There was a possibility that the nurses were more likely to detect the confounders 
during the second simulation, i.e. they had learnt from their first simulation. I 
therefore compared the number of confounders detected for the first and second 
simulations (Table 5.4). 14 nurses did double checking as their first participation, 
and 13 of these nurses did single checking as their second simulation. Surprisingly, 
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these nurses were less likely to detect confounders during their second simulation 
than their first simulation. Additionally, 7 nurses did single checking first and 6 of 
these then did double checking. These nurses were slightly more likely to detect 
confounders during their second simulation compared to their first simulation. 
Table 5.4: Comparison between first and second simulation results 
Checking 
Double checking 
(as 1 st simulation) 
Single checking 
(as 2nd simulation) 
Single checking 
(as 1st simulation) 
Double checking 
(as 2nd simulation) 
No. of 
participants 
14 
13 
7 
6 
No. of confounders not 
detected (%) 
2 (7) 
20 (40) 
7 (28) 
3 (23) 
5.4.5 Actual errors made by participants 
No. of confounders 
detected (%) 
27 (93) 
31 (60) 
18 (72) 
10 (77) 
Five preparation and administration errors and one near miss were identified in the 
simulation sessions (Table 5.5). Four errors were made during single checking and 
one error was made during double checking. One near miss was identified during 
the single checking process. 
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Table 5.5: Medication errors 
Checking 
Single 
Double 
Error 
- Wrong dose of cefotaxime IV was 
withdrawn from vial after reconstitution 
(1.44 ml instead of O.9ml). 
• Patient was given the due dose of 
paracetamol but the nurse did not sign the 
chart for administration. 
- Wrong diluent volume was added to 
cefotaxime IV (5.4 ml instead of 2.3 ml), 
and wrong dose was also given to the 
patient (1.8 ml instead of 0.9 ml). 
- Paracetamoi/ibuprofen dose was due but 
the nurse did not give the dose . 
• Did not label the flush saline syringe. 
5.4.6 Time taken for medication administration 
Near miss 
- Paracetamol bottle was 
selected by participant rather 
than ibuprofen, but detected 
before administration . 
The time taken for drug administration was similar with both the· single and double 
checking processes (Table 5.6). 
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Table 5.6: Time taken for drug administration 
Scenarios Cases Time taken by double checking Time taken by single checking P-value 
(minutes) (minutes) 
Mean SO Mean SO 
Case 1 24.2 2.2 24.9 8.3 0.896 
Scenario 1 
Case 2 17 8.1 15.5 6.4 0.895 
Case 1 19.1 5 16.6 3.7 0.343 
Scenario 2 
Case 2 16 4.5 17.2 3.2 0.516 
Total 76.3 19.8 74.2 21.6 P-value = 0.861 
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5.4.7 Qualitative evaluation 
The level of knowledge and confidence among the participants and the clinical 
performance feedback for participants, were interesting issues arising out of this 
part of the study. 
5.4.7.1 Level of confidence 
None of the participants were familiar with the single checking process except one 
nurse, who had previously worked in a children's hospital that used the single 
checking process for medication administration. This participant was clearly more 
confident than the other nurses when required to do the single checking process, 
but did not detect all confounders in that session (she missed a drug 
contraindication confounder). All other participants checked the BNF-C at every step 
to confirm their information. Most of the participants also tried to confirm the correct 
information with the investigators or seek reassurance during the medication 
preparation and administration. The level of confidence and unfamiliarity of most 
nurses with the single checking process may have affected their detection of the 
confounders that were built in to each prescription in the single checking process. 
5.4.7.2 Clinical performance feedback 
At the end of each simulation session, the chief i ~ v e s t i g a t o r r and I gave the 
participants feedback on their performance in order to improve their knowledge and 
skills of the double checking process and medication administration. If the 
participants did the process according to the hospital policy and procedure and 
when no errors were made by participants then positive feedback was given. If there 
was any step missed, or. not performed properly or any confounders undetected or 
errors made during the medication administration process the participants were 
made aware of these in a supportive and friendly manner. 
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All participants in this study accepted the feedback that they received from the 
investigators and most of them stated that they had learned new information. 
5.5 DISCUSSION 
This observational simulation study was conducted to determine whether single or 
double checking is most effective in identifying and reducing MEs in a children's 
hospital. To our knowledge it is the first simulation study conducted to assess the 
effectiveness of double checking in paediatric hospital. As reported in Chapter 2, 
from the literature only one quantitative study has previously compared single and 
double checking and that study was in a geriatric hospital. 
Our study showed that single checking detected significantly fewer confounders 
than double checking (P = 0.0136). Additionally, there were a greater number of 
actual errors that occurred with single checking than double checking. These 
findings are in contrast with the previous study by Jarman et al (2002) which was 
conducted in an adult hospital. Jarman et ai's (2002) study suggested that single 
checking was as safe as double checking. However, paediatric patients are more 
susceptible to MEs, which may occur up to three times more often than in adult 
patients (Kaushal et aI., 2001 a). Our findings suggest that double checking is more 
effective than single checking. It is possible, however, that the lack of detection of 
confounders and errors made with single checking by our nurses, was due to their 
inexperience in the hospital with single checking. 
One nurse commented that 
"/ have 20 years experience in drug administration but this is the first time that I 
prepared and administered the drug to the patient a/one without double checking 
with another nurse'. 
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Another participant said that 
"All my work experience as a paediatric nurse was with neonatal patients. I did not 
give drugs to a child patient before'. 
Another participant refused to do a simulated single checking process and justified it 
saying 
'" do not have enough knowledge and experience to prepare IV drugs by myself'. 
The difference between the two processes in terms of drug administration time was 
not significant. However, two nurses were involved in the double checking process 
and the committed time therefore is effectively doubled. In our study however the 
time measured and assessed was for the checking process itself and not according 
to the number of nurses. Previous studies found that the use of a single checking 
process in drug administration round saved up to 9 hours per week (Anderson & 
Webster 2001), and 17 hours of nursing time per 1000 medications administered 
(Kruse et al. 1992), which came from just one nurse being involved. 
5.6 Barriers and challenges 
Nurses are obviously required to provide care for patients, ahead of anything else. 
The researcher therefore faced various issues and challenges during this study's 
implementation. One of the most significant challenges faced was the recruitment of 
nurses to be involved in the study. All the nurses working in the wards received full 
information about the study. Unfortunately, after one month, only 6 nurses had 
agreed to participate. 
After this stage the chief investigator and I worked intensively for a few days to 
persuade as many nurses as possible from different wards to participate. In the end 
23 nurses agreed. 
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The second biggest challenge that I met was matching two nurses together to do 
double checking for medication administration. Each nurse was required twice, once 
alone to do single checking and once with another nurse as part of the double' 
checking process. The single checking process was less challenging to arrange 
logistically because only one nurse's agreement and availability was needed. 
Matching the availability of two nurses for double checking from either the same or 
different areas was however, a significant challenge, because different nurses 
worked in different wards, within different ward situations, and at different shift times. 
To address this, I drew up a timetable to arrange involvement of all the participants 
and for them to do different scenarios or prescriptions in each session, without a 
repetition of scenarios. 
I spent a lot of time checking nurse availability but on a few days either both nurses 
or one nurse was unavailable due to the ward being busy, so they did not have 
enough time to take part. In addition, I tried to prepare the environment and place of 
the study to be as close to real practice as possible. Dummy patients were ready in 
each session with an IV cannula and patient wristbands to make it as realistic as 
possible. 
Real medicines were prepared and administered by the participants according to 
the prescriptions. All medicines had been purchased from and stored in the 
pharmacy department within the hospital. I collected the medicines every day from 
the pharmacy and returned them all after the sessions finished each day, in order to 
store the drugs in a safe place. 
In addition, the study was conducted at a critical time for the nurses because many 
changes were happening in the hospital, so most of the nurses were busy with 
interviews and taking up new positions during the study time. These changes also 
affected recruitment rates. 
124 
5.7 Limitations 
A few limitations have been highlighted in this study. Firstly, we only had 21 nurses 
participate in our study due to the reasons above. Secondly, the study participants 
were all recruited from one children's hospital and all of them were familiar with 
double checking but only one of them was familiar with single checking, so the 
results may not be generalisable to other hospitals. Finally, the participants may 
have been more cautious in the second scenario after they had done the first 
scenario which may have affected the study results for both checking processes. 
Analysis of the results did not show this however. 
5.8 Future research 
Although the design of the simulation study has safety advantages over other study 
designs, there are a few areas identified from this study that can be highlighted for 
future development and research. For example, the comparison between two 
groups of nurses from two different children's hospitals having different levels of 
experience with single and double checking would be helpful for future studies. 
5.9 CONCLUSION 
This study highlighted that the double checking process is more likely to identify 
errors and contraindicated drugs than single checking. Less errors were made with 
double checking compared to single checking. The time taken for drug 
administration was similar between these two processes. The confidence and 
familiarity of the nurses was lower with single checking compared to the double 
checking process. 
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CHAPTER SIX 
MEDICATION ERRORS IN THE MIDDLE EAST COUNTRIES: A 
SYSTEMATIC REVIEW OF THE LITERATURE 
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6.1 INTRODUCTION . 
The Middle East region is strategically, politically and economically important for the 
whole world. There are fifteen countries between Western Asia and North Africa 
which make up the Middle East region (World Bank, 2007). All of these countries 
speak the same l a n g u ~ g e e except for Iran and Israel. Economically, Middle Eastern 
countries are ranked by the World Bank according to their Gross Domestic Product 
(GOP) on Purchasing Power Parity (PPP) per capita. The High Income Countries 
(HIC) includes Qatar, United Arab Emirates (UAE), Bahrain, Saudi Arabia, Kuwait, 
Israel and Oman. The Upper-Middle Income Countries (UMIC) are Iran, Jordan and 
Lebanon. The Lower-Middle Income Countries (LMIC) are Egypt, Palestine, Syria, 
Yemen and Iraq (World Bank, 2007). The Gulf countries (Qatar, Bahrain, Oman, 
Saudi Arabia, Kuwait and U.A.E) which are a part of the Middle East, have 
established the Gulf Co-operation Council (GCC) which has placed increasing 
emphasis on an improved healthcare system during the last decade. In most of 
these countries the governments are the main provider of the health care service 
system. 
6.1.1 Patients behaviour 
Many people in the Middle East fear hospital admission because they think that the 
hospital is a place of misfortune where people go to die. The use of medications in 
the Middle East is common and this is partly because a preventive care system 
does not exist. Many patients complain about doctors if they have not received a 
prescription or have not received what they want to receive from medications 
(Lipson & Meleis, 1983). Many patients in the Middle East have different behaviour 
compared to other patients in other places in the world regarding medication dosage 
forms, colour and quantity. For example, they prefer injections over other dosage 
forms, coloured pills over uncoloured and larger tablets over smaller ones (Lipson & 
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Meleis, 1983). In addition, the main problems that health care professionals may 
face with Middle East patients are the difficulty in obtaining clear and complete 
information from them which may affect their diagnosis and treatment plan. This is 
especially the case when the disease is in a critical place or sensitive area. The 
Compliance, Modalities by Population, Lifestyle and Geography (COMPLY) study in 
the Middle East revealed that patient behavior - particularly the failure to complete 
full courses of medication - reduces the effectiveness of antibiotic treatment of 
infections (Arabian Business, 2007). This study identified a tendency to stop taking 
medication once symptoms disappear. A survey conducted among 4,500 people in 
11 countries, revealed that only six in ten people understood that taking an antibiotic 
improperly may reduce its effectiveness (Arabian Business, 2007). Communication 
between the clinicians and Middle East patients may be somewhat difficult as the 
Middle East patient's family often has more chance to communicate with the 
clinicians and ask questions than the patient himself. A lack of education about 
medication use and diseases is common among rural and less educated people. 
The population of Middle East countries is approximately 300 million with a 
population growth rate of 1.86% (United Nations, 2010). Elderly people of 65 years 
or over represent 3.63% of the total population of Middle East people compared to 
10 % in developed countries (United Nations, 2010). Middle East countries have a 
higher proportion of children with 35% of all people under the age of 15 years 
compared to 18% in developed countries (United Nations, 2010). The International 
Diabetes Foundation estimates that 26.6 million adults (8.6% of the population) in 
the Middle East and North Africa currently have diabetes (International Diabetes 
Federation, 2009). Obesity rates in the Middle East and North Africa are also 
among the highest in the world, particularly in the Gulf countries. 
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6.1.2 Medication Errors 
MEs occur in all countries of the world and are under-reported (Osborne et aI., 
1999), particularly in L1C and UMIC. MEs present a universal problem and can 
cause serious consequences for the patients, especially for patients with acute 
complex medical conditions (Kozer, 2009). 
In the UK"around 7000 doses of medication are administered daily in a typical NHS 
hospital. MEs represent around 10 - 20% of all reported adverse events in NHS 
hospitals (DoH, 2004). The incidence and nature of MEs in UK hospitals are similar 
to those reported in the US (Dean et al. 2002). Prescribing errors occur in 1.5% of 
prescriptions, and administration errors occur in 3 - 8% of oral doses (Dean, 1999; 
Dean et al., 2002). 
Most of the research on MEs has been conducted in the Western HIC. Information 
on the incidence of MEs in the Eastern HIC, Lie and LMIC is limited. Different 
countries have different health care systems. . 
A recent world report shows that the use of generic and essential medicines may 
have increased slightly over the past 20 years in developing countries, overall use 
of medicines has increased and compliance with guidelines has remained low 
(Kohler & Baghdadi - Sabeti, 2011). Data from the World Health Organisation 
(WHO) database show that more than 80% of all prescribed medicines in 
developing countries are dispensed by unqualified personnel and the average 
dispensing time for each patient is one minute (Kohler and Baghdadi-Sabeti, 2011). 
Only half of patients are told how to take their medicines, and about one third of 
patients do not know how to take their medicines immediately on leaving the facility. 
20-50% of medicines dispensed are not labelled (Kohler and Baghdadi-Sabeti, 
2011). In such circumstances it is not surprising that patient adherence to medicines 
is poor. 
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In this research I have focused on Middle East countries because no previous 
systematic review has been conducted about MEs in those countries. However, I 
am from Saudi Arabia and I wished to highlight the problem of MEs in Middle East 
countries in the hope that this wi" help decision makers to develop a response to 
increase the awareness among health care organisations in those countries. 
Another reason is that the Middle East Pharmaceutical market is projected to grow 
at a Compound Annual Growth Rate of around 11 % during 2010/2011 
(Pharmaceutical Drug Manufacturers, 2010). 
In addition, another reason to conduct this review was that in most Middle Eastern 
countries the patients can obtain medicines from a community pharmacy without 
prescriptions. A lack of information on the incidence and nature of MEs in Middle 
East countries is the final reason to do this research. 
6.2 AIMS AND OBJECTIVES 
This systematic literature review aimed to review studies of the incidence and types 
of MEs in Middle East countries, and to identify the main contributing factors for 
MEs in those countries. 
6.3 METHODS 
6.3.1 Search Strategy 
A systematic review of literature relating to MEs in prescribing, transcribing, 
dispensing, administration and documentation in adults and children in Middle 
Eastern countries was conducted in October 2011. The following electronic 
databases were searched: Embase (1980 - October 2011), Medline (1948 -
October 2011), Pubmed (until October 2011). British Nursing Index (1985 - October 
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2011) and Cumulative Index to Nursing & Allied Health Literature (CINAHL) (1982 -
October 2011). These databases were used to ensure that all articles were included 
in this search. The search strategy included all ages and all languages. Also, all 
searches involved all types of trials and studies. Reference lists of all included 
articles were also reviewed manually to check for other relevant articles. 
6.3.2 Search Terms 
In this review the following key words were used as search terms: medication error 
(s), prescribing error (s), dispensing error(s), administration error(s), documentation 
error (s), transcribing error(s), medication mistake(s), drug mistake(s), prescribing 
mistake(s), dispensing mistake(s), administration mistake(s), transcribing mistake 
(s), wrong medication, wrong drug (s), wrong dose (s), wrong route of administration, 
wrong calculation(s), physician(s), pharmacist (s) and nurse(s). Each of these key 
words were combined using "OR" then combined using "AND" with Middle East and 
also with the names of the appropriate countries (15 countries). There was no 
restriction on the type of the patient or age that was included, or language of the 
publication. 
6.3.3 Review procedure 
From previous systematic reviews in this area of research, different researchers 
found that the studies' results were heterogeneous, as they were conducted in 
different countries and used different methods to collect data (Ghaleb et aI., 2006; 
Conroy et aI., 2007). For this reason in this review I did not try to analyse the data 
from a statistical viewpoint but the results are summarised according to the type of 
MEs. 
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6.3.4 Inclusion/Exclusion criteria 
In this systematic review I included any type of study, randomised controlled trials 
"and other research methods such as non-randomised controlled trials, longitudinal 
studies, cohort or case-control studies, or descriptive studies that reported the 
incidence of MEs or identified the causes of MEs in the Middle East countries, either 
in adults or children. I excluded any review studies, letters, conference papers, 
opinions, reports or editorial papers. 
6.3.5 Quality assessment 
In this systematic review a quality assessment of the studies was performed. 
reviewed all the relevant studies based on 12 criteria adapted from two previous 
studies in MEs (Allan & Barker, 1990; Ghaleb et ai, 2006). The criteria were adapted 
to apply to any type of MEs study. Additionally, I evaluated and assessed the ethical 
approval obtained for each study. I therefore evaluated the papers according to the 
following 13 criteria. 
1. Aims/objectives of the study clearly stated. 
2. Definition of what constitutes a ME. 
3. Error categories specified (for example, omission errors; wrong dose errors, 
etc.) 
4. Error categories defined (for example, omission error: when a patient has not 
received his or her medication by the time the next dose is due (insulin)). 
5. Presence of a clearly defined denominator. 
6. Data collection method described clearly. 
7. Setting in which study conducted described. 
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8. Sampling and calculation of sample size described (unit of measurement). 
9. Reliability measures. (e.g. methods of measuring the stability or consistency of 
questionnaire scores over time). 
10. Measures in place to ensure that results are valid. 
11. Limitations of study listed. 
12. Mention of any assumptions made. 
13. Ethical approval. 
6.4 RESULTS 
6.4.1 Search results 
The results of this search can be found in figure 6.1. More than 5,080 articles were 
excluded from their titles and abstracts as the papers were not related to the 
specified countries or not relevant to MEs. 204 articles remained for .full text review. 
A further 163 articles were excluded again because they were not relevant to the 
topic, not related to the specified countries and others were opinion articles, letters, 
editorials and reports. 
A few studies evaluated both MEs and inappropriate use of medicines. These 
studies used the American National Coordinating Council for MEs Reporting and 
Prevention (DoH, 2004) definition. I have therefore included all these studies in my 
systematic review. 
Forty-one articles were identified to be relevant. Four additional relevant studies 
were identified after hand searching of the references of these studies. 
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As a final result, 45 articles appeared to be relevant and are included in this 
systematic review as shown in figure 6.1 (The abstracts were in English but the full 
text of four studies were in other languages, 3 in Persian and 1 in Hebrew), and 
those papers were translated into the English language. 
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Databases: Embase. Medline, CNAHL. r------- British Nurse Index and Pubmed 
Identified studies 
7,784 
Titles & abstract screened 
5,286 
Full text studies reviewed 
204 
Removal of duplicates (n= 2498) 
5,082 titles excluded due to: 
- 515 not relevant to the specified 
coontries 
- 4,448 not related to the topic 
119 Opinions, letters, editorials 
and reports 
~ - - - - - - - - - - . . 163 full texts excluded because 
4 Studiti were a d ~ ~
from hand search 
132 not relevant to the research 
question 
- 5 not related to specified 
countries 
26 Corrrnentaries, letters, 
editorials and reports 
Studies included in the review 
45 
Figure 6.1: Flow chart for search and review process. 
135 
6.4.2 Countries with data 
The search produced data for 10 of the 15 countries of the traditional Middle East. 
There was no available data on MEs in the following countries: Yemen, Kuwait, Iraq, 
Oman and Syria. The 45 studies included 13 studies in Iran, 10 studies in Israel and 
9 studies from Saudi Arabia. These and the remaining studies are shown in Table 
6.1. 
Table 6.1: Describes the number of studies for each country. 
COUNTRY NUMBER OF STUDIES 
IRAN 13 
ISRAEL 10 
SAUDI ARABIA 9 
BAHRAIN 4 
Egypt 3 
JORDAN 2 
QATAR 1 
UNITED ARAB EMIRATES 1 
PALESTINE 1 
LEBANON 1 
OMAN 0 
SYRIA 0 
YEMEN 0 
KUWAIT 0 
IRAQ 0 
TOTAL 45 
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6.4.3 Quality assessment of studies 
After the application of the quality assessment criteria, no study met all the 13 
criteria. Only 1 study fulfilled 10 criteria, 3 studies met 9 criteria, and 5 met 8 criteria. 
The remaining studies met 7 or less criteria (Figure 6.2). All individual data for 
quality assessment criteria for each study are given in Appendix D. It was noted that 
10 of the 45 studies did not specify the type of MEs. Also, it was noted that 14 of the 
45 studies did not clearly state their ethical approval. This does not mean that these 
studies were conducted without approval: 
13 
12 
~ ~
.... 
S 
:= 11 
b 
3 
~ - - . - - _ _ 5 
o 
Quality assessment criteria 
10 20 
Nl1mhfkJ' of Stl1fljPS 
Number of studies 
30 
Figure 6.2: Quality Assessment criteria of included studies. 
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6.4.4 Types of included studies 
Twenty-one of the 45 studies assessed prescribing errors as shown in Tables 6.2-
6.5. Most (seven) of these studies were conducted in Saudi Arabia and in Israel 
(five). One study assessed transcribing errors (Table 6.6). Eleven studies measured 
medication administration errors and most of these studies were performed in Iran 
(Table 6.7- 6.9). The remaining 12 studies were intervention studies that have been 
performed in Middle Eastern countries for adults and paediatric patients. Four of 
these studies were conducted in Israel. There were no studies identified which 
evaluated dispensing errors and documentation errors in Middle East countries, (as 
shown in figure 6.3). Nine (20%) studies out of the 45 studies were focused on MEs 
in paediatric patients. 
• Prescribing 
• Tr anscribing 
Administr ation 
• Interventions 
Figure 6.3: Study Classification by stage of medication process. 
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6.4.5 Incidence of medication errors 
The incidence of MEs in this review differs between studies because different 
methodologies and different definitions have been used. In this review I classified 
the results according to where they occurred during the medication treatment 
process, i.e. prescribing, transcribing and administration (Figure 6.4). I also divided 
each study according to whether it had been a prospective, retrospective or 
questionnaire study. In addition, all the intervention studies were classified in 
separate tables and divided according to the type of patients, i.e. adults or children. 
6.4.5.1 Prescribing errors 
Prescribing errors have been defined as MEs that occurred during the prescribing 
process (Lesar et aI., 1997). These include the incorrect selection of medication, 
wrong dose, wrong strength, wrong frequency, incorrect route of administration, 
inadequate instruction for use of a medication and wrong dosage form (Lesar et ai, 
1997). 
Twenty - one (46%) of the studies reported MEs that occurred during the prescribing 
stage of the medication process (Tables 6.2 - 6.4). Eight studies identified in this 
review used the above definition (Lustig, 2000; Alkhaja et ai, 2005; Alkhaja et ai, 
2007; Alkhaja et ai, 2010; Vessal, 2010; Khaja et ai, 2008; Ben-Yehuda et ai, 2011; 
Aljeraisy et ai, 2011), while the remaining studies did not clearly state a definition of 
prescribing errors. 
Thirteen of the 21 prescribing errors studies were prospective and were conducted 
in 6 countries (Lustig, 2000; Alkhaja et ai, 2005; Alkhaja et ai, 2007; Alkhaja et ai, 
2010; Vessal, 2010; AIKhaja et ai, 2008; Ben-Yehuda et ai, 2011; Azoulay et ai, 
2005; Sweileh et ai, 2007; Sabry et ai, 2009; Neyaz et al. 2011; Aldhawailie, 2011; 
Khoja et ai, 2011). Five were retrospective studies (Aljeraisy et al. 2011; Irshaid et ai, 
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2005; Valizadeh et ai, 2008; Lifshitz et ai, 2012; Dibbi et ai, 2006), and the 
remaining 3 studies were questionnaires (Vaknin et ai, 2003; Bar-Oz et ai, 2008; 
Magzoub et ai, 2011). Four studies assessed prescribing errors in children (Alkhaja 
et ai, 2007; Alkhaja et ai, 2010; Valizadeh et ai, 2008; Aljeraisy et ai, 2011). . 
The prospective study design was the most common method used among those 
studies to detect MEs at the prescribing stage (Alkhaja et ai, 2005; Azoulay et ai, 
. 2005; Vessal, 2010; Neyaz et ai, 2011; Khoja et ai, 2011). Other studies used 
different designs. Ben-Yehuda and colleagues used a case-control study design, 
the control group included patients of the same sex and age (± 2 years) who. were 
admitted to the same department in the same year and month but for whom no MEs 
were observed (Ben-Yehuda et ai, 2011). 
Estimates of the results were difficult to compare between studies because rates of 
error were expressed differently. AIKhaja et al. reported the highest error rate which 
was detected in 90.5% of prescriptions (AIKhaja et ai, 2007), while the lowest rate, 
reported by AI-Dhawailie, was detected in 7.1 % of prescriptions (AI-Dhawailie, 
2011). This difference in error rate was due to the difference in the setting between 
these two studies, one being conducted in primary care (AIKhaja et ai, 2007), and 
the other in a teaching hospital (AI-Dhawailie, 2011). 
Serious prescribing errors were measured in two studies. AI-Jeraisy et al. reported 
that 78.8% of errors detected were potentially harmful (AI-Jeraisy et ai, 2011). In 
contrast, Khoja et al. found that only 0.15% of prescribing errors in their study were 
serious for patients (Khoja et ai, 2011). This large difference in the rates of serious 
errors between the two studies was due to the difference in the MEs definitions 
used, and also in the study settings. One study was conducted in a tertiary care 
setting (AI-Jeraisy et aI., 2011) and the other conducted in primary care (Khoja et aI., 
2011 ). 
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The most common types of prescribing errors reported among the Middle East 
countries were incorrect dose, wrong frequency and wrong strength. 
Out of 13 prospective studies, 4 were carried out in Bahrain by one group, 3 in 
Saudi, 2 studies in each of Iran and Israel and one study in each of Palestine and 
Egypt. Most of these studies used the number of prescriptions as a denominator for 
error incidence rate, and identified a high incidence rate of prescribing errors (60.6% 
- 90.5%) (Lustig, 2000; Alkhaja et aI., 2005). Four of the 13 studies found that 
incorrect drug dose was the most frequently reported error (Lustig, 2000; Sweileh et 
ai, 2007; Sabry etal, 2009; Ben-Yehuda et ai, 2011). Other studies reported 
duration of therapy, wrong frequency and wrong strength as the most frequent error 
(Alkhaja et ai, 2010; Vessal, 2010; Aldhawailie, 2011). One study aimed to 
determine whether appropriate dosage adjustments were made for drugs used by 
patients with renal impairment and found that dosing errors were common among 
these types of patients during their hospitalization (Sweileh et ai, 2007). This study 
also identified that doctor's inadequacies in clinical pharmacokinetic knowledge of 
prescribed drugs was the key factor for prescribing errors among renal impairment 
patients (Sweileh et ai, 2007). 
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Table 6.2: Prospective observational studies describing prescribing errors 
STUDY COUNTRY SETTING STUDY DESIGN STUDY SAMPLE KEY FINDINGS 
Lustig, 2000 Israel General Hospital Prescriptions were reviewed in 14,385 prescriptions 160 medication errors were detected 
pharmacy, for six month period. 
Error rate was 11.2 per 1000 prescriptions 
97 (60.6%) were prescribing errors 
63 (39.4%) were therapy errors (i.e. incorrect choice of 
drugs, incorrect drug or interactions between drugs). 
Incorrect dosage 44(27.5%) was the most common type 
Alkhaja et ai, Bahrain 18 health care Prescriptions with errors were 77,511 Prescriptions 5,959 (7.7%) out of 77511 prescriptions were identified 
2005 centres collected on a daily basis by the to contain errors. 
(pharmacies) pharmacists during first two weeks 
of September 2003. Prescription The number of drug items in the 5,959 prescriptions was 
errors were classified to omission 16091. 
errors (incomplete prescription 
components), commission errors 13630 (84.7%) drug items were identified with errors 
(incorrect written components) 
and integration (potential drug - 23692 errors were identified. These included omission 
drug interaction or drug allergies) 22180 (93.6%) and commission 1512 (6.3%) errors. 
Errors of integration were in 548 (9.2%) prescription. 
Azoulay et ai, Iran Teaching Prescriptions from elderly patient 3000 elderly patients 829 (27%) patients received at least one inappropriate 
2005 hospital visits to physicians were collected prescriptions ( ~ 6 5 5 prescription (unnecessary medication or having a high 
during study period (from years old). risk of adverse drug reaction) 
September to December 2002) 
285 (9.5%) patients had at least one drug interaction 
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Table 6.2: Contd 
STUDY 
AI·Khaja et 
al,2007 
Sweileh et 
al,2007 
Sabry et 
al,2009 
COUNTRY SETTING 
Bahrain 20 health care 
centres (those 
who treat infants) 
Palestine General Hospital, 
internal wards 
Egypt Teaching hospital, 
leu 
STUDY DESIGN 
Prescriptions dispensed for infants were 
collected on daily basis by the pharmacists 
from 9 -23 May 2004. 
Cross-sectional study conducted to determine 
whether appropriate dosage adjustment was 
made for drugs, for four months period. 
Direct observational study by pharmacist was 
conducted to report and record the frequency of 
medication related problems in the ICU, for one 
year period. 
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STUDY 
SAMPLE 
2282 
prescriptions 
78 patients 
220 ICU patients 
and 2286 
medications 
KEY FINDINGS 
2066 (90.5%) prescription were identified to contain 7667 
errors of omission, commission and errors of integration. 
4282 (74.5%) out of 5745 medications contained drug 
related errors 
4146 (54.1 %) out of 7667 errors were with omission 
errors, length of therapy/quantity (27.7%) and dosage 
form (12.8%) were the common omission errors 
3338 (43.5%) out of 7667 errors were commission 
errors, dosing frequency was incorrectly written in 20.8%, 
and dose-strength was incorrectly stated in 17.7% 
183 (2.4%) out of 7667 errors were integration errors 
such as adverse drug-drug interactions were possible. 
63 (80%) patients had at least one inappropriate 
medication 
Analysis of inappropriate doses of medications that are 
nephrotoxic, excreted, or metabolized by the kidney 
showed that the patients were exposed to an average of 
1.5 - 3 folds greater than the recommended dose. 
619 medication related problems were detected in a total 
of 213 patients. Only 3.18% of the patients were free of 
any medication related problems. Incorrect dosing 
regimen was the most common reported errors in the ICU 
followed by duplication and prescribing unnecessary 
medication, 136 (21.97%), 72 (12%), respectively. 
Table 6.2: Contd 
STUDY 
AI-Khaja 
et ai, 
2010 
Vessal, 
2010 
Neyaz et 
al,2011 
AI-
Dhawailie, 
2011 
COUNTRY SETTING STUDY DESIGN 
Bahrain 18 health care 
centres 
(pharmacies) 
Infant prescriptions with iron preparations were 
collected & reviewed from 9-23 May 2004 (two 
weeks) 
Iran 
Saudi 
Arabia 
Saudi 
Arabia 
Teaching Hospital Medication order sheets & drug orders In 
nephrology ward were reviewed by clinical 
pharmacist for four months. 
10 Primary 
health care 
centres (5 
public, 5 
private), Riyadh 
University teaching 
hospital, medical 
wards only 
Two-methods; prescription reviewed and 
questionnaire completed by physiCians for 
prescription quality assessment (one day 
study) in public and private health care centres 
Medication charts and orders data collected 
daily by ward pharmacists, for one month 
period (Nov-Dec 2009). 
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STUDY SAMPLE 
2,282 Prescriptions 
76 adult patients and 818 
medications 
600 prescriptions selected 
randomly, written by 87 
Physicians (47 public, 40 
private) 
1582 written medication 
orders 
KEY FINDINGS 
159 (7%) of prescriptions included an iron 
preparation. 42 (26.4%) out of 159 
prescriptions were issued without dosage 
forms and 14 (8.8%) without duration of 
therapy. Prescribing of unavailable paediatric 
dosage forms was in 11 (6.9%). 
86 (10.5%) prescription errors were detected in 
46 (60.5%) of the admissions 
Error rate was 10.5 per 100 medication orders 
Wrong frequency (37.2%), wrong drug 
selection (19.8%), and overdose (12.8%) were 
the most common types of errors 
64 (72%) physicians were classified as writing 
low quality prescription 
23 (28%) physicians were classified as writing 
high quality prescriptions 
113 (7.1 %) prescribing errors were detected 
Most common errors were wrong strength 39 
(35%) Followed by wrong dose frequency 26 
(23%) 
Table 6.2: Contd 
STUDY COUNTRY SETTING 
AI·Khaja et 
al,2008 
Khoja et, 
2011 
Ben-Yehuda 
et al. 2011 
Bahrain 
Saudi 
Arabia 
Israel 
3 health care centres 
(training centres) 
10 Primary health care centres 
(5 public 15 private). Riyadh 
Teaching hospital 
STUDY DESIGN 
Prescriptions issued by the 
residents were collected by 
pharmacists in May 2004 and May 
2005. 
All medication prescriptions were 
analysed for one working day 
between public & private 
Cohort Case-Control study 
conducted for 18 month period. 
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STUDY SAMPLE KEY FINDINGS 
2692 prescriptions 2372 (88.1 %) prescriptions had errors of 
omission, commission and integration errors 
The total numbers of errors were 7139. 
Of 5880 medication prescribed, 4447 (75.6%) 
had drug related errors. 
4972 (69.6%) out of 7139 errors were major 
omission errors, dosage forms and length of 
treatment were not specified in 39.4% and 
18.5%, respectively. 
1759 (24.7%) out of 7139 errors were 
commission errors, dosing frequency and 
incorrect strength/dose were the most common 
errors 19.9% and 2.7%, respectively. 
Integration errors were 408 (5.7%) of the overall 
prescribing errors. 
5299 prescriptions 990 (18.7%) prescribing errors identified 
Only 8 (0.15%) prescribing errors had serious 
effect on the patients. 
274 elderly patients (137 137 MEs were identified in patients group, 
patients harmful MEs 
group, and 137 control 63 (46%) errors were prescribing. 
group) 
74 (54%) errors were transcribing. 
Five retrospective studies describing prescribing errors in the Middle East countries 
were identified (Table 6.3). Three studies were conducted in Saudi Arabia and one 
study in each of Iran and Israel. Of these, two studies were conducted in paediatric 
patients (Valizadeh et ai, 2008; AI-Jeraisy et ai, 2011) and 3 in adults (Irshaid et ai, 
2005; Dibbi et .al., 2006; Lifshitz et ai, 2012). The main finding from these 
retrospective studies was that the incidences of MEs were high (36.1% - 56%) in 
both types of patients (adults and paediatrics). MEs in the Emergency Department 
were higher than in Emergency vehicles (Lifshitz et ai, 2012). Like the prospective 
studies the retrospective studies also identified dosing errors to have the highest 
incidence rate. 
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Table 6.3: Retrospective studies describing prescribing errors 
STUDY COUNTRY SETIING 
Irshaid et ai, 2005 Saudi Arabia . Teaching hospital 
Valizadeh et ai, 
2008 
Iran 
Lifshitz et ai, 2012 Israel 
Paediatric hospital 
Teaching hospital, 
Emergency Department 
and Emergency vehicles 
(ambulances) 
STUDY DESIGN STUDY SAMPLE 
All prescriptions obtained during one year 
period from pharmacy were analysed by 
pharmacists and physicians. 
3796 prescriptions 
Descriptive cross·sectional and hospital 898 medical charts 
information based study was performed from 
January-June 2004 
Charts review was performed by two 
physicians for adult patients transferred by 
ambulance to large hospital, from January-
December 2007. 
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471 patient charts 
KEY FINDINGS 
No prescription contained the 
patient's weight 
94% of prescriptions had no 
quantity indicated 
90.7% of prescriptions had 
incomplete instructions for patient 
74.1 % of medication orders did not 
contain drug administration 
precautions 
47.8% time of drug administration 
were not recorded 
24 (12.7%) of 188 patients in 
vehicle were subject to MEs 
120 (36.1%) of 332 patients had 
MEs in ED 
MEs in the ED were more than in 
emergency vehicles 
Table 6.3: Contd. 
STUDY 
AI-Jeraisy et ai, 
2001 
Dibbi et ai, 2006 
COUNTRY 
Saudi 
Arabia 
Saudi 
Arabia 
SETTING 
Tertiary care hospital, 
PICU and general 
paediatric wards 
General Hospital 
STUDY DESIGN 
Study of paediatric physician 
medication orders for five weeks 
Medical records were reviewed for adults 
from June 2oo0-June 2002 
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STUDY SAMPLE 
2,380 medication orders 
2627 patient files 
KEY FINDINGS 
1,333 medication errors were found 
1,051 (78.8%) errors were potentially 
harmful 
Incidence rate was 56 errors per 100 
medication orders 
Dose errors were the highest incidence 
(22.1%) 
452 (33.9%) errors occurred in PICU. 
3963 medication errors were identified 
60% of patient files contained one error 
30% of patient files contained two errors 
10% of patient files contained three errors or 
more 
In 1223 (46.5%) patient files, human factors 
were the main cause of MEs 
The most common type of errors were the 
wrong strength (34.8%) in 914 patients 
The third type of study describing prescribing errors was questionnaire studies 
(Table 6.4). Three questionnaire studies were identified in this review. Two surveys 
were in Israel and 1 was in Saudi Arabia. All of these studies agreed that physicians 
have limited information about drug prescribing and pharmacology (Vaknin et ai, 
2003; 8ar-Oz et ai, 2008; Magzoub et ai, 2011). 
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Table 6.4: Questionnaire studies describing prescribing errors 
STUDY COUNTRY SETTING STUDY DESIGN STUDY SAMPLE KEY FINDINGS 
Vaknin et ai, Israel N/A Questionnaire N/A Only 46 (18%) out of 256 doctor 
2003 orders, and 82 (37%) out of 224 
nurses transcriptions were written 
according to the hospital standard. 
The rate of compliance with 
Emergency department policy was 10 
(3%) out of 319 doctors orders, and 
80 (25%) of nurses transcriptions 
Bar-Oz et ai, Israel N/A Structured questionnaire was sent to 9320 active 627 (6.7%) physicians 470 (78.9%) physician made an error 
2008 physicians, to evaluate the rate of responded . in prescribing 
acknowledgment of MEs as reported by 
physicians, with questions on the rate and type of 376 (63.1 %) physicians made more 
MEs that they had encountered during their career than one error 
94 (15.8%) physicians made one error 
Magzoub et Saudi Arabia 10 Primary Self - administered questionnaire designed to 87 Physicians (47 in public, 57 (65%) of physicians had not 
al,2011 health care explore factors influencing prescribing. 40 in private) received training in drug prescribing 
centres (5 
public,5 30 (34%) of physicians had consulted 
private), a pharmacist before drug prescribing 
Riyadh 
47 (54%) of physicians believed that 
limited knowledge of pharmacology is 
a main cause of prescribing errors. 
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6.4.5.2 Types of errors 
Incorrect dose was the most common type of error reported in 12 studies (Lustig et 
aI., 2000; Alkhaja et aI., 2005; Alkhaja et aL, 2007; Alkhaja et aI., 2008; Sabry et aL, 
2009; Alkhaja et aL, 2010; Vessal, 2010; Aldhawailie, 2011; Khaja et aL, 2011; Ben-
Yehuda et ai, 2011; AI-Jeraisy et ai, 2011; Lifshita et ai, 2012) as shown in Table 
6.5. This review revealed that the incidence rates of dosing errors in the Middle East 
countries fluctuated from 0.15% to 34.8% of total prescriptions (Table 6.5). Also, 
other studies included wrong frequency (Alkhaja et ai, 2007; Vessal, 2010), wrong 
strength (Aldhawailie, 2011; Alkhaja et ai, 2007, Alkhaja et ai, 2005), wrong or 
missing dosage form (Alkhaja et ai, 2010; Alkhaja et ai, 2007; Alkhaja et ai, 2005; 
Alkhaja et ai, 2008) and duration of therapy not stated (Alkhaja et ai, 2010; Alkhaja 
et ai, 2008; Alkhaja et ai, 2007; Alkhaja et ai, 2005). 
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Table 6.5: prescriptions with dosing errors 
Country (setting) No. of prescriptions or Dosing errors (number) Dosing errors (%) References 
medication orders 
Israel (General hospital) 14,385 prescriptions 44 prescriptions 0.3 Lustig, 2000 
Bahrain (Primary care) 77,511 prescriptions 1,413 prescriptions 1.8 Alkhaja et ai, 2005 
Bahrain (Primary care) 2,282 prescriptions 795 prescriptions 34.8 Alkhaja et ai, 2007 
Egypt (Teaching hospital) 2,286 medication prescribed 503 medication prescribed 22 Sabry et ai, 2009 
Bahrain (Primary care) 2,282 prescriptions 60 prescriptions 2.6 Alkhaja et ai, 2010 
Iran (Teaching hospital) 86 prescriptions 11 prescriptions 12.8 Vessal, 2010 
Saudi (Primary care) 1,582 medication orders 14 medication orders 0.89 Aldhawailie, 2011 
Saudi (Primary care) 5,299 prescriptions 8 prescriptions 0.15 Khoja et ai, 2011 
Bahrain (Primary care) 5880 medication orders 397 medication orders 6.7 Khaja et ai, 2008 
Israel (Teaching hospital) 4736 prescriptions 31 prescriptions 0.65 Ben·Yehuda et ai, 2011 
Israel (Teaching hospital) 471 medication orders 12 medication orders 2.5 Lifshitz et ai, 2012 
Saudi (Tertiary hospital) 2,380 medication orders 526 medication orders 22.1 Aljeraisy et ai, 2011 
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6.4.5.3 Transcribing errors 
One prospective study of transcription errors using a direct observational method 
was performed in Iran (Table 6.6) (Fahimi et ai, 2009). Transcribing errors were 
defined as any deviation in transcribing a medication order from the previous step. 
A direct observational method was used in this study. A total of 287 charts with 558 
opportunities for error (OEs) were analysed. Of those OEs, 167 (30%) resulted in 
errors. Omission transcription errors (patients did not receive the medication that 
was ordered) were the highest (52%) type of errors identified in this study. 
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Table 6.6: Prospective studies describing transcribing errors 
STUDY 
Fahimi 
et ai, 
2009 
COUNTRY SETTING 
Iran Teaching 
hospital 
STUDY DESIGN 
Direct observation was used to detect 
transcribing errors (April - August 2004). 
STUDY SAMPLE 
287 medication charts 
were reviewed during 
study period 
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KEY FINDINGS 
289 errors were identified with average one error per 
chart 
Omission error was rated as the highest (52%) 
transcription error. 
6.4.5.4 Administration errors 
Administration errors have been defined as a discrepancy between the drug therapy 
received by the patient and that intended by the prescriber or according to standard 
hospital policies and procedures (Greengold et ai, 2003; Dean, 1999). Three studies 
used the above definition (Fahimi et ai, 2008; Drach-Zahavy & Pud, 2010; Alshara, 
2011), while the remaining eight studies mainly used general definitions of MEs 
rather than a MAEs definition. 
Two of 11 administration errors studies were prospective studies and conducted in 2 
countries (Table 6.7) (Fahimi et ai, 2008; Drach-Zahavy and Pud, 2010). One of 
these studies, in Israel, used a variety of methods (observations, interviews and 
administrative data) (Drach-Zahavy and Pud, 2010), and the other study was an 
observational study in Iran which assessed the administration of IV drugs (Fahimi et 
ai, 2008). The variation between the studies definitions and the methods used for 
data collection made comparisons difficult. The study that defined errors in 
preparation and administration, found that the error rates were higher in the 
administration process compared to the preparation process in intravenous 
medications, and within the administration process the technique of administration 
of bolus injection was the most common error (43.4%) (Fahimi et ai, 2008). 
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Table 6.7: Prospective studies describing administration errors 
STUDY 
Fahimi et ai, 
2008 
COUNTRY SETTING 
Iran Teaching hospital, ICU 
Drach-Zahavy Israel 
& Pud, 2010 
Three hospitals, 32 
surgical and intemal 
medicine wards 
STUDY DESIGN 
Random observational study for 
preparation and administration of 
IV drugs by nurses in the ICU was 
conducted by pharmacist (16 
days) 
Multi methods (observations, 
interviews and administrative 
data) were conducted to test the 
effectiveness of leaming 
mechanisms to limit medication 
administration errors. Data were 
collected during 2006. 
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STUDY SAMPLE 
524 preparations and 
administrations process 
173 nurses 
KEY FINDINGS 
380 (9,4%) errors were identified out of 4040 
opportunities for errors . 
33.6% were related to the preparation process 
66.4% were to the administration process. 43.4% of 
errors were the injection of bolus doses faster than 
recommended 
One patient in three was exposed to medication 
administration error each time they received 
medication 
Two studies were retrospective and conducted in 2 countries (Saab et ai, 2006; 
Sad at-Ali et ai, 2010) (Table 6.8). The error rates reported in administration errors 
studies overall ranged from 9.4% to 80% (Fahimi et ai, 2008; Saab et ai, 2006). 
Saab et al. reviewed patient records and confirmed their results through interviews 
with patients (Saab et ai, 2006). This study also found that the use of an 
inappropriate drug was higher when patients used both over-the-counter (OTC) and 
prescription medicines (Saab et ai, 2006). Sadat-Ali and colleagues assessed the 
prevalence and characteristics of MEs in patients admitted to a teaching hospital. 
The authors found that the prevalence of MEs was low (1.58 per 1000 admission) 
and this could be due to under reporting of the errors (Sadat-Ali et ai, 2010). This is 
likely to be due to the method used in the study, which was a retrospective review of 
incident reports - notorious for underestimation of error rates (Sadat-Ali et ai, 2010). 
In addition, the authors revealed that most of the MEs (50%) occurred during the 
night shift (Sadat-Ali et ai, 2010). 
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Table 6.8: Retrospective studies describing administration errors 
STUDY 
Saab et ai, 
2006 
Sadat-Ali et 
al,2010 
COUNTRY 
Lebanon 
SETTING 
10 different 
community 
pharmacies 
Saudi Arabia Teaching Hospital 
STUDY DESIGN STUDY SAMPLE 
Each patient profile was reviewed 277 elderly patients 
and to confirm patient record 
information, in-person interviews, 
from November 2004 to May 2005 
by qualified pharmacists. 
Incident reports documented by 
physicians and nurses were 
collected from January 2008 -
December 2009 
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23957 admissions 
KEY FINDINGS 
59.6% of the patients were taking at least one 
inappropriate medication 
Missing doses were in 18.8% of the patients with 
inappropriate drug use 
Inappropriate frequency of administration was in 
13% of the patients with inappropriate drug use 
38 medication errors were reported, 24 with adults, and 
14 with children 
Incidence rate of medication error was 1.58 per 1000 
admission 
Missed medication was the most common error in 15 
(39.5%) patients, mainly in paediatric medicine and 
obstetrics 
19 (50%) of the errors occurred during night shift 
Seven questionnaire studies of nurses' perceptions of describing administration 
errors (Table 6.9), 5 studies were conducted in Iran and 2 in Jordan. All these 
studies evaluated nurses and student nurses opinion about the drug administration 
errors in their area of work (Table 6.9). Two studies reported the rate of nurses 
failing to report MEs. This ranged from 17.1% to 60% (Marryan et ai, 2007) 
(Koohestani et ai, 2008). Wrong patient and wrong dose of medication were the 
most common error reported. 
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Table 6.9: Questionnaire studies of nurses perceptions of describing administration errors 
STUDY COUNTRY SETTING 
Mrayyan et ai, 
2007 
Jordan 24 hospitals 
Koohestani & Iran 
Baghcheghi, 2008 
Koohestani et ai, 
2008 
Iran 
Koohestani & Iran 
Baghcheghi,2oo9 
Cardiac Care 
Unit 
Teaching 
hospital 
Three nursing 
schools at 
University of 
Medical 
Sciences 
STUDY DESIGN STUDY SAMPLE 
Descriptive study of nurses' 799 registered nurse 
perceptions about rate, causes and 
reporting of MEs 
Descriptive study to determine the 60 nursing students 
frequency, type and causes of 
MEs in cardiac care unit. 
Descriptive study was conducted to 76 nursing students 
investigate the frequency, type and 
causes of MEs of nursing student. 
Descriptive study was conducted 240 nursing students 
using self -report questionnaires. in 
winter 2008. 
MEs: Medication Errors; MAEs: Medication Administration Errors 
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KEY FINDINGS 
Average number of recalled MEs per nurse was 2.2 
42.1 % of MEs rate were reported to nurse managers 
60% of nurses failed to report MEs because they 
were afraid that they might lose their jobs 
10% of nursing students had made medication errors 
48.3% of nursing students did not report any errors. . 
Incorrect drug calculation, poor pharmacologic knowledge 
were the most common type of errors 
17.1 % of nursing students reported medication errors 
Wrong dose of medication was the most common type of 
error. 
Poor pharmacological knowledge was the most common 
cause of error. 
Response rate was 100% 
124 medication administration errors were made by 
students 
Only 80% of them were reported to instructors. 
1.93 MAEs were recalled for each student nurse. 
Administrative barriers and fear were the main two reasons 
for not reporting MAEs among nursing students 
Table 6.9: Contd 
STUDY COUNTRY SETTING 
Islamian et ai, Iran Different hospitals 
2010 
AI-Shara et ai, Jordan 
2011 
Joolaee et ai, Iran 
2011 
Teaching Hospital 
Six educational I 
non-educational 
hospitals were 
selected 
STUDY DESIGN STUDY SAMPLE 
Descriptive study was conducted to 239 nurses and head nurses 
identify nursing errors and the related 
factors, in 2010. 
Descriptive study to determine the 126 registered nurses 
types, stages, and factors contributing 
to MEs and related area of 
improvement. 
Descriptive study was performed to 286 nurses 
evaluate the relationship between the 
incidence and reporting of MEs by 
nurses and work conditions, from 
November 2008 to May 2009. 
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KEY FINDINGS 
Lack of reviewing of the drug allergies and the 
medical history of the patient was the highest rate of 
error (31.7%) 
Disregarding the administration time for prescription 
of the medicine error rate was 31.7% 
Wrong patient (26.2%) and wrong dosage 
(22.2%) were the highest types of MEs 
reported. 
Rates of MEs of nurses, physicians and 
pharmacists were 48.4%,31.7%,11.1%. 
Heavy workload (41.4%), and new staff 
(20.6%) were the main causes of MEs 
19.5 ME cases were recalled by each nurse 
1.3 cases of MEs were reported by each nurse 
during three months 
Relationship between error incidence and nursing 
work load was statistically significant (PsO.OOOI) 
There was no significant relationship between 
reporting the occurred error and nurses' work 
conditions (PSO.255). 
6.4.6 Interventional studies 
Twelve (27%) studies were identified describing interventions used to reduce MEs. 
Of these, seven interventions were implemented on adult patients (Table 6.10) and 
five interventions on paediatric and neonatal patients (Table 6.11). The 
interventions had been evaluated in studies from 3 months to 3 years, and most 
studies involved a comparison of computerised drug order entry system, with or 
without Clinical Decision Support Systems (CDSS), and/or with handwritten 
prescriptions. The outcomes for all interventions were positive and led to the 
prevention and reduction of MEs. 
Four out of 7 studies (interventions) were identified that specifically examined the 
role of the clinical pharmacist in reducing MEs (Elnour et ai, 2008; Hooper et ai, 
2009; Abou - alsoud et ai, 2010; Khalili et ai, 2011). All these studies were assessed 
and implemented on adult patients only. These interventions led to a significant 
reduction in the number of MEs. Most of the interventions detected were in the 
prescribing stage. Incorrect drug dosing, incorrect drug choice and drug interactions 
were the most common errors detected by clinical pharmacists. One of the 
intervention studies used a self-reported questionnaire design to collect data after 
the clinical pharmacists established training and educational materials for inpatient 
nurses about MEs but there was no MEs data actually observed or collected (Elnour 
et ai, 2008). 
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Table 6.10: Interventional studies describing MEs in adults 
STUDY 
(Oliven et aI., 
2002) 
(Oliven et a!., 
2005) 
(Elnour et aI., 
2008) 
COUNTRY 
Israel 
Israel 
U.A,E 
SETTING 
Teaching Hospital, 
Internal medicine 
department 
Teaching Hospital, Internal 
medicine A and B 
Teaching Hospital 
INTERVENTION 
Comparison between prescription orders 
using comprehensive CDOE system and 
handwritten prescription orders in similar 
department, evaluated by physicians. 
Comparison between CDOE and 
handwritten drug orders in a similar 
department. Prescribing Errors (PEs) 
weredivided into, Type 1 PEs: relating to 
the individual patient, Type 2 PEs 
resulting from drug -laboratory, drug -
disease, and drug - allergy interaction. 
STUDY SAMPLE 
4600 hospitalization 
days 
1350 adult patients 
(641 handwritten, 709 
CDOE). 
Clinical pharmacists established training 370 nurses 
and educational materials for inpatient 
nurses about MEs, Pre/Post self -
reported questionnaire used to collect 
data, duration of study from September 
2006 to December 2006. 
CDOE: Computerized Drug Order Entry; PEs: Prescribing Errors; MEs: Medication Errors; U.A.E: United Arab Emirates 
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KEY FINDINGS 
Prescribing errors occurring in 
handwritten orders were 11.3 % 
errors, compared to 3.2% errors in 
computerized drug orders per 100 
hospitalization day 
The use of CDOE was associated with 
a significant reduction in mean 
hospital stay. 
Incidence of type 1 PEs was 5.21 in 
handwritten orders and 1.36 in CDOE 
orders per 100 hospitalization days. 
Incidence of type 2 PEs were more 
common 7.2 in handwritten orders, 
and 3.02 in CDOE orders per 100 
hospitalization days 
CDOE has a large impact on the 
prevention of prescribing errors 
There were differences in the 
knowledge of nurses about the causes 
and reporting of medication errors. 
The clinical pharmacist's program has 
improved knowledge of the in-patient 
nursing staff in terms of raising their 
awareness about medication errors 
Table 6.10: Contd 
STUDY COUNTRY 
(Hooper et aI., Qatar 
2009) 
(Abou Alsoud 
et aI., 2010) 
(Khalili et aI., 
2011) 
Egypt 
Iran 
SETTING 
FourPHC 
Services 
Teaching hospital, 
National cancer 
centre 
Teaching 
Hospital, 
Infectious 
diseases ward 
PHC: Primary Health Care; MEs: Medication Errors 
INTERVENTION 
Pharmacists in four clinics within the 
service used online, integrated health 
care software to document all clinical 
interventions made. Study conducted 
from January to March 2008 
Clinical pharmacy interventions 
(Detecting MEs, correcting those 
errors, sending recommendations to 
medical staff) were documented in 
the study for one year period. 
To assess the role of the clinical 
pharmacists intervention in 
detecting and preventing of MEs 
that occurred in one year period. 
164 
STUDY SAMPLE 
82,800 patients 
100 patients (89 
adults and 11 
paediatrics) 
861 patients 
KEY FINDINGS 
589 patient prescriptions were intercepted for suspected 
errors 
10.8% of the total prescriptions intercepted were for 
children 
54% of all interventions were related to drug choice 
problems 
42% of the interventions related to drug safety problem 
51 % of the interventions were related to dosing errors 
The clinical pharmacy interventions reduced the number 
of MEs from 1548 to 444 error which was statistically 
significant (P=0.004). 
76% of the errors recorded occurred in the prescribing 
stage 
20% in the administration stage and 3.8% in the 
dispensing stage 
112 MEs were detected by clinical pharmacists, (0.13 errors 
per patient) 
Physicians were responsible for MEs more than nurses and 
patients 55 (49.1%), 54 (48.2%), and 3 (2.7%), respectively 
Drug dosing, drug choice, drug use and drug interaction were 
the most common error types 
Table 6.10: Contd 
STUDY 
(Qureshi et 
al., 2011) 
COUNTRY 
Saudi 
Arabia 
PHC: Primary Health Care 
SETTING 
Three 
Government 
centres 
INTERVENTION 
Three types of intervention were evaluated: Pre-
intervention sites (5 health care centres), and 
Post-intervention sites (3 health care centres, 
each receiving a different intervention): 
1. Training physicians about quality 
prescribing. 
2. Regulatory and administrative measures 
to improve rational drug prescribing. 
3. Multi - faceted approach using previous 
2 strategies plus additional elements. 
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STUDY SAMPLE 
61 physicians 
KEY FINDINGS 
All 3 types of intervention improved the 
quality of physicians' prescriptions 
In Pre intervention 198(8%) out of 2463 
prescribed drugs were with major errors 
8 (3.9%) out of 206 prescribed drugs 
analysed during training intervention had 
major errors, 94 (46%) out of 204 
prescribed drugs during administrative 
intervention had major errors, and 2% were 
in post intervention: training. administrative 
and multiple, respectively. 
Educationalists need to develop targeted 
courses in drug prescribing to assist in 
developing the prescribing skills of 
physicians. 
In paediatric and neonatal patients, the computerised physician order entry 
intervention, with and without CDSS, was the most commonly used intervention. All 
interventions that were implemented in paediatric patients found that MEs rates 
decreased after the CDSS was added to the computerised physician order entry 
system (Table 6.11). Vardi et al in their first part of the study found that only 3 errors 
were identified in 13124 prescriptions (Vardi et ai, 2007) but this was much lower 
than the expected rate for errors. There are a few possible explanations for this, one 
of which is that errors happen but are not reported and this leads to unrealistic study 
results. Another possible explanation may be that when an error is detected, the 
observers or researchers may feel that it is not important enough to be reported if it 
does not cause any problem. 
In addition, one study among the interventional studies in paediatric patients was 
conducted to compare two different medication order entry methods: the Physician 
Order Entry (POE) and Nurse Order Entry (Kazemi et ai, 2010), The authors found 
that the error rates decreased within the NurSing Order Entry (NOE) period 
compared to the errors within the POE period (Kazemi et ai, 2010). 
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Table 6.11: Interventional studies describing MEs in paediatric and neonatal patients 
STUDY 
(Vardi et aI., 
2007) 
(Kadmon et 
al., 2009) 
(Kazemi et aI., 
2010) 
COUNTRY 
Israel 
Israel 
Iran 
SETTING 
Tertiary care 
children's 
hospital,(PCCD) 
Tertiary Children 
Hospital, PICU 
Teaching 
Hospital, Neonatal 
ward 
INTERVENTION 
Before and after implementation of CPOE and 
CDSS. Intervention carried out for 3 years. 
STUDY SAMPLE 
13124 CPR drug orders 
in first part, 46970 
orders in second part, 
over 1 year period. 
CPOE implemented in four different periods from 5000 PICU medication 
September 2004 to September 2007 orders 
Comparison between POE and NOE methods 
effect on reducing dosing MEs. Study conducted 
within four months. 
158 neonates 
KEY FINDINGS 
In the first part of the study only three errors 
were identified, one was a 10 -fold mistake in 
dose calculation, and the remaining two 
errors were doses exceeding the adult 
maximal dose. 
In second part: no errors of any type were 
found 
273 (5.5%) out of 5000 PICU medication 
orders contained prescription errors 
No significant difference between period 1 
and 2 in medication prescribing errors 
83% of prescription errors were reduced after 
CDSS implemented (period 3), and a 
combination with prescription authorization 
(period 4). 
80% of non-intercepted medication errors in 
Physician Order Entry (POE, period 1) occurred in 
the prescribing stage compared to 60% during 
NOE period 2. 
Prescribing errors decreased from 10.3% with 
POE to 4.6% with NOE period, respectively. 
Error per patient was reduced from 2 errors with 
POE to no error with NOE period, respectively. 
CPOE: Computerised Physician Order Entry; CDSS: Clinical Decision Support System; PCCD: Paediatric Clinical Care Department; PICU: Paediatric Intensive Care Unit; POE: Physician Order 
Entry; NOE: Nurse Order Entry. 
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Table 6.11: Contd 
STUDY COUNTRY 
(Kazemi et aI., Iran 
2011) 
(Alagha et aI., 
2011) 
Egypt 
SETTING 
Tertiary Care 
Hospital, 
Neonatal ward 
INTERVENTION 
Comparison of the CPOE effect without and 
with CDSS in three periods, for 7.5 months 
period. 
Teaching hospital, Pre-Post intervention (physician education; new 
PICU medication chart; physician feedback) study of 
prescribing errors in PICU was conducted for 
10 months period. 
PICU: Paediatric Intensive Care Unit. 
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STUDY SAMPLE 
248 patients were included 
in this study 
Pre-intervention, 1417 
medication orders were 
evaluated for 139 
patients 
Post-intervention, 1096 
orders for 101 patients 
KEY FINDINGS 
Medication errors rates before intervention 
implemented (Period 1) was 53% 
After the CPOE implemented without CDSS the 
MEs rate was 51% 
After CDSS was added to the CPOE the MEs 
rate was 34% 
Overdose was the most frequent type of MEs 
Of Pre-intervention orders 1107 (78.1%) 
had at least one prescribing errors 
The intervention resulted in significant 
reduction in prescribing error rate to 35.2% 
post-intervention (P<O.OOl) 
The intervention resulted also in a 
significant reduction in the rate of 
potentially severe errors from 29.7% pre-
intervention to 7% post-intervention 
(P<O.OOl) 
6.4.7 Medications involved in medication errors studies 
Differences in the reporting of medications between studies results were obvious; 
some studies involved the medications names, and others listed the therapeutic 
class. Most of the errors were related to antihistamines (Alkhaja et ai, 2008; Azoulay 
et ai, 2005; Alkhaja et ai, 2007), antibiotics (Sabry et ai, 2009; Lustig A, 2000; 
Sweileh et ai, 2007; Alagha et ai, 2011) and anticoagulants (Khalili et ai, 2011; 
Koohestani et ai, 2008; Alagha et ai, 2011). 
In addition, medications reported in studies that were conducted on paediatric 
patients found. that antihistamines, paracetamol, electrolytes and bronchodilator 
drugs were the most common drugs associated with errors (Alkhaja et ai, 2007; 
. Aljeraisy et ai, 2011). These are however the most frequently prescribed drugs in 
this area, particularly antihistamine drugs, because the weather in most of the 
Middle East countries have dust or storms which lead to allergies which require 
treatment with antihistamine drugs. 
6.4.8 Severity of reported medication errors 
The majority of studies did not assess the clinical consequences of reported MEs. 
Six (13%, 6/45) attempted to classify the severity of the MEs (Lustig, 2000; Aljeraisy 
et ai, 2011; Aldhawailie, 2011; Lifshitz et ai, 2012; Dibbi et ai, 2006) (Table 6.12). 
Only one study reported the severity of the MEs in detail, but was a retrospective 
study (Aljeraisy et ai, 2011). Two other studies were retrospective (Valizadeh et ai, 
2008; Dibbi et ai, 2006), while the other three were prospective studies (Lustig, 
2000; Aldhawailie, 2011; Lifshitz et ai, 2012). One study reported 26 deaths and felt 
that MEs were a contributory factor (Dibbi et ai, 2006). 
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Table 6.12: Clinical consequences of reported medication errors 
Country Type of error Medicines Clinical consequences Reference 
Israel Prescribing Anti-infectives, Errors divided into potentially Lustig, 2000 
errors TPN, cytotoxics serious, clinically significant 
and clinically non-significant. 
MEs most frequent in 
haemato-oncology and these 
were the errors that had 
greatest clinical significance 
Saudi Prescribing Not stated Examples of potentially Aldhawailie, 
Arabia errors serious errors were given 2011 
including tenfold errors of 
amphotericin and captopril 
Israel Prescribing Cardiovascular 14 MEs (8%) were clinically Valizadeh et ai, 
errors drugs significant. There were also 3 2008 
(2%) severe MEs 
Saudi Prescribing IV fluids, antibiotics, Majority of MEs were Aljeraisy et ai, 
Arabia errors bronchodilators, potentially harmful (1051, 2011 
opioid analgesics, 79%) 
cardiovascular 
drugs, sedatives 
Saudi Prescribing and Antibiotics, MEs were a contributory Dibbi et ai, 2006 
Arabia administration cardiovascular factor to 26 deaths 
errors drugs 
Iran Administration Antibiotics, No clinically significant errors Fahimi et ai, 
errors antacids, detected 2008 
corticosteroids 
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6.4.9 Factors contributing to medication errors 
The determination of factors contributing to MEs is an important aspect in this 
review because preventing MEs from reaching the patient depends on a sound 
knowledge of the causes or contributing factors. The factors contributing to MEs 
were reported in 12 studies. Differences in contributing factors between studies 
were due to the difference between countries and health care systems in Middle 
East countries. The most common factors reported in this review are as follows: 
6.4.9.1 Lack of knowledge of prescribing skills 
Several studies identified in the review have cited lack of knowledge of prescribing 
skills as a contributory factor to MEs (AI-khaja et aI., 2008, AI-Dhawailie, 2011, 
Irshaid et aI., 2005). AI-Khaja et al. evaluated the prescription skills of final year 
residents in a family practice residency programme in Bahrain for those who had 
and had not graduated with problem based learning (AI-Khaja et aI., 2008). Their 
. study concluded that the prescription writing skill of the final year residents in a 
family practice residency programme was suboptimal for all graduates. 
Another study in Saudi Arabia highlighted that the lack of knowledge of prescribing 
skills was the main cause of errors (AI-Dhawailie, 2011), Irshaid and colleagues in 
Saudi Arabia found poor handwriting was a serious problem in prescribing and was 
a major cause of MEs. Poor handwriting may lead to pharmacy dispensing the 
wrong drug (Irshaid tal, 2005). 
6.4.9.2 Lack of pharmacological knowledge between physicians and nurses 
Physicians are accountable for the medication they prescribe and this requires 
knowledge of the indication, dosing, mechanism of action and side effects of 
medicines. Nurses also have to update their knowledge of drugs. With an increasing 
number of medicines available, physicians and nurses are responsible for updating 
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their knowledge of medicines. Different studies in this review revealed that a lack of 
pharmacological knowledge between physicians and nurses is a contributory factor 
to MEs in the Middle East countries. Sweileh and colleagues performed a cross-
sectional study in Palestine to determine whether appropriate dosage adjustments 
were made for drugs that are nephrotoxic in patients with renal impairment. This 
study revealed that dosing errors were common among patients with renal 
impairment during hospitalization and the inadequacy of physician's knowledge of 
clinical pharmacokinetics was a contributing factor for MEs (Sweileh et aI., 2007). 
However, an interventional study performed in Egypt by clinical pharmacists found 
that when the clinical pharmacists' activities focussed on improving physician drug 
knowledge and awareness of errors shown, there was an effective reduction in the 
rate of prescribing errors and their severity in PICU (Alagha et aI., 2011). 
Drug name confusion was one of the most common causes of MEs in a hospital in 
Saudi Arabia e.g. Cefoxtem which could be confused with Cefotaxem (Dibbi et ai, 
2006). 
Two studies have been conducted in Iran to identify the factors contributing to MEs 
(Koohestani et ai, 2008, Islamian et ai, 2010). The first was a descriptive study to 
investigate the frequency, type and causes of MEs of nursing students in Iran and 
found that most of the causes of MEs were related to poor pharmacological 
knowledge and drug calculation errors (Koohestani et ai, 2008). The second study 
was conducted to assess the nursing error rate and related factors. The results of 
this study showed that all the nurses believed that more than one factor was 
involved in errors. The highest rate of errors had been related to lack of compiling 
and reviewing the history of patient's consumed medicines, lack of observing the 
appropriate time for prescribed medicines and lack of assessing the laboratory tests 
of patients with respect to relevant medicines (Islam ian et aI., 2010). 
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6.4.9.3 Poor compliance with drug prescribing and administration guidelines' 
Although medication prescribing and administration guidelines and policies exist in 
all the Middle East countries, it would appear from· the identified studies that the 
adherence to these guidelines and policies was poor. AI-Khaja et al. concluded that 
a lack of adherence to the basic prescribing information and adherence to essential 
drug lists could have contributed to MEs (AI-Khaja et ai, 2007; AI-Khaja et ai, 2005). 
In addition, Vaknin and colleagues in their survey study checked compliance in 
relation to hospital standards, with regards to the quality of the medication 
administration process, and highlighted that poor compliance to guidelines on the 
part of doctors and nurses have an effect on the quality of medication administration 
(Vaknin et ai, 2003). 
6.4.9.4 Unreported medication errors 
Reporting MEs improves patient safety and provides helpful information for the 
prevention of MEs for future practice. Koohestani et al. found that medication 
administration error occurrences among nursing students were often underreported 
due to administrative barriers and fear of decreasing evaluation scores (Koohestani 
et ai, 2009). Another two studies in this review found that unreported MEs in 
hospitals may be due to the hospital staff not knowing the true extent of the problem; 
there is a need to raise the awareness of the importance of reporting MEs (Sadat et 
ai, 2010; Elnour et ai, 2008). 
Another study conducted in Jordan to describe nurses' perceptions about various 
issues related to MEs, found that the nurses failed to report MEs because they were 
afraid that they might be subjected to disciplinary actions or even lose their jobs 
(Mrayyan et ai, 2007). 
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6.4.9.5 Heavy workload and new staff 
Heavy workload and errors due to new staff have been shown as a high cause of 
MEs in different studies in the Middle East (AI-Shara M, 2011; Joolaee et ai, 2011). 
AI-Shara et al. conducted an exploratory study to determine the factors contributing 
to MEs and related areas for improvement, as perceived by nurses (Table 6.10). 
The authors found that the highest level of MEs was 48.4% and related to nurses; 
the main causes being a heavy workload and new staff (AI-Shara M, 2011). Another 
study has been performed to determine the relationship between medication error 
incidents and working conditions, as reported by Iranian nurses in different hospitals 
(Joolaee et ai, 2011). The authors revealed a relationship between nursing MEs and 
working conditions as being statistically significant and contributing to MEs (Joolaee 
et ai, 201.1). 
6.4.9.6 Miscommunications between health care professionals 
Among the reviewed studies, four studies argued that poor communications 
between prescribers, nurses and pharmacists were a common contributing factor for 
MEs in the Middle East region (Dibbi et ai, 2006; AI-khaja et ai, 2010; AI-Dhwailie A, 
2011; Alagha et ai, 2011). Such miscommunication leads to misinterpretation of 
orders particularly in the prescribing ·stage. For example, heparin orders failed to 
specify the type of heparin (whether it is calcium or sodium) (Dibbi et aI., 2006). 
In general, most of the studies focused on the urgent need for educational 
. programmes in medical schools and in health care organisations for all health care 
professionals. A priority was to improve the prescribing skills of physicians and the 
procedure of drug administration for nurses (Azoulay et ai, 2005; Sweileh et ai, 2007; 
Bar-Oz et ai, 2008; Qureshi et ai, 2011; Hooper et ai, 2009; Irshaid et ai, 2005;). All 
these studies recommended educational programmes to prevent the occurrence of 
MEs and to enhance patient safety. Another study emphasised the need for 
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continuous education and implementation of clinical pharmacist's interventions 
(Khalili et ai, 2011). 
6.5 DISCUSSION 
MEs are an important variable reflecting the effectiveness of patient safety services. 
In turn, it is essential to realise the weak pOints of health care professionals and the 
systems they work in the medication treatment process and to try to make 
improvements to avoid occurrence of these errors. Although it is well recognised 
that medication use can improve patient health, this review revealed that studies of 
MEs in Middle East countries were few in number compared to ~ h e e total number of 
MEs in other parts of the world, particularly in children. 
To our knowledge, there are no previous systematic reviews that have evaluated 
MEs in Middle East countries. The aim of this systematic review was to review 
studies of the incidence and types of MEs in Middle East countries and to identify 
the main contributory factors involved. The studies reviewed were varied in terms of 
their objectives, definitions, settings, methods of detection and evaluation of MEs. 
6.5.1 A limited and unclear picture 
This systematic literature review has shown that the scientific literature on MEs 
published in Middle East countries is limited. No information was available on five of 
the countries included in the review. Many studies focused mainly on elderly people. 
The quality of the studies was low as more than 80% of identified studies met less 
than 7 criteria in the quality assessment. 
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6.5.2 Prescribing errors 
Many differences were found with regard to how the studies reported and identified 
MEs. In this review, most of the MEs studies in Middle East countries evaluated the 
MEs during the prescribing stage. Reported incidence rates of prescribing errors in 
this review broadly ranged from 7.1 % to 90.5% of medication orders. Other studies 
have shown that a high rate of prescribing errors is an international problem (Lewis 
et ai, 2009; Dean et ai, 2002). In a previous systematic review conducted in the UK 
to identify the prevalence, incidence and nature of prescribing errors in hospital 
inpatients, prescribing errors were found to be a common occurrence (Lewis et ai, 
2009), and this is consistent with our findings. The incidence of prescribing errors in 
that review however were 2 - 14% of medication orders (Lewis et ai, 2009), which is 
lower than that found in our review of MEs in Middle East countries. 
Another study in the UK however found that prescribing errors rates vary widely, 
ranging from 0.3% to '39.1 % of medication orders (Franklin et ai, 2005). From this 
information it appears that the incidence rate of prescribing errors in the Middle East 
countries is higher than that reported in other countries in the world, for example in 
the UK. 
In addition, my review reveals that dosing error rates in prescriptions vary widely 
from 0.15% to 34.8% of total prescriptions, higher than the rates reported by other 
studies (Barker et aL, 2002; Lisby et aL, 2005) Barker et al reported that 19% of 
doses contained errors (Barker et aL, 2002) and another study found that 28% of 
dosing errors occurred at the prescribing stage (Lisby et aI., 2005). 
In contrast, a previous systematic review found that dose or frequency error rates 
ranged from 30% to 42% of errors that occurred on admission to the hospital (Tam 
et aL, 2005). 
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6.5.3 Transcribing errors 
Although some studies classified the transcribing stage as the third important area 
in the medication treatment process, Lisby et al. have identified the transcribing 
stage as the area in which most errors occur (Lisby et aI., 2005). In this review only 
one study assessed transcribing errors and we found that over 50% of omission 
errors occurred at the transcription stage. This is consistent with the findings of 
other studies (Lisby et ai, 2005; Jimenez-Munoz et ai, 2010). The shortage of 
studies of this stage of medication treatment may distort the reality of the incidence 
rate of errors. 
6.5.4 Administration errors 
My review showed that the reported incidence rate of administration errors is 9.4% 
to 80% of drug administrations. This range is higher than that reported in other 
studies in developed countries. Two observational studies found that the MAEs rate 
in the acute care setting varied between 14.9% and 32.4% (Tissot et aI., 2003; 
Schneider et aI., 1998). In my review only one observational study determined the 
frequency of MEs occurring during the preparation and administration of intravenous 
drugs in an intensive care unit, and found that the rate of errors in drug 
administration (66.4%) was higher than in preparation (33.6%) (Fahimi et aI., 2008). 
One study also found that the MAEs rates for intravenous medication are 
significantly higher than other types of medications (Wirtz et aI., 2003). Wirtz et al 
observed the preparation error rate as 26% and the administration error rate as 34% 
(Wirtz et ai, 2003). The study findings are therefore consistent with previous studies' 
results that highlighted the occurrence of administration errors of intravenous 
medication are more frequently than preparation errors. 
Armitage and Knapman found that the frequency of administration errors ranges 
from 2.4% to 47.5%, depending on the drug distribution system in place (e.g. Unit 
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dose dispensing systems) (Armitage, 2003). In the UK a recent report by the NPSA 
highlighted that 56% of reported errors associated with severe harm occurred at the 
administration step (NPSA, 2007). 
6.5.5 Frequency and Types of medication errors 
My study results indicate that the most common types of errors reported were 
incorrect drug dose, wrong frequency and wrong strength during the prescribing 
stage. This is consistent with previous studies' results. In comparison studies of 
MEs in US and UK hospitals, the authors found that incorrect doses were the most 
common type of error in UK hospitals and also in US hospitals (Dean et aI., 1995). 
The NPSA reported that the most common type of MEs that occurred in the NHS 
was wrong dose or wrong frequency of medications (NPSA, 2009), and this is 
consistent with the findings in my review. 
6.5.6 Contributory factors for medication errors 
Based on my review results, the main factor contributing to the MEs in the Middle 
East countries is poor knowledge of medicines in both doctors (prescribers) and 
nurses (administering drugs), and this finding is compatible with other studies' 
results concerning this point (O'Shea, 1999). Educational programmes for drug 
prescribers and nurses concerning drug therapy are urgently needed to avoid drug 
errors and to improve patient safety. Different studies have found that clinical 
pharmacists play a significant role in delivering training and competency 
assessment (Conroy et aI., 2008). 
6.5.7 Limitations of this review 
Some limitations of this review should be considered in interpreting the results. The 
search strategy and search terms were designed in order to be as comprehensive 
as possible but the databases used were directly biased to English language 
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research and studies. I cannot therefore be sure whether or not some studies have 
been missed because the original languages of the included countries of the Middle 
East is not English; all of the included countries speak Arabic except Iran (Persian) 
and Israel (Hebrew). The use of a limited number of databases for the search could 
be another source of missed information. 
6.5.8 Further research 
There are a number of areas identified in this review that can be targeted for future 
development and research. Further research is needed to explore the incidence of 
MEs and the contributory factors that lead to MEs in the Middle East countries. 
Additional research is also needed to evaluate the incidence rate and the greatest 
impact factors on the dispensing and documentation stages of the medication 
treatment process. More research is needed to measure the severity of the MEs 
among those countries and also assessment of the interventions designed to 
reduce MEs, such as educational and training programmes, are urgently needed. 
In addition, strong co-operation between the Middle East countries in future is a very 
important issue in order to develop the process of medication treatment in these 
countries. 
6.6 CONCLUSION 
As the first systematic review to describe MEs in Middle East countries, this review 
aimed to find out what scientific literature has previously reported on or evaluated 
MEs in Middle East countries. Although the studies related to MEs in the Middle 
East countries were relatively few in number, there was a wide variation between 
studies in the incidence error rates reported, and this may due to the variations in 
the terms of their definitions of MEs, settings and the methodologies used to detect 
MEs among Middle East countries. Most of the studies on MEs were conducted on 
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adult patients, while very few MEs studies have been performed in paediatric 
hospitals. Many studies focused on prescribing errors and factors contributing to 
MEs. This study highlighted that the prescribing error rates varied widely from 7.1 % 
to 90.5% of prescriptions. Dosing errors were the most common reported errors in 
the studies with a range from 0.15% to 34.8%. In drug administration, the error rates 
were from 9.4% to 80% of drug administration. Poor knowledge of medicines was 
the main contributory factor of MEs for both prescribers and nurses administering 
drugs. From this review, I can conclude that the Middle East countries urgently need 
to introduce educational programmes to improve the prescribing skills and 
knowledge of prescribers, and also other programmes to encourage nurses to 
improve their quality of drug administration. 
6.7 RECOMMENDATIONS FOR FUTURE RESEARCH 
According to the review results, the following recommendations are suggested to 
decision makers to improve the medication safety or reduce MEs in Middle East 
countries. 
• Increase the awareness of MEs between health care professionals. 
• Prescribers need to pay more attention to drug dose calculation. 
• Improve the MEs reporting system and policy among the Middle East 
countries without any barriers, and encourage health care professionals to 
report MEs, and clarify the importance of MEs reporting process. 
• Clinical consequences of MEs should be assessed and evaluated in future 
studies 
• Perform more research on MEs involving prescription and non-prescription 
drugs, particularly in paediatric hospitals in Middle East countries. 
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• Carry out regular intensive educational and training programmes in 
pharmacotherapy for undergraduate medical and paramedical students to 
improve patient safety: 
• Educational programmes by clinical pharmacists and clinical 
pharmacologists on drug therapy are urgently needed for doctors and nurses. 
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CHAPTER SEVEN 
CONCLUSION 
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7.1 INTRODUCTION 
Most of the published studies about double checking before my work were 
qualitative rather than quantitative. Despite that, different authors have different 
opinions about double checking in practice. Some of them supported double 
checking and others single checking. Those who support double checking feel that it 
reduces MEs. The other suggested benefit of double checking is that it can improve 
the nurses knowledge of medication administration (Dickinson et aI., 2010). 
The opponents of double checking stated that deference to authority, reduction of 
responsibility and automatic processing mean that double checking does not 
prevent MEs (Armitage, 2008). Kruse et al (2002) found that there was no 
significant differences in error rates between double checking and single checking in 
three clinical services. 
In this thesis, I have tried to add new evidence about the double checking process 
as a strategy that is used in different hospitals to prevent MEs and also to improve 
patient safety in the paediatric population. 
~ 2 S U M M A R Y O F A N r n N G S S
There were only 16 studies identified in my systematic review of double checking 
and most of these were qualitative studies. Only three studies were quantitative 
(Kruse et aI., 1992; Ross et aI., 2000; White et aI., 2010). These three studies were 
conducted in different places and with different types of patients. The first study was 
conducted in three wards in a geriatric hospital, and reported a lower error rate with 
double checking. However, the difference was not statistically significant and the 
clinical advantages were unclear (Kruse et aI., 1992). The second study was carried 
out in the pharmacy within a large children's hospital in the UK. Dispensing errors 
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were lower after double checking but reported error rates were very low (Ross et aI., 
2000). The third study was a simulation study of outpatients in a chemotherapy 
centre in a Canadian hospital. A reduction in errors in patient identification occurred 
with a checklist process (White et aI., 2010). So, my systematic review concluded 
that there was insufficient evidence to justify the double checking of medicines to 
reduce MEs. 
I decided with my supervisors to do three different studies (Chapters 3 - 5). Those 
studies were conducted because it is unethical to perform a randomised controlled 
trial study of single versus double checking on children since there is a lack of 
evidence to support this as being safe. 
The main findings from the prospective observational study (Chapter 3) were that 
there was variation between paediatric nurses adherence to double checking steps 
during medication administration. Drug dose calculation, the rate of administering 
intravenous bolus drugs, labelling of flush syringes and the administration of 
medicines to the patients without supervision from both nurses were the steps with 
the lowest adherence rates. 
In addition, this study identified 191 MAEs with an error rate of 9.6% of drug 
administrations. The most frequent type of administration errors involved the 
medicine being given to the parents to administer to the child when the nurse was 
not present. 
The second study conducted was a questionnaire study (Chapter 4). This study 
revealed that the nurses have unclear knowledge and perceptions of the double 
checking policy and its implementation in practice. The findings from this study 
therefore confirmed the findings obtained from my previous observational study. 
This suggests that paediatric nurses in the hospital need more education of the 
double checking policy in the medication administration process. 
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The third study was a simulation study involving 21 paediatric nurses (Chapter 5). 
Overall. 118 confounders were built into the simulation sessions. These were 
prescribing errors and lack of information available to allow the nurses to safely 
administer medicines without first questioning the researcher. 27 (35%) confounders 
were not detected during single checking compared to only 5 (12%) during double 
checking. Significantly fewer confounders (49, 64%) were detected during single 
checking compared to double checking (37,88%) (P= 0.0136). 
Double checking was significantly more likely to identify errors and contraindicated 
drugs than single checking. The difference between the two processes in terms of 
drug administration time was not statistically significant, although two nurses were 
required for the double checking process effectively doubling the time. Five MEs 
and one near miss were made. These involved 4 errors and 1 near miss with single 
checking and just one 1 error during double checking. This may be due to the 
participants being less confident and unfamiliar with single checking leading to an 
increased risk of errors to occur. 
I decided to do a systematic review of MEs in the Middle East countries because I 
am originally from the Middle East (Saudi Arabia), and I have plans in the future to 
do more research on MEs in the Middle East. This study can be considered as the 
first step towards my future research. 
My systematic review (Chapter 6) revealed that the MEs studies in the Middle East 
countries were limited in numbers particularly with paediatric patients and also the 
identified studies were of poor quality. This systematic review showed that the lack 
of knowledge about medicines among doctors and nurses.was identified as a major 
contributory factor of MEs. 
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7.3 PRACTICE IMPLICATIONS 
Based on the above findings I have the following suggestions for all healthcare 
professionals (particularly those who are working in children's hospitals), decision 
makers in the children's hospitals, and researchers in this field: 
1. Double checking appears to be more effective than single checking. 
2. More quantitative studies are needed to investigate the relationship between 
MEs and staffing conditions in the children's hospitals. 
3. Better clarification of the double checking steps is required for all nurses in 
the hospitals who use the process. 
4. Educational programmes should be established for nurses to improve 
nurses' adherence to the double checking process and to improve their lack 
of knowledge and clarity about the double checking steps. 
5. In the Middle East, awareness of MEs should be increased among 
healthcare professionals and researchers in this area. 
6. The quality of MEs studies in the Middle East should be improved. 
7. Educational and training programmes about drug information and 
administration in the Middle East countries should be established by clinical 
pharmacists and clinical pharmacologists in the hospitals. 
7.4 LIMITATIONS OF THIS THESIS 
In this thesis there were two systematic reviews (Chapter 2 & 6), and some 
limitations of those reviews were considered and discussed in detail within each 
chapter. 
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The clinical studies I conducted were performed in one children's hospital and that 
may affect the generalisability of the findings. My presence may have had an effect 
on the nurses during their medication preparation, particularly on IV drug 
preparation. This may have increased their adherence to the double checking steps 
as they knew that they were being closely observed. Alternatively it may have made 
them nervous and distracted them, however I tried hard not to do this. 
Because the Derbyshire Children's Hospital policy for drug administration requires 
two nurses to do double checking before each drug dose administration, the nurses 
in the hospital are familiar with double checking but not with single checking. This 
may have affected their performance and level of confidence with the single 
checking process when I compared these two checking processes in the simulation 
study. 
7.6 FINAL CONCLUSION 
Finally, this research has achieved its main objectives; to get a clearer evaluation of 
the effectiveness of double checking. There was variation in the adherence rate to 
the different steps of the double checking process and also a lack of clarity of the 
double checking process details among paediatric nurses. Double checking is seen 
to be more effective than single checking in reducing MEs in children. More needs 
to be done in the Middle East in relation to research in this area. Educational 
programmes of prescribers are required to improve their prescribing skills, and also 
for nurses to improve their knowledge about medication administration. 
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Zayad Alsulami with the Derby Hospitals NHS Foundation Trust for a placement in lhe 
Children's Hospital as a PhD Student from 23/4/12 to 31/12113. 
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Safety and Security. 
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damage to, personal property. You are recommended to Investigate the possibility of 
insuring yourself and take advantage of any facilities in ttJe Trust which may e)(lst for the 
safekeeping of property. 
8. All staff involved in the care and trealment of patients during ll1e course of their 
employment are covered by NHS Indemnity for acts or omissions which amount to 
clinical negligence. This does not cov'!r work which is or Is deemed to be outSide of their 
appointment including work undertaken as part of private practice, whether on Trust 
premises or not. or as part of personal research. 
9. You are at art times expected to carry oul your duties in accordance with the Trust's 
Policies and Procedures, agreed clinical protocols alld in accordance with their 
professional <::Odes of practice. 
10. Any uniform. protective clothing Of other items Which may be issued to you remain the 
property of the Trust and must be rekJmed on terminattOn of your appointment. 
11. If appropriate, your appoinlment is subject to you being registered WIth your 
professional or appropriate statutory body and you will be ( ~ u l r e d d to produce evidence 
of your registration. 
12. Members of staff shotJld only know cw possess personal data about patients or 
employees where their jobfrole exphcitly permits it 
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Personal data held on a computer may only be held or processed by a member of 
staff in accordance with the principles of the Data Protection Act 1998. Access to 
computers is strictly limited under the terms of the Computer Misuse Act 1990. 
You have a right and a duty Ur'lder the Procedure for Dealing with Staff Concerns on 
Health Service Matters to make known any concerns you may have on health service 
activities. The Procedure enables you to raise concerns, in confidence, with Trust 
officers, Trade Unions, Professional Organisations. Statutory Bodies or Professional 
Bodies. 
13. Research Governance Framewor/( 
The Trust supports and promotes high quality research as part of its aim to develop 
and Implemen! best practice in the delivery of care and to contribute to the national 
body of research designed to enhance clinical practice. Any research which you 
undertake as an employee of the Trust must compty with Trust policies and 
procedures and the Research Governance Framework and all research undertaken 
must be approved by an NHS Research Ethics Committee. 
Finally, r would Wlsh to emphasise to you the confidential nature of tfealth Service work, not 
only in relation to patient information wtlich is of course strictly confidential, but also in respect 
of Security of Information relating to members of staff, and to the business interests of t ~ e e
Trust of which you may b e c o ~ ~ aware d:Jring the course of your Honorary AppOintment with 
the Trust 
If you agree to accept the HOflorary Appointment offered in this letter of the terms specified, 
please sign the attached and return one copy to Human Resources, London Road Community 
Hospital. The second copy is for your retention. 
Yours sincerery 
Human Resource Assistant 
on behalf of tOO Oerby Hospitals NHS Foundation Trust 
Date: 9 May 2012. 
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DATA COLLECTION FORM 
WARD NAME (DEPARTMENT): 
Patient Initial: D.O.B: WEIGHT: DIAGNOSIS: BED NO: 
;x Drug name & Drug Correct Correct Dose Drug Measurement 01 IV volume Drug Drug Rate 01 IV Flush Allergy Patient ID Administration to Document to formed due drug dosage calculation diluents & dose & rate route expiry bolus syringes check (using patient MAR Ime administered form volume date labelled wristband) 
Z 
w 
::::iE 
::::iE 
Den 
Ur-
NON-CHECKED = 0, CHECKED = 1, NOT APPLICABLE = 2 
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Interpretation of data collection form content 
Demographic information: 
Details of the patient initial, date of birth and weight should be collected by observer. 
Drug name & form: 
The approved name (generic) of the selected medicine should be checked and 
confirmed by both nurses with the prescribed drug on the prescription chart. 
Drug due: 
The both nurses should be checked the frequency of the prescribed medication that 
the time of administration is correct including confirming where the last dose was 
given. 
Correct drug: 
The pharmacy label and all instruction or any precaution stated should be checked 
by both nurses. 
Correct dosage form: 
The dosage form for each prescribed drug should be checked with the one that is 
prepared for administration and its appropriateness for the patient clinical situation. 
Dose calculation: 
Two qualified nurses should independently calculate the drug dose that to be 
prepared or administered and confirming the result with each other of the prescribed 
drug. 
Measurement of dose: 
The two nurses should be prepared and checked the drug dose before 
administration. 
Drug route: 
The route of drug administration should be checked and confirmed by nurses and 
should be suitable for the patient situation and age. 
Drug expiry date: 
Check the drug expiry date before administration and that it is in an acceptable 
condition to be considered effective. 
Rate of IV bolus: 
Check the drug concentration and administer correct dose at proper push rate. 
I.V infusion volume and rate: 
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The two paediatric nurses should be checked the volume and the rate of the pump 
over a determined time interval for the prescribed drug. 
Drug diluents and volume: 
The two qualified paediatric nurses should be checked that the appropriate diluents 
and volume have been used according to the hospital intravenous preparation 
guidelines. 
Drug allergy: 
The patient drug or food allergy should be checked by both nurses by asking the 
patient himself or his parents and comparing that with what is written in medication 
chart 
Patient 10 (using wristband): 
The patient name, date of birth and ID number that written on wristband should be 
checked by two nurses and comparing that with the information written on the 
medication chart 
Administration to the patient: 
Both nurses should be present at the patient bed to administer the medicines to the 
patient. When the parents want to give the medicine to their child both nurses should 
witness the patient when he/she take the medicine. 
Documentation to MAR: 
Both nurses should be document and record the drug administration information 
after the giving the prescribed drug and sign for each medication administration 
episode. 
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The University of 
Nottingham 
CONSENT FORM 
MEDICINES ADMINISTRATION OBSERVATION PROJECT 
Name of Researcher: 
Name of Parent I Care: Please initial bOI 
The researcher will directly observe the nurse who is going to give medication to the patient 
from preparation until administration. During that time the observer will be collecting data by 
specific data collection forms. This study will take place over four months. Also, during this 
study there are rio discomforts or stresses and no risks on the patient. 
1. 
2. 
3. 
I understand that participation is voluntary and that I am free to withdraw at D 
any time, without giving any reason, and without my medical care or legal 
rights being affected. I understand that should I withdraw then the infoonation 
collected so far cannot be erased and that this information may still be used In 
the project analysis. 
I understand that data collected from this study will be looked at by authorised D 
individuals from the University of Nottingham, the research group and 
regulatory authorities where it Is relevant to my taking part in this study. I give 
permission for these individuals to have access to these records and to collect 
store, analyse and publish infoonation obtained from participation In this stUdy. 
I understand that my child's personal details will be not be recorded. 
I agree for my child's medicines administration to be observed. D 
Name of Parent I Care Date Signature 
Name of Person taking consent Date Signature 
(if different from Principal Investigator) 
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A SURVEY OF PAEDIATRIC NURSES' PERCEPTIONS OF DOUBLE CHECKING 
OF MEDICATION ADMINISTRATION IN CHILDREN HOSPITAL 
PURPOSE 
This survey has been designed to evaluate paediatric nurses' knowledge of and 
opinion on the double checking process and how this process impacts on the 
paediatric nurses' practice. 
ELIGIBILITY 
Registered paediatric nurses at Derbyshire Children's Hospital, who have 
responsibility for administering medicines, will be eligible for inclusion into the survey. 
CONFIDENTIALITY 
No identifying information will be collected from you and your responses are 
therefore anonymous. All information obtained as a result of this survey is 
considered confidential. 
PARTICIPATION 
The decision regarding participation in this survey is entirely voluntary. You can 
withdraw at any time without any penalty. 
IF YOU HAVE ANY QUESTION ABOUT THIS SURVEY PLEASE CONTACT: 
Chief Investigator: Dr Sharon Conroy 
Phone number: 01332724692 
Email address: Sharon.conroy@nottingham.ac.uk 
OR 
Co-Investigator: Mr Zayed Alsulami 
Phone number: 01332724721 
Email address: mzxza@nottingham.ae.uk 
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The University of 
Nottingham 
DOUBLE CHECKING MEDICINES ADMINISTRATION IN CHILDREN -
WHAT DO YOU THINK? 
Dear colleague, 
As part of a PhD student project we wish to find out what you think about double 
checking medicines administration. We hope that you will be able to help us by 
completing and returning this questionnaire. It asks for your views on the double 
checking process and its effectiveness in preventing medication administration errors 
in paediatric patients. 
Completing this questionnaire will take about 10 minutes. Please return it to us by 
putting your completed form in the enclosed envelope in the box provided in your 
clinical area or ward. 
Please remember that we would like to know what happens in real life and 
what you think· not the ideal or the best practice. There are no wrong or right 
answers and all answers will be anonymous and confidential. 
If you prefer not to answer particular questions please leave them blank. 
If you have any queries, please don't hesitate to contact us using the details below. 
We look forward to your response and many thanks for your participation. 
Best Wishes 
Zayed Alsulami 
PhD student 
Phone number: 01332724721 
Email: mzxza@nottingham.ac.uk 
Dr Sharon Conroy 
Lecturer in Paediatric Clinical 
Pharmacy, Academic Division of Child 
Health, University of Nottingham 
Medical School at Derby 
Phone number: 01332 724692 
Email: sharon.conroy@nottingham.ac.uk 
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DOUBLE CHECKING PROCESS QUESTIONNAIRE 
1. Have you seen the Trust double checking process written down (either in 
paper format or on the intranet)? 
DYes o No 
comments ............................................................................................... . 
2. Do you know exactly what the Trust double checking process should 
involve? If so, Can you briefly tell us? 
DYes o No 
comments ............................................................................................... . 
3. Have you undergone any specific training in the Derbyshire Children's 
Hospital, on how to do double checking for administration of medicines to 
paediatric patients? If so, when was it, who was involved and what did the 
session consist of? 
DYes o No 
comments ............................................................................................... . 
............................................................................................................... 
............................................................................................................... 
4. Which of the following do you always double check with another paediatric 
nurse? 
o Oral preparation o Oral administration 
o Intravenous preparation o Intravenous administration 
5. What is the main reason for you doing the double checking process? Please 
choose the one most important to you. 
o Because the hospital policy says that I must. 
o To protect children from medication errors. 
o To learn more about the medicines. 
o To protect myself from making a mistake. 
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6. Is double checking more effective with oral or IV medicines? Can you 
explain why? 
o Oral medicines, explain 
why ................................................................................................. . 
o Intravenous, explain 
why ...................................................................................................... . 
Comments .................................................................................. .. 
................................................................................................. 
7. What are the most common factors that you think have a direct effect on 
your ability to do double checking on your ward? (Tick any you think apply) 
o Shortage of paediatric nurses and workload. 
o Disturbance and interruption by other staff members. 
o Unavailable second person to carry out the double check. 
o Trust double checking process is unclear. 
o Time consuming process without any effect on patient safety. 
8. Do you think the double checking process by another nurse is effective in 
detecting medication preparation and administration errors? 
• Medication preparation errors 
errors 
o Ineffective 
o Effective 
o Very effective 
• Medication administration 
o Ineffective 
o Effective 
o Very effective 
9. Can you follow the double checking process more easily on:-
o Weekdays, if so why ..................................................•...••..•..•......•......•.•..• 
o Weekends, if 50 why ............................................................................... .. 
o No difference, if 50 why .......................................................................... .. 
10. Can you follow the double checking process more easily In the: 
o Morning (08:00- 12:00)? If 50 
why .................................................................... . 
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o Afternoon (12:00-16:00)? If so 
why ................................................................... . 
o Evening (16:00-20:00)? If so 
why .................................................................... . 
o At night (20:00-08:00)? If so 
why .................................................................... . 
11. How many medication preparation/administration errors do you remember 
making and/or finding last month that were identified during the double 
checking process? 
o No errors 05 -10 errors. 
o Less than five errors. o More than 10 errors. 
12. What are the three elements of the double checking process you are least 
likely to pay attention to when you are performing a check during medication 
preparation and administration? 
IV medications Oral medications 
o o 
o o 
o o 
13. The literature suggests that double checking is carried out in a variety of 
ways, with varying degrees of effectiveness. How do you think an effective 
process should be performed and do you do this in practise? 
............................................................................................................... 
............................................................................................................... 
14. Do you think single checking (i.e. one nurse prepares and administers the 
medicine alone) should be allowed for: 
o Oral medicines only? If so why, 
..................................................................................................... 
o Intravenous medicines only? If so why, 
.................................................................................................... 
o All types of medicines? If so why, 
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o No medicines? If so why 
o Certain medicines? If so which medicines and why, 
15. Do you have anything else that you wish to say about the double checking 
process? 
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DEMOGRAPHIC INFORMATION 
1. Gender 
o Female o Male 
2. Age Group (Years) 
o Under 21 021-30 031-40 041-50 051+ 
3. How long in total have you worked as a paediatric nurse? 
o Less than 12 months 
o One year to less than two years 
o Two years to less than five years 
o Five years to less than 1 0 years 
DOver 10 years 
4. What is your current employment status? 
o Permanent full-time o Temporary full-time 
o Permanent part-time o Temporary part-time 
5. How long in total have you prepared and administered medicines for 
paediatric patients? 
o Less than 12 months 
o One year to less than two years 
o Two years to less than five years 
o Five years to less than 1 0 years 
DOver 10 years 
Thank you very much for your participation! 
Please return in the box provided on the ward. 
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Direct line/e-mail 
+44 (0) 115 8231063 
louise.Sabir@nottingham.ac.uk 
16th t4ay 2012 
Dr Sharon Conroy 
Academic Division of Child Health 
r·ledical School 
Royal Derby Hospitals 
Uttoexter Road 
Derby 
DE223DT 
Dear Dr Conroy 
Ethics Reference No: N19042012 (12038) GEt,lS 
The University of 
Nottingham 
Faculty of Medicine and 
Health Sciences 
Medical School Research Ethics 
Committee . 
Division of Therapeutics & 
Molecular Medicine 
D Floor, South Block 
Queen's Medical Centre 
Nottingham 
NG72UH 
Tel: +44 CO) 115 8231063 
Fax: +44 (0) 115 8231059 
Study Title: Simulation Study of Paediatric Drug Administration Procedures 
Chief Investigator: Dr Sharon Conroy, lecturer in Paediatric Clinical Pharmacy, 
Academic Division of Child Health, School of Graduate Entry Nediclne, Derby 
Co Investigators: Nr Zayed N Alsulami, PHD Student, Professor Imti Choonara, 
Professor In Child Health, Academic Division of Child Health, School of Graduate 
Entry Nedicine, Derby 
Duration of Study: 05/2012-10/2012 6 months No of Participants: 30 
Thank you for your letter dated 9th t·lay 2012 responding to the issues raised by the 
committee. The following documents have been received: 
• NhsRdForm.pdf 05/04/2012 
• 12038 Simulation study protocol final v1.doc 05/0412012 
• 12038 consent form DC project final v1.doc 05/04/2012 
• 12038 Simulation study PIS final v1.docx 05/04/2012 
• 12038 Reminder letter of Invitation simulation final v1.doc 05/04/2012 
• FuIlDatasetTrfaIForm(3).pdf 05/0412012 
• t<led School ethics application simulation study t<lay 12.doc 15/5/2012 
• E-mail response to Committee 09 Nay 2012 12: 51 
• 12038 Simulation study PIS final v2.doc 09/512012 
These have been reviewed and are satisfactory and the study is approved. 
Approval is given on the understanding that the Conditions of Approval set out below 
are followed. 
Conditions of Approval 
You must follow the protocol agreed and any changes to the protocol will require 
prior Ethics' Committee approval. 
This study is approved for the period of active recruitment requested. The 
Committee also provides a further 5 year approval for any necessary work to be 
performed on the study which may arise in the process of publication and peer 
review. 
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You promptly inform the Chairman of the Research Ethics Committee of 
(i) Deviations from or changes to the protocol which are made to eliminate 
immediate hazards to the research subjects. 
(ii) Any changes that increase the risk to subjects and/or affect significantly the 
conduct of the research. 
(iii) All adverse drug reactions that are both serious and unexpected. 
(iv) New information that may affect adversely the safety of the subjects or the 
conduct of the study. 
(v) The attached End of Project Progress Report is completed and returned when 
the study has finished. 
Yours sincerely 
, r A 
. ~ ) & &
Dr Clodagh Dugdale 
. Chair, Nottingham University Medical School Research Ethics Committee 
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gHf7 Re!ea:.i1 & Imcvati:ln D ~ ~ ~ en! 
ISSUED 
24 JUL 2012 
Derby Hospitals b'l:kj 
NHS Foundation Trust 
Research and Development Office 
TRUST APPROVAL LETTER 
Dr Sharon Conroy 
Lecturer in Paedlstnc Clinical Pharmacy 
Academic DivIsion of Child Health 
University of No:tlngham Medical School 
Royal Derby Hospital 
\ . ~ r rD e a r ~ " ' ' ~ \ J " ' '
Royal O ~ r b y y H o ~ p i t d l l
Uttoxeter RO<Id 
Derby 
DE223NE 
Tel: 01332340131 
Mlnlcom: 01332 254944 
( O n t i ! { l l 1 ~ C I ' d e r b y h ~ p i l d l \ \ nhs.uk 
www.demyhospitals "hs.uk 
Re: Double chocking and rMdicatlon administration errors In paediatric patients -
simulation study 
R&D Ref: DHR0120121034 
I am pleased to confirm Trust management approval for you to proceed in accordance Itfith 
the agreed proto·::oI, the Trust's finanCial procedures for research and development and the 
Research Gover18nce Framework (whICh Indudes the Data Protection Act 1996 and the 
Health & Safety at Work Act 1974). 
Please supply tha follOWing to Dr Teresa Gneve, Assistant Director of R&D: 
• the actual start and end dates of this study (before the study commenc .. ). 
• details of any pubhcatlons arising from this research project. 
• a final report and a report rury mix months if the study duration is greater than six 
months 
• notifICation of any SUSARS, amendments, urgent safety measures or if U1e trial is 
abandoned 
Please note that approval for this study is dependent on full compliance with ell of the above 
conditions. 
ThiS project did not require ethICal revIew by a ResearCh Ethics Committee under the UK 
Health Departme'1!s' Governance Arrangements for Research EthiCS Committees (GAfREC) 
in accordance with the NRES algorithm dated August 2011. 
I would like to take this opport\Jnity to Wish you every success With this study 
Yours sincerely, 
. <<t':--L 
Prof. Richard Donnelly MD, PhD, FRCP, FRACP 
Director of Research & Development 
Smokin\l i. not p ... milt ... ·j .nywh ... " i" th. buHdin\15 Mld g.ound. 
of D e . b ~ · · s H",p,l"ll,. roo idvole .. l1d support about 9, ... lng up smoking 
pie..,,,, call F."", ~ ~ OtOO 1f)16810 
234 
Ch,ef hecut,"e Suwn Jan'M 
Chair: Joh" II,,,,,,, 
R&D referen:e: DHR[)"2012·034 
Derby Hospitals ~ ~
NHS Foundation Trust 
Royal Derby Hospital 
Uttoxl'ter Road 
Derby 
DE22 3NE 
TE'I; 01332 340131 
Mlnicom: 01332 254944 
( o n t a r t l l s @ d e r b J ' h o ~ p i 1 a l s , n h s . l J k k
www,dcrbyhosplt..lls.nhs.uk 
In accordance with your application and subsequent R&D approval dated 24th July 2012, 
the following documentation was reviewed and may therefore be used on the above study 
with Trust approval. 
• Protocol Final Version 1.0 dated 03.04.12 
• Consent Form Final version 1.0 dated 02.04.12 
• Participant InformaMn Sheet Final version 2,0 dated 09.05.12 
• Remi1der letter of Invitation v1 dated 04.01.12 
• letter of I n v i t a ~ i o n n v1 dated 04 01.12 
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DOUBLE CHECKING AND MEDICATION ERRORS IN PAEDIATRIC PATIENTS: 
A SIMULATION STUDY 
Letter of invitation to participate in a study to determine whether single or 
double checking is more effective in detecting errors when administering 
medicines to children 
Dear Colleague, 
My name is Zayed Alsulami and I am a second year PhD student in the Academic 
Division of Child Health at the University of Nottingham. Together with my supervisor 
Dr Sharon Conroy (paediatric pharmacist) I am conducting a study to evaluate the 
effectiveness of double checking processes in reducing drug administration errors in 
paediatric inpatients. We would very much like you to help with a simulation study 
using dummy patients to examine whether single or double checking is more 
effective in detecting and reducing medication administration errors. 
Please read the attached participant information sheet. If you are happy and 
interested in participating, please complete and sign the consent forms. Please keep 
one copy of the consent form for yourself and return the other one to me in the 
envelope provided using the box provided on the ward. 
If you have any questions about the study please contact the Chief Investigator, Dr 
Sharon Conroy on extension 72 24692 or email: 
Sharon.Conroy@nottingham.ac.uk 
Your participation in this study is highly valued. 
Best regards, 
Zayed Alsulami 
Postgraduate student 
Academic Division of Child Health, Graduate Entry Medicine and Health Science 
The Medical School, Derby, University of Nottingham, 
DE22 3DT, Derby, UK 
Email: mzxza@nottingham.ac.uk 
Tel: +44(0)1332724692 
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Participant Information Sheet 
Final Version 2.0: 9/5/12 
DOUBLE CHECKING AND MEDICATION ERRORS 
IN PAEDIATRIC PATIENTS - SIMULATION STUDY 
Derby Hospitals ' ~ l : k j j
NHS Foundation Trust 
Name of Researcher(s): Sharon Conroy and Zayed Alsulami 
We would like to invite you to take part in our research study. Before you decide we 
would like you to understand why the research is being done and what it would 
involve for you. One of our team will go through the information sheet with you and 
answer any questions you have. Talk to others about the study if you wish. Ask us if 
there is anything that is not clear. 
What is the purpose of the study? 
The study is part of a PhD project and wi" evaluate the effectiveness of double 
checking processes in reducing medication errors in paediatric inpatients and to find 
out whether single checking is as effective as double checking. 
Why have I been invited? 
You are being invited to take part because you are a registered paediatric nurse at 
the Derbyshire Children's Hospital and you have responsibility for administering 
medicines to children. We are inviting a" nurses in the hospital like you to take part. 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If 
you decide to take part you are still free to withdraw at any time and without giving a 
reason. This would not affect your legal rights. 
What will happen to me if I take part? 
Nurses who agree to participate will be given a prescription scenario in a room on 
Puffin ward and be asked to prepare and administer drugs used commonly on the 
wards to a dummy patient. They will be asked to prepare and administer the drugs in 
pairs with double checking as they do in everyday practice and then (on a different 
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day) a similar prescription alone (single checking). Participation is anticipated to take 
a maximum of two hours in total. 
All data collected during this exercise will be identified by a participant code. 
Individual results will not be shared with the Trust and will not affect your work in any 
way. You will be given feedback on your performance by the chief investigator for 
your own professional development. If gross bad practice is identified however, then 
this will be discussed with you and your manager will be informed if deemed 
necessary by the Chief Investigator of the study. 
Expenses and payments 
Participants will not be paid to participate in the study. 
What are the possible disadvantages and risks of taking part? 
There are no risks to participation. The only "disadvantage" is the time that you will 
be asked to set aside to take part. 
What are the possible benefits of taking part? 
We cannot promise the study will help you directly but the information we get from 
this study may help to decide whether single or double checking of medicines 
administration to children is most effective in reducing medication errors in children. 
You will also be given feedback on your performance by the Chief Investigator for 
your own professional development. 
What happens when the research study stops? 
We will analyse our results, write papers to publish them in paediatric journals and 
also tell others about our findings at meetings and conferences. 
What if there is a problem? 
If you have a concern or question about any aspect of this study, you should ask to 
speak to the researchers who will do their best to answer your questions. The 
researcher's contact details are given at the end of this information sheet. If you 
remain unhappy and wish to complain formally, you can do this by contacting the 
Ethics Committee Secretary, Mrs Louise Sabir, Division of Therapeutics and 
Molecular Medicine, 0 Floor, South Block, Queen's Medical Centre, Nottingham, 
NG72UH. 
Telephone: 0115 8231063. E-mail:louise.sabir@nottingham.ac.uk. 
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Will my taking part in the study be kept confidential? 
Others may know that you have taken part in the study but all data collected and 
results obtained will be identified only by a code. Your name will not be collected or 
used in any way other than it being on the consent form which you will be asked to 
sign before you take part. All data that we collect will be stored in locked offices in 
the University of Nottingham and/or on password protected computer systems. No 
one in the Trust will be informed about how individual nurses performed in the study 
(though please see note above regarding gross bad practice). We will follow ethical 
and legal practice and all information about you will be handled in confidence. 
If you join the study, some parts of the data collected for the study may be looked at 
by authorised persons from the University of Nottingham. The data may also be 
looked at by authorised people to check that the study is being carried out correctly. 
All will have a duty of confidentiality to you as a research participant and we will do 
our best to meet this duty. 
No information which will identify you will be collected during the course of the 
research (other than the consent form) and all information will be kept strictly 
confidential, stored in a secure and locked office, and on a password protected 
database. Any information about you which leaves the hospital will be anonymous 
and a unique code will be used so that you cannot be recogn.ised from it. 
All research data will be kept securely for 7 years. After this time the data will be 
disposed of securely. During this time all precautions will be taken by all those 
involved to maintain the confidentiality of all data. Only members of the research 
team will have access to your personal data. 
If any participant makes us aware of something which may require reporting then this 
will be done through the hospital's incident reporting system. 
What will happen if I don't want to carryon with the study? 
Your participation is voluntary and you are free to withdraw at any time, without 
giving any reason, and without your legal rights being affected. If you withdraw then 
the information collected so far cannot be erased and this information may still be 
used in the project analysis. 
What will happen to the results of the research study? 
Once we have analysed our results we will write papers to publish them in paediatric 
journals and also tell others about our findings at meetings and conferences. We 
hope this will be done within a few months/year of the study finishing. The project will 
also be written up as part of one the researchers PhD project. You will not be 
identified in any report'publication. 
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Who is organising and funding the research? 
This research is being organised and funded by the University of Nottingham. 
Who has reviewed the study? 
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
and given favourable opinion by University of Nottingham Medical School Research 
Ethics Committee. 
Further Information and contact details 
If you would like further information please contact Dr Sharon Conroy, Lecturer in 
Paediatric Clinical Pharmacy, The Medical School, Derbyshire Children's Hospital, 
Uttoxeter Road, Derby, DE22 3DT. 
Tel: 01332 724692 or 
Email: Sharon.conroy@nottingham.ac.uk. 
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DOUBLE CHECKING AND MEDICATION ERRORS IN PAEDIATRIC PATIENTS: 
A SIMULATION STUDY 
Reminder letter of invitation to participate in a study to determine whether 
single or double checking is more effective in detecting errors when 
administering medicines to children 
Dear Colleague, 
My name is Zayed Alsulami and I am a second year PhD student in the Academic 
Division of Child Health at the University of Nottingham. I contacted you recently 
about the above study but have not yet heard from you hence this gentle reminder. 
Together with my supervisor Dr Sharon Conroy (paediatric pharmacist) I am 
conducting a study to evaluate the effectiveness of double checking processes in 
reducing drug administration errors in paediatric inpatients. We would very much like 
you to help with a simulation study using dummy patients to examine whether single 
or double checking is more effective in detecting and reducing medication 
administration errors. 
Please read the attached participant information sheet. If you are happy and 
interested in participating, please complete and sign the consent form. 
If you have any questions about the study please contact the Chief Investigator, Dr 
Sharon Conroy on extension 72 24692 or email: 
Sharon.Conroy@ nottingham.ac.uk 
Your participation in this study is highly valued. 
Best regards, 
Zayed Alsulami 
Postgraduate student 
Academic Division of Child Health 
Graduate Entry Medicine and Health Science 
The Medical School, Derby 
Nottingham University 
DE22 3DT, Derby, UK 
Email: mzxza@nottingham.ac.uk 
Tel: +44(0)1332724692 
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The University of 
Nottingham Derby Hospitals rll/:l/.1 NHS Founddtion Trust 
CONSENT FORM 
(Final version 1.0: 214/12) 
DOUBLE CHECKING AND MEDICATION ADMINISTRATION ERRORS 
IN PAEDIATRIC PATIENTS 
REC ref: N19042012 (12038) GEMS 
Name of Researcher: 
Name of Participant: Please initial box 
1. 
2. 
3. 
I confirm that I have read and understand the information sheet 
version number 2 dated 9/5/2012 for the above study and have had 
the opportunity to ask questions. 
I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, and without my legal 
rights being affected. I understand that should I withdraw then the 
information collected so far cannot be erased and that this information 
may still be used in the project analysis. 
I understand that data collected in the study may be looked at by 
authorised individuals from the University of Nottingham, the research 
group and regulatory authorities where it is relevant to my taking part 
in this study. I give permission for these individuals to have access to 
these records and to collect, store, analyse and publish information 
obtained from my participation in this study. I understand that my 
personal details will be kept confidential. 
4. I agree to take part in the above study. 
Name of Participant Date Signature 
Name of Person taking consent Date Signature 
2 copies: 1 for participant, 1 for the project notes 
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D 
D 
D 
D 
DATA COLLECTION FORM FOR SIMULATION STUDY 
DRUG NAME and FORM ADMINISTERED ( ) 
Scenario Name: 
Participant Code: 
Observer: 
Time start: Time finish: 
Drug administration Double Checking Comments 
process 1 at 2nd 
Drug due 
Correct drug 
Correct dosage form 
Dose calculation 
Drug diluents & volume 
Measurement of dose 
IV volume & rate 
Drug route 
Drug expiry date 
Rate of IV bolus 
Flush Syringes labelled 
Allergy check 
Patient 10 (wristband) 
Administration to 
patient 
Document to MAR 
Not checked =0, Checked = 1 
MAR (Medication Administration Record) 
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DATA COLLECTION FORM FOR SIMULATION STUDY 
DRUG NAME and FORM ADMINISTERED ( ) 
Scenario Name: 
Participant Code: 
Observer: 
Time start: Time finish: 
Drug administration Single Checking Comments 
process 
Drug due 
Correct drug 
Correct dosage form 
Dose calculation 
Drug diluents & volume 
Measurement of dose 
IV volume & rate 
Drug route 
Drug expiry date 
Rate of IV bolus 
Flush Syringes labelled 
Allergy check 
Patient I D (wristband) 
Administration to 
oatient 
Document to MAR 
.. MAR (Medication Administration Record) 
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APPENDIX D 
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Quality assessment criteria are included: 
1. Aims/objectives of the study clearly stated. 
2. Definition of what constitutes a ME. 
3. Error categories specified (for example, omission errors; wrong dose errors, 
etc.) 
4. Error categories defined (for example, omission error: when a patient has not 
received his or her medication by the time the next dose is due (insulin)). 
5. Presence of a clearly defined denominator. 
6. Data collection method described clearly. 
7. Setting in which study conducted described. 
8. Sampling and calculation of sample size described (unit of measurement). 
9. Reliability measures. (e.g. methods of measuring the stability or consistency of 
questionnaire scores over time). 
10. Measures in place to ensure that results are valid. 
11. Limitations of study listed. 
12. Mention of any assumptions made. 
13. Ethical approval. 
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Quality assessment criteria of each individual study 
Study Authors Country Criteria available Fulfilled 
(Year) 
Ben-Yehuda et al. Israel 1,2,3,4,6,7,8,9,11,13 10/13 
(2011) 
Joolaee et ai, (2011) Iran 1,2,3,6,7,8,9,11,13 9/13 
Lifshitz et ai, (2011) Israel 1,2,3,4,6,7,8,11,13 9/13 
Alagha et al. (2011) Egypt 1,2,3,4,5,6,7,11,13 9/13 
Fahimi et al. (2008) Iran 1,2,3,5,6,7,11,13 8/13 
Kazemi et al. (2010) Iran 1,2,3,4,6,7,9,11 8/13 
Kadmon et al. Israel 1,2,3,4,7,9,11,13 8/13 
(2009) 
Aljeraisy et ai, Saudi 1,2,3,4,6,7,11,13 8/13 
(2011) 
Alkhaja et al. (2005) Bahrain 1,2,3,4,6,7,9,11 8/13 
Drach-Zahavy & Pud Israel 1,2,6,7,8,11,13 7/13 
(2010) 
Saab et ai, (2006) Lebanon 1,3,6,7,8,11,13 7/13 
Vessal G, (2010) Iran 1,2,3,4,6,7,11 7/13 
Koohestani et ai, Iran 1,3,4,7,11,12,13 7/13 
(2009) 
Kazemi et al. (2011) Iran 1,2,3,4,7,11,13 7/13 
Koohestani et ai, Iran 1,2,3,4,6,11,13 7/13 
(2008) 
Azoulay et al. (2005) Iran 1,3,4,6,7,13 6/13 
Lusting (2000) Israel 1,2,3,4,7,13 6/13 
Khoja et al. (2011) Saudi 1,2,3,4,6,7 6/13 
Alkhaja et ai, (2008) Bahrain 1,3,4,5,6,7 6/13 
Alkhaja et al. (2010) Bahrain 1,2,3,4,6,7 6/13 
Sabry et ai, (2009) Egypt 1,2,3,6,7,11 6/13 
Qurashi et al. (2011) Saudi 1,3,4,6,7,13 6/13 
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Mrayyan et al. Jordan 1,2,3,6,7,13 6/13 
(2007) 
AI-Shara M. (2011) Jordan 1,2,3,6,7,13 6/13 
Khalili et al. (2011) Iran 1,2,3,4,7,13 6/13 
Oliven et al. (2005) Israel 1,2,3,4,6,7 6/13 
Neyaz et al. (2011) Saudi 1,6,7,9,11,13 6/13 
Alkhaja et al. (2007) Bahrain 1,3,4,6,7,13 6/13 
Fahimi et al. (2009) Iran 1,2,3,4,7,13 6/13 
Abou alsoud et al. Egypt 1,3,6,7,11,13 6/13 
(2010) 
Hooper et al. (2009) Qatar 1,2,3,4,7 5/13 
Koohestanl et al. Iran 1,3,6,7,13 5/13 
(2008) 
Sad at-Ali et al. Saudi 1,2,7,11,13 5/13 
(2011) 
Sweileh et al. (2007) Palestine 1,3,4,6,7 5/13 
Vardi et al. (2007) Israel 1,6,7,9,13 5/13 
Vaknin et al. (2003) Israel 1,2,3,4,13 5/13 
Valizadeh et al. Iran 1,2,4,6,7 5/13 
(2008) 
Aldhawailie A. Saudi 1,3,7,13 4/13 
(2011) 
Magzoub et al. Saudi 1,6,7,13 4/13 
(2011) 
Irshaid et al. (2005) Saudi 1,6,7,13 4/13 
Bar-Oz et al. (2008) Israel 1,6,11,13 4/13 
Islamian et al. Iran 1,6,7,13 4/13 
(2010) 
Dibbi et al. (2006) Saudi 1,3,7 3/13 
Elnour et al. (2008) United Arab 1,7 2/13 
Emirates 
Oliven et al. (2002) Israel 6,7 2/13 
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